WO2004083406A2 - Genes that are up- or down-regulated during differentiation of human embryonic stem cells - Google Patents
Genes that are up- or down-regulated during differentiation of human embryonic stem cells Download PDFInfo
- Publication number
- WO2004083406A2 WO2004083406A2 PCT/US2004/008883 US2004008883W WO2004083406A2 WO 2004083406 A2 WO2004083406 A2 WO 2004083406A2 US 2004008883 W US2004008883 W US 2004008883W WO 2004083406 A2 WO2004083406 A2 WO 2004083406A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cells
- protein
- markers
- undifferentiated
- expression
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 310
- 230000004069 differentiation Effects 0.000 title claims abstract description 154
- 241000282414 Homo sapiens Species 0.000 title claims abstract description 64
- 230000001105 regulatory effect Effects 0.000 title claims abstract description 26
- 210000001671 embryonic stem cell Anatomy 0.000 title claims abstract description 20
- 210000004027 cell Anatomy 0.000 claims abstract description 466
- 230000014509 gene expression Effects 0.000 claims abstract description 178
- 239000003550 marker Substances 0.000 claims abstract description 55
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 14
- 201000011510 cancer Diseases 0.000 claims abstract description 13
- 238000000034 method Methods 0.000 claims description 89
- 102000004169 proteins and genes Human genes 0.000 claims description 85
- 108020004999 messenger RNA Proteins 0.000 claims description 57
- 101000595198 Homo sapiens Podocalyxin Proteins 0.000 claims description 37
- 102100036031 Podocalyxin Human genes 0.000 claims description 37
- 101000655352 Homo sapiens Telomerase reverse transcriptase Proteins 0.000 claims description 30
- 101100369076 Mus musculus Tdgf1 gene Proteins 0.000 claims description 29
- 102000005962 receptors Human genes 0.000 claims description 28
- 108020003175 receptors Proteins 0.000 claims description 28
- 102000004862 Gastrin releasing peptide Human genes 0.000 claims description 23
- 108090001053 Gastrin releasing peptide Proteins 0.000 claims description 23
- 210000001519 tissue Anatomy 0.000 claims description 20
- PUBCCFNQJQKCNC-XKNFJVFFSA-N gastrin-releasingpeptide Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C)C1=CNC=N1 PUBCCFNQJQKCNC-XKNFJVFFSA-N 0.000 claims description 18
- 108010073466 Bombesin Receptors Proteins 0.000 claims description 17
- 102000047481 Gastrin-releasing peptide receptors Human genes 0.000 claims description 17
- 108091006207 SLC-Transporter Proteins 0.000 claims description 16
- 102000037054 SLC-Transporter Human genes 0.000 claims description 16
- 210000002950 fibroblast Anatomy 0.000 claims description 16
- 230000012010 growth Effects 0.000 claims description 14
- 230000027455 binding Effects 0.000 claims description 13
- 210000002459 blastocyst Anatomy 0.000 claims description 13
- 239000000523 sample Substances 0.000 claims description 13
- 101000976645 Homo sapiens Zinc finger protein ZIC 3 Proteins 0.000 claims description 12
- 102100023495 Zinc finger protein ZIC 3 Human genes 0.000 claims description 12
- 238000003556 assay Methods 0.000 claims description 12
- 102000039446 nucleic acids Human genes 0.000 claims description 12
- 108020004707 nucleic acids Proteins 0.000 claims description 12
- 150000007523 nucleic acids Chemical class 0.000 claims description 12
- 102100041002 Forkhead box protein H1 Human genes 0.000 claims description 11
- 101000892840 Homo sapiens Forkhead box protein H1 Proteins 0.000 claims description 11
- 102100023202 Potassium channel subfamily K member 5 Human genes 0.000 claims description 11
- 238000012258 culturing Methods 0.000 claims description 11
- 102100037241 Endoglin Human genes 0.000 claims description 10
- 102000004264 Osteopontin Human genes 0.000 claims description 10
- 108010081689 Osteopontin Proteins 0.000 claims description 10
- 102100023543 Vascular cell adhesion protein 1 Human genes 0.000 claims description 10
- 101710185494 Zinc finger protein Proteins 0.000 claims description 10
- 102100023597 Zinc finger protein 816 Human genes 0.000 claims description 10
- 102100032912 CD44 antigen Human genes 0.000 claims description 9
- 102100030322 Ephrin type-A receptor 1 Human genes 0.000 claims description 9
- 101710116744 Ephrin type-A receptor 1 Proteins 0.000 claims description 9
- 101000868273 Homo sapiens CD44 antigen Proteins 0.000 claims description 9
- 101150052863 THY1 gene Proteins 0.000 claims description 9
- 102100026404 Teratocarcinoma-derived growth factor 1 Human genes 0.000 claims description 9
- 101001049829 Homo sapiens Potassium channel subfamily K member 5 Proteins 0.000 claims description 8
- 101000976643 Homo sapiens Zinc finger protein ZIC 2 Proteins 0.000 claims description 8
- -1 Oct 3/4 Proteins 0.000 claims description 8
- 238000012408 PCR amplification Methods 0.000 claims description 8
- 101710126211 POU domain, class 5, transcription factor 1 Proteins 0.000 claims description 8
- 102100035071 Vimentin Human genes 0.000 claims description 8
- 108010065472 Vimentin Proteins 0.000 claims description 8
- 239000000427 antigen Substances 0.000 claims description 8
- 108091007433 antigens Proteins 0.000 claims description 8
- 102000036639 antigens Human genes 0.000 claims description 8
- 102000040430 polynucleotide Human genes 0.000 claims description 8
- 108091033319 polynucleotide Proteins 0.000 claims description 8
- 239000002157 polynucleotide Substances 0.000 claims description 8
- 210000005048 vimentin Anatomy 0.000 claims description 8
- 239000011701 zinc Substances 0.000 claims description 8
- 229910052725 zinc Inorganic materials 0.000 claims description 8
- 102100034433 Protein kinase C-binding protein NELL2 Human genes 0.000 claims description 7
- 101710097760 Protein kinase C-binding protein NELL2 Proteins 0.000 claims description 7
- 102100023492 Zinc finger protein ZIC 2 Human genes 0.000 claims description 7
- 210000002536 stromal cell Anatomy 0.000 claims description 7
- 102100032558 Glypican-2 Human genes 0.000 claims description 6
- 101000881679 Homo sapiens Endoglin Proteins 0.000 claims description 6
- 101001014664 Homo sapiens Glypican-2 Proteins 0.000 claims description 6
- 101001094700 Homo sapiens POU domain, class 5, transcription factor 1 Proteins 0.000 claims description 6
- 101000800116 Homo sapiens Thy-1 membrane glycoprotein Proteins 0.000 claims description 6
- 101000622304 Homo sapiens Vascular cell adhesion protein 1 Proteins 0.000 claims description 6
- 102000004856 Lectins Human genes 0.000 claims description 6
- 108090001090 Lectins Proteins 0.000 claims description 6
- 101710185710 Teratocarcinoma-derived growth factor 1 Proteins 0.000 claims description 6
- 102100033523 Thy-1 membrane glycoprotein Human genes 0.000 claims description 6
- 238000004113 cell culture Methods 0.000 claims description 6
- 239000002523 lectin Substances 0.000 claims description 6
- 238000012163 sequencing technique Methods 0.000 claims description 6
- 108050004726 Armadillo repeat protein deleted in velo-cardio-facial syndrome Proteins 0.000 claims description 5
- 108010020650 COUP Transcription Factor II Proteins 0.000 claims description 5
- 108090000852 Forkhead Transcription Factors Proteins 0.000 claims description 5
- 102000004315 Forkhead Transcription Factors Human genes 0.000 claims description 5
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 5
- 241000288906 Primates Species 0.000 claims description 5
- 230000004009 axon guidance Effects 0.000 claims description 5
- 239000002243 precursor Substances 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 210000001541 thymus gland Anatomy 0.000 claims description 5
- 108010036395 Endoglin Proteins 0.000 claims description 4
- 108010063919 Glucagon Receptors Proteins 0.000 claims description 4
- 102100040890 Glucagon receptor Human genes 0.000 claims description 4
- 102100029283 Hepatocyte nuclear factor 3-alpha Human genes 0.000 claims description 4
- 101001073597 Homo sapiens Gamma-aminobutyric acid receptor subunit beta-3 Proteins 0.000 claims description 4
- 101001062353 Homo sapiens Hepatocyte nuclear factor 3-alpha Proteins 0.000 claims description 4
- 101001065554 Homo sapiens Lymphocyte antigen 6H Proteins 0.000 claims description 4
- 101001067168 Homo sapiens Plexin-B3 Proteins 0.000 claims description 4
- 102100032128 Lymphocyte antigen 6H Human genes 0.000 claims description 4
- 102100034390 Plexin-B3 Human genes 0.000 claims description 4
- 108700008625 Reporter Genes Proteins 0.000 claims description 4
- 102100037205 Sal-like protein 2 Human genes 0.000 claims description 4
- 108010000134 Vascular Cell Adhesion Molecule-1 Proteins 0.000 claims description 4
- 230000006907 apoptotic process Effects 0.000 claims description 4
- 210000001638 cerebellum Anatomy 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 4
- 239000001963 growth medium Substances 0.000 claims description 4
- 206010059866 Drug resistance Diseases 0.000 claims description 3
- 101000967920 Homo sapiens Left-right determination factor 1 Proteins 0.000 claims description 3
- 101000802413 Homo sapiens Zinc finger protein 770 Proteins 0.000 claims description 3
- 102100040508 Left-right determination factor 1 Human genes 0.000 claims description 3
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 3
- 101000967917 Mus musculus Left-right determination factor 2 Proteins 0.000 claims description 3
- 101710185490 Potassium channel subfamily K member 5 Proteins 0.000 claims description 3
- 102100034984 Zinc finger protein 770 Human genes 0.000 claims description 3
- 230000002159 abnormal effect Effects 0.000 claims description 3
- 230000000692 anti-sense effect Effects 0.000 claims description 3
- 230000010261 cell growth Effects 0.000 claims description 3
- 239000002771 cell marker Substances 0.000 claims description 3
- 231100000518 lethal Toxicity 0.000 claims description 3
- 230000001665 lethal effect Effects 0.000 claims description 3
- 210000002901 mesenchymal stem cell Anatomy 0.000 claims description 3
- 229940002612 prodrug Drugs 0.000 claims description 3
- 239000000651 prodrug Substances 0.000 claims description 3
- 108010006533 ATP-Binding Cassette Transporters Proteins 0.000 claims description 2
- 102000005416 ATP-Binding Cassette Transporters Human genes 0.000 claims description 2
- 102100035930 Gamma-aminobutyric acid receptor subunit beta-3 Human genes 0.000 claims description 2
- 102100031547 HLA class II histocompatibility antigen, DO alpha chain Human genes 0.000 claims description 2
- 101000866278 Homo sapiens HLA class II histocompatibility antigen, DO alpha chain Proteins 0.000 claims description 2
- 102000001759 Notch1 Receptor Human genes 0.000 claims description 2
- 108010029755 Notch1 Receptor Proteins 0.000 claims description 2
- 210000001185 bone marrow Anatomy 0.000 claims description 2
- 108050009312 plexin Proteins 0.000 claims description 2
- 102000002022 plexin Human genes 0.000 claims description 2
- 102000008523 COUP Transcription Factor II Human genes 0.000 claims 2
- 230000000779 depleting effect Effects 0.000 claims 2
- 102100031464 Armadillo repeat protein deleted in velo-cardio-facial syndrome Human genes 0.000 claims 1
- 102000007350 Bone Morphogenetic Proteins Human genes 0.000 claims 1
- 108010007726 Bone Morphogenetic Proteins Proteins 0.000 claims 1
- 229940112869 bone morphogenetic protein Drugs 0.000 claims 1
- 230000036210 malignancy Effects 0.000 claims 1
- 210000001778 pluripotent stem cell Anatomy 0.000 abstract description 10
- 238000002560 therapeutic procedure Methods 0.000 abstract description 3
- 238000007619 statistical method Methods 0.000 abstract description 2
- 235000018102 proteins Nutrition 0.000 description 82
- 239000002299 complementary DNA Substances 0.000 description 35
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 28
- 108091060211 Expressed sequence tag Proteins 0.000 description 28
- 239000000047 product Substances 0.000 description 27
- 239000002609 medium Substances 0.000 description 24
- 210000000130 stem cell Anatomy 0.000 description 20
- 238000013518 transcription Methods 0.000 description 16
- 230000035897 transcription Effects 0.000 description 16
- 108010058682 Mitochondrial Proteins Proteins 0.000 description 15
- 102000006404 Mitochondrial Proteins Human genes 0.000 description 15
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 15
- 108090000765 processed proteins & peptides Proteins 0.000 description 15
- 229930002330 retinoic acid Natural products 0.000 description 15
- 229960001727 tretinoin Drugs 0.000 description 15
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 14
- 241000699666 Mus <mouse, genus> Species 0.000 description 14
- 102000004196 processed proteins & peptides Human genes 0.000 description 14
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 description 13
- 238000004458 analytical method Methods 0.000 description 13
- 210000002242 embryoid body Anatomy 0.000 description 13
- 238000002474 experimental method Methods 0.000 description 13
- 102100035423 POU domain, class 5, transcription factor 1 Human genes 0.000 description 12
- 108090000708 Proteasome Endopeptidase Complex Proteins 0.000 description 12
- 102000004245 Proteasome Endopeptidase Complex Human genes 0.000 description 12
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 12
- 229920001184 polypeptide Polymers 0.000 description 12
- 230000008859 change Effects 0.000 description 11
- 238000003753 real-time PCR Methods 0.000 description 10
- 102100023086 Anosmin-1 Human genes 0.000 description 9
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 9
- 101001050039 Homo sapiens Anosmin-1 Proteins 0.000 description 9
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 9
- 230000007423 decrease Effects 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 230000037361 pathway Effects 0.000 description 9
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 8
- 108010078791 Carrier Proteins Proteins 0.000 description 8
- 238000010208 microarray analysis Methods 0.000 description 8
- 239000013598 vector Substances 0.000 description 8
- 108050009437 Left-Right Determination Factor Proteins 0.000 description 7
- 102000002092 Left-Right Determination Factor Human genes 0.000 description 7
- 102000040945 Transcription factor Human genes 0.000 description 7
- 108091023040 Transcription factor Proteins 0.000 description 7
- 230000003321 amplification Effects 0.000 description 7
- 238000012512 characterization method Methods 0.000 description 7
- 238000003199 nucleic acid amplification method Methods 0.000 description 7
- 230000035945 sensitivity Effects 0.000 description 7
- 238000010186 staining Methods 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 6
- 108010051118 Bone Marrow Stromal Antigen 2 Proteins 0.000 description 6
- 102100037086 Bone marrow stromal antigen 2 Human genes 0.000 description 6
- 108020004414 DNA Proteins 0.000 description 6
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 6
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 102100027842 Fibroblast growth factor receptor 3 Human genes 0.000 description 6
- 101710182396 Fibroblast growth factor receptor 3 Proteins 0.000 description 6
- 102000010956 Glypican Human genes 0.000 description 6
- 108050001154 Glypican Proteins 0.000 description 6
- 101001123298 Homo sapiens PR domain zinc finger protein 14 Proteins 0.000 description 6
- 101001071145 Homo sapiens Polyhomeotic-like protein 1 Proteins 0.000 description 6
- 108010068425 Octamer Transcription Factor-3 Proteins 0.000 description 6
- 102100028974 PR domain zinc finger protein 14 Human genes 0.000 description 6
- 102100033222 Polyhomeotic-like protein 1 Human genes 0.000 description 6
- 102000013529 alpha-Fetoproteins Human genes 0.000 description 6
- 108010026331 alpha-Fetoproteins Proteins 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 210000000349 chromosome Anatomy 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 229940088598 enzyme Drugs 0.000 description 6
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 6
- 230000002438 mitochondrial effect Effects 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 230000035755 proliferation Effects 0.000 description 6
- 230000019491 signal transduction Effects 0.000 description 6
- 230000014616 translation Effects 0.000 description 6
- 102100025423 Bone morphogenetic protein receptor type-1A Human genes 0.000 description 5
- 102100028226 COUP transcription factor 2 Human genes 0.000 description 5
- 238000000729 Fisher's exact test Methods 0.000 description 5
- 108050007237 Glypican-3 Proteins 0.000 description 5
- 101000740205 Homo sapiens Sal-like protein 1 Proteins 0.000 description 5
- 102100033420 Keratin, type I cytoskeletal 19 Human genes 0.000 description 5
- 108010066302 Keratin-19 Proteins 0.000 description 5
- 102100040756 Rhodopsin Human genes 0.000 description 5
- 102100037204 Sal-like protein 1 Human genes 0.000 description 5
- 108010017842 Telomerase Proteins 0.000 description 5
- 102100032938 Telomerase reverse transcriptase Human genes 0.000 description 5
- 229940024606 amino acid Drugs 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 230000001143 conditioned effect Effects 0.000 description 5
- 230000000875 corresponding effect Effects 0.000 description 5
- 230000001419 dependent effect Effects 0.000 description 5
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 5
- 210000002257 embryonic structure Anatomy 0.000 description 5
- 239000012091 fetal bovine serum Substances 0.000 description 5
- 238000003365 immunocytochemistry Methods 0.000 description 5
- 238000012423 maintenance Methods 0.000 description 5
- 238000002493 microarray Methods 0.000 description 5
- 230000000877 morphologic effect Effects 0.000 description 5
- 239000002773 nucleotide Substances 0.000 description 5
- 125000003729 nucleotide group Chemical group 0.000 description 5
- 239000002953 phosphate buffered saline Substances 0.000 description 5
- 230000002441 reversible effect Effects 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000013519 translation Methods 0.000 description 5
- 108091006112 ATPases Proteins 0.000 description 4
- 102000057290 Adenosine Triphosphatases Human genes 0.000 description 4
- 102000016217 Armadillo repeat protein deleted in velo-cardio-facial syndrome Human genes 0.000 description 4
- 102100024348 Beta-adducin Human genes 0.000 description 4
- 102100026189 Beta-galactosidase Human genes 0.000 description 4
- 108010040422 Bone Morphogenetic Protein Receptors Proteins 0.000 description 4
- 102000001893 Bone Morphogenetic Protein Receptors Human genes 0.000 description 4
- 102100029136 Collagen alpha-1(II) chain Human genes 0.000 description 4
- 102000029816 Collagenase Human genes 0.000 description 4
- 108060005980 Collagenase Proteins 0.000 description 4
- 102100034976 Cystathionine beta-synthase Human genes 0.000 description 4
- 108010073644 Cystathionine beta-synthase Proteins 0.000 description 4
- 102100024810 DNA (cytosine-5)-methyltransferase 3B Human genes 0.000 description 4
- 102100031387 Fibrillin-3 Human genes 0.000 description 4
- 102100023593 Fibroblast growth factor receptor 1 Human genes 0.000 description 4
- 101710182386 Fibroblast growth factor receptor 1 Proteins 0.000 description 4
- 102100023600 Fibroblast growth factor receptor 2 Human genes 0.000 description 4
- 101000689619 Homo sapiens Beta-adducin Proteins 0.000 description 4
- 101000765010 Homo sapiens Beta-galactosidase Proteins 0.000 description 4
- 101000771163 Homo sapiens Collagen alpha-1(II) chain Proteins 0.000 description 4
- 101001018431 Homo sapiens DNA replication licensing factor MCM7 Proteins 0.000 description 4
- 101001033293 Homo sapiens Interleukin enhancer-binding factor 3 Proteins 0.000 description 4
- 101000634835 Homo sapiens M1-specific T cell receptor alpha chain Proteins 0.000 description 4
- 101000896657 Homo sapiens Mitotic checkpoint serine/threonine-protein kinase BUB1 Proteins 0.000 description 4
- 101000992387 Homo sapiens Oxysterol-binding protein-related protein 9 Proteins 0.000 description 4
- 101000634836 Homo sapiens T cell receptor alpha chain MC.7.G5 Proteins 0.000 description 4
- 101000835745 Homo sapiens Teratocarcinoma-derived growth factor 1 Proteins 0.000 description 4
- 102100037877 Intercellular adhesion molecule 1 Human genes 0.000 description 4
- 102100039062 Interleukin enhancer-binding factor 3 Human genes 0.000 description 4
- 102100021691 Mitotic checkpoint serine/threonine-protein kinase BUB1 Human genes 0.000 description 4
- 108700020796 Oncogene Proteins 0.000 description 4
- 102100032162 Oxysterol-binding protein-related protein 9 Human genes 0.000 description 4
- 102100022239 Peroxiredoxin-6 Human genes 0.000 description 4
- 102100023211 Polypeptide N-acetylgalactosaminyltransferase 12 Human genes 0.000 description 4
- 102100022033 Presenilin-1 Human genes 0.000 description 4
- 102100036221 Tax1-binding protein 3 Human genes 0.000 description 4
- 101710193790 Tax1-binding protein 3 Proteins 0.000 description 4
- 102100040537 Threonine-tRNA ligase 1, cytoplasmic Human genes 0.000 description 4
- 102100022012 Transcription intermediary factor 1-beta Human genes 0.000 description 4
- 230000004075 alteration Effects 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 230000033228 biological regulation Effects 0.000 description 4
- 230000008614 cellular interaction Effects 0.000 description 4
- 229960002424 collagenase Drugs 0.000 description 4
- 239000003636 conditioned culture medium Substances 0.000 description 4
- 230000002596 correlated effect Effects 0.000 description 4
- 230000002950 deficient Effects 0.000 description 4
- 210000003494 hepatocyte Anatomy 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- 210000001161 mammalian embryo Anatomy 0.000 description 4
- 230000036961 partial effect Effects 0.000 description 4
- 238000007747 plating Methods 0.000 description 4
- 230000000644 propagated effect Effects 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 230000003612 virological effect Effects 0.000 description 4
- NCYCYZXNIZJOKI-IOUUIBBYSA-N 11-cis-retinal Chemical compound O=C/C=C(\C)/C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-IOUUIBBYSA-N 0.000 description 3
- 102100021546 60S ribosomal protein L10 Human genes 0.000 description 3
- 201000010028 Acrocephalosyndactylia Diseases 0.000 description 3
- 102000004373 Actin-related protein 2 Human genes 0.000 description 3
- 108090000963 Actin-related protein 2 Proteins 0.000 description 3
- 108090000104 Actin-related protein 3 Proteins 0.000 description 3
- 102000016904 Armadillo Domain Proteins Human genes 0.000 description 3
- 108010014223 Armadillo Domain Proteins Proteins 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- 108010077544 Chromatin Proteins 0.000 description 3
- 102100034528 Core histone macro-H2A.1 Human genes 0.000 description 3
- 101710184999 Core histone macro-H2A.1 Proteins 0.000 description 3
- 102100030960 DNA replication licensing factor MCM2 Human genes 0.000 description 3
- 108010031042 Death-Associated Protein Kinases Proteins 0.000 description 3
- 108010089760 Electron Transport Complex I Proteins 0.000 description 3
- 102000008013 Electron Transport Complex I Human genes 0.000 description 3
- 102100030801 Elongation factor 1-alpha 1 Human genes 0.000 description 3
- 201000009051 Embryonal Carcinoma Diseases 0.000 description 3
- 102100031780 Endonuclease Human genes 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 101710175017 Fibrillin-3 Proteins 0.000 description 3
- 102100021736 Galectin-1 Human genes 0.000 description 3
- 102100035042 Histone-lysine N-methyltransferase EHMT2 Human genes 0.000 description 3
- 101000934638 Homo sapiens Bone morphogenetic protein receptor type-1A Proteins 0.000 description 3
- 101000583807 Homo sapiens DNA replication licensing factor MCM2 Proteins 0.000 description 3
- 101000920078 Homo sapiens Elongation factor 1-alpha 1 Proteins 0.000 description 3
- 101000998969 Homo sapiens Inositol-3-phosphate synthase 1 Proteins 0.000 description 3
- 101000599852 Homo sapiens Intercellular adhesion molecule 1 Proteins 0.000 description 3
- 101001039696 Homo sapiens Lysophospholipid acyltransferase 7 Proteins 0.000 description 3
- 101000957434 Homo sapiens Mitochondrial basic amino acids transporter Proteins 0.000 description 3
- 101000982010 Homo sapiens Myelin proteolipid protein Proteins 0.000 description 3
- 101001096178 Homo sapiens Pleckstrin homology domain-containing family A member 5 Proteins 0.000 description 3
- 101001125496 Homo sapiens Pre-mRNA-processing factor 19 Proteins 0.000 description 3
- 101000617536 Homo sapiens Presenilin-1 Proteins 0.000 description 3
- 101000666607 Homo sapiens Rho-related BTB domain-containing protein 3 Proteins 0.000 description 3
- 101000611338 Homo sapiens Rhodopsin Proteins 0.000 description 3
- 101000753286 Homo sapiens Transcription intermediary factor 1-beta Proteins 0.000 description 3
- 102100036881 Inositol-3-phosphate synthase 1 Human genes 0.000 description 3
- 102100025947 Insulin-like growth factor II Human genes 0.000 description 3
- 108090000965 Insulin-like growth factor binding protein 3 Proteins 0.000 description 3
- 102100022708 Insulin-like growth factor-binding protein 3 Human genes 0.000 description 3
- 102100023972 Keratin, type II cytoskeletal 8 Human genes 0.000 description 3
- 108010070511 Keratin-8 Proteins 0.000 description 3
- 102100040589 Leucine-rich PPR motif-containing protein, mitochondrial Human genes 0.000 description 3
- 102100040986 Lysophospholipid acyltransferase 7 Human genes 0.000 description 3
- 108010052285 Membrane Proteins Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 102100038735 Mitochondrial basic amino acids transporter Human genes 0.000 description 3
- 102100026784 Myelin proteolipid protein Human genes 0.000 description 3
- 102100023181 Neurogenic locus notch homolog protein 1 Human genes 0.000 description 3
- 108700037638 Neurogenic locus notch homolog protein 1 Proteins 0.000 description 3
- 102000002584 Octamer Transcription Factor-3 Human genes 0.000 description 3
- 102100040283 Peptidyl-prolyl cis-trans isomerase B Human genes 0.000 description 3
- 201000004014 Pfeiffer syndrome Diseases 0.000 description 3
- 102100037866 Pleckstrin homology domain-containing family A member 5 Human genes 0.000 description 3
- 102000002727 Protein Tyrosine Phosphatase Human genes 0.000 description 3
- 102100038342 Rho-related BTB domain-containing protein 3 Human genes 0.000 description 3
- 108090000820 Rhodopsin Proteins 0.000 description 3
- 102100037219 Syntenin-1 Human genes 0.000 description 3
- 108090000631 Trypsin Proteins 0.000 description 3
- 102000004142 Trypsin Human genes 0.000 description 3
- 102100031929 UDP-N-acetylglucosamine-peptide N-acetylglucosaminyltransferase 110 kDa subunit Human genes 0.000 description 3
- 102100037820 Voltage-dependent anion-selective channel protein 1 Human genes 0.000 description 3
- 102100024661 Zinc finger protein 331 Human genes 0.000 description 3
- 238000000429 assembly Methods 0.000 description 3
- 230000000712 assembly Effects 0.000 description 3
- 150000001556 benzimidazoles Chemical class 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000034303 cell budding Effects 0.000 description 3
- 230000024245 cell differentiation Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 210000003483 chromatin Anatomy 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 238000012136 culture method Methods 0.000 description 3
- 108091092330 cytoplasmic RNA Proteins 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 230000003828 downregulation Effects 0.000 description 3
- 238000007877 drug screening Methods 0.000 description 3
- 230000013020 embryo development Effects 0.000 description 3
- 238000000684 flow cytometry Methods 0.000 description 3
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 210000004602 germ cell Anatomy 0.000 description 3
- 239000005090 green fluorescent protein Substances 0.000 description 3
- 238000003018 immunoassay Methods 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 230000003834 intracellular effect Effects 0.000 description 3
- 239000003446 ligand Substances 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 230000001537 neural effect Effects 0.000 description 3
- 210000002569 neuron Anatomy 0.000 description 3
- 239000013612 plasmid Substances 0.000 description 3
- 108020000494 protein-tyrosine phosphatase Proteins 0.000 description 3
- 238000003908 quality control method Methods 0.000 description 3
- 230000001172 regenerating effect Effects 0.000 description 3
- 230000000717 retained effect Effects 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 102000035160 transmembrane proteins Human genes 0.000 description 3
- 108091005703 transmembrane proteins Proteins 0.000 description 3
- 239000012588 trypsin Substances 0.000 description 3
- 241001430294 unidentified retrovirus Species 0.000 description 3
- 102100026205 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 Human genes 0.000 description 2
- 102100027833 14-3-3 protein sigma Human genes 0.000 description 2
- 108050008974 14-3-3 protein sigma Proteins 0.000 description 2
- YHPKGSLWSUCJQK-UHFFFAOYSA-N 2-[[2-[[2-[[2-[[2-[[2-[[5-amino-2-[[2-[(2,4-diamino-4-oxobutanoyl)amino]-4-methylpentanoyl]amino]-5-oxopentanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-4-methylsulfanylbutanoyl]amino]-3-carboxypropanoyl]amino]-5-(diaminomethylideneamino) Chemical compound NC(N)=NCCCC(C(=O)NC(C(C)C)C(O)=O)NC(=O)C(CC(O)=O)NC(=O)C(CCSC)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(N)CC(N)=O YHPKGSLWSUCJQK-UHFFFAOYSA-N 0.000 description 2
- 102100033828 26S proteasome regulatory subunit 10B Human genes 0.000 description 2
- 102100021565 28S rRNA (cytosine-C(5))-methyltransferase Human genes 0.000 description 2
- 102100028830 28S ribosomal protein S25, mitochondrial Human genes 0.000 description 2
- 102100031765 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase Human genes 0.000 description 2
- 102100026163 39S ribosomal protein L12, mitochondrial Human genes 0.000 description 2
- 102100027559 39S ribosomal protein L16, mitochondrial Human genes 0.000 description 2
- 102100034488 39S ribosomal protein S18a, mitochondrial Human genes 0.000 description 2
- 102100024113 40S ribosomal protein S15a Human genes 0.000 description 2
- 102100038686 5'-nucleotidase domain-containing protein 2 Human genes 0.000 description 2
- BZTDTCNHAFUJOG-UHFFFAOYSA-N 6-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C11OC(=O)C2=CC=C(C(=O)O)C=C21 BZTDTCNHAFUJOG-UHFFFAOYSA-N 0.000 description 2
- 102100037965 60S ribosomal protein L21 Human genes 0.000 description 2
- 102100040768 60S ribosomal protein L32 Human genes 0.000 description 2
- 102100030982 60S ribosomal protein L38 Human genes 0.000 description 2
- 102100040623 60S ribosomal protein L41 Human genes 0.000 description 2
- 102000009062 ADP Ribose Transferases Human genes 0.000 description 2
- 108010049290 ADP Ribose Transferases Proteins 0.000 description 2
- 102100023818 ADP-ribosylation factor 3 Human genes 0.000 description 2
- 101710139744 ADP-ribosylation factor 3 Proteins 0.000 description 2
- 102100027447 ATP-dependent DNA helicase Q1 Human genes 0.000 description 2
- 102100035720 ATP-dependent RNA helicase DDX42 Human genes 0.000 description 2
- 102100023388 ATP-dependent RNA helicase DHX15 Human genes 0.000 description 2
- 102100022413 ATP-dependent RNA helicase DHX30 Human genes 0.000 description 2
- 101710159080 Aconitate hydratase A Proteins 0.000 description 2
- 101710159078 Aconitate hydratase B Proteins 0.000 description 2
- 102000003741 Actin-related protein 3 Human genes 0.000 description 2
- 102100034111 Activin receptor type-1 Human genes 0.000 description 2
- 102100022385 Activity-dependent neuroprotector homeobox protein Human genes 0.000 description 2
- 102100022089 Acyl-[acyl-carrier-protein] hydrolase Human genes 0.000 description 2
- 102100025976 Adenosine deaminase 2 Human genes 0.000 description 2
- 108090000115 Adenylate kinase 2 Proteins 0.000 description 2
- 102000003829 Adenylate kinase 2 Human genes 0.000 description 2
- 102100040439 Adenylate kinase 4, mitochondrial Human genes 0.000 description 2
- 102100039736 Adhesion G protein-coupled receptor L1 Human genes 0.000 description 2
- 108010058060 Alanine-tRNA ligase Proteins 0.000 description 2
- 102100037399 Alanine-tRNA ligase, cytoplasmic Human genes 0.000 description 2
- 102100025683 Alkaline phosphatase, tissue-nonspecific isozyme Human genes 0.000 description 2
- 101710161969 Alkaline phosphatase, tissue-nonspecific isozyme Proteins 0.000 description 2
- 102100032956 Alpha-actinin-3 Human genes 0.000 description 2
- 102100040410 Alpha-methylacyl-CoA racemase Human genes 0.000 description 2
- 108010044434 Alpha-methylacyl-CoA racemase Proteins 0.000 description 2
- 101710191958 Amino-acid acetyltransferase Proteins 0.000 description 2
- 102000052584 Anaphase-Promoting Complex-Cyclosome Apc7 Subunit Human genes 0.000 description 2
- 102100036818 Ankyrin-2 Human genes 0.000 description 2
- 102000004120 Annexin A3 Human genes 0.000 description 2
- 108090000670 Annexin A3 Proteins 0.000 description 2
- 102000004121 Annexin A5 Human genes 0.000 description 2
- 108090000672 Annexin A5 Proteins 0.000 description 2
- 102100021325 Antizyme inhibitor 1 Human genes 0.000 description 2
- 102100034150 Apoptosis-enhancing nuclease Human genes 0.000 description 2
- 102000009042 Argininosuccinate Lyase Human genes 0.000 description 2
- 102100039995 Arginyl-tRNA-protein transferase 1 Human genes 0.000 description 2
- 101710201319 Arginyl-tRNA-protein transferase 1 Proteins 0.000 description 2
- 102100034224 Armadillo repeat-containing X-linked protein 2 Human genes 0.000 description 2
- 102100023927 Asparagine synthetase [glutamine-hydrolyzing] Human genes 0.000 description 2
- 108010070255 Aspartate-ammonia ligase Proteins 0.000 description 2
- 102100035553 Autism susceptibility gene 2 protein Human genes 0.000 description 2
- 101710180107 Autism susceptibility gene 2 protein Proteins 0.000 description 2
- 241000271566 Aves Species 0.000 description 2
- 102100024273 BTB/POZ domain-containing protein 3 Human genes 0.000 description 2
- 102100020857 Beta-1,3-glucuronyltransferase LARGE2 Human genes 0.000 description 2
- 108010049955 Bone Morphogenetic Protein 4 Proteins 0.000 description 2
- 102100024505 Bone morphogenetic protein 4 Human genes 0.000 description 2
- 101710120270 Bone morphogenetic protein receptor type-1A Proteins 0.000 description 2
- 101710186200 CCAAT/enhancer-binding protein Proteins 0.000 description 2
- 101710104127 CCAAT/enhancer-binding protein zeta Proteins 0.000 description 2
- 102100031168 CCN family member 2 Human genes 0.000 description 2
- 102100031033 CCR4-NOT transcription complex subunit 3 Human genes 0.000 description 2
- 102100037904 CD9 antigen Human genes 0.000 description 2
- 102100038451 CDK5 regulatory subunit-associated protein 2 Human genes 0.000 description 2
- 102100028372 COP9 signalosome complex subunit 6 Human genes 0.000 description 2
- 101150099461 CTL2 gene Proteins 0.000 description 2
- 102100025589 CaM kinase-like vesicle-associated protein Human genes 0.000 description 2
- 101710111871 Calcineurin-binding protein 1 Proteins 0.000 description 2
- 102100024123 Calcineurin-binding protein cabin-1 Human genes 0.000 description 2
- 102100029303 Calcium-regulated heat-stable protein 1 Human genes 0.000 description 2
- 102100025579 Calmodulin-2 Human genes 0.000 description 2
- 102100032581 Caprin-2 Human genes 0.000 description 2
- 102100033029 Carbonic anhydrase-related protein 11 Human genes 0.000 description 2
- 102100032378 Carboxypeptidase E Human genes 0.000 description 2
- 108010058255 Carboxypeptidase H Proteins 0.000 description 2
- 102000014914 Carrier Proteins Human genes 0.000 description 2
- ZEOWTGPWHLSLOG-UHFFFAOYSA-N Cc1ccc(cc1-c1ccc2c(n[nH]c2c1)-c1cnn(c1)C1CC1)C(=O)Nc1cccc(c1)C(F)(F)F Chemical compound Cc1ccc(cc1-c1ccc2c(n[nH]c2c1)-c1cnn(c1)C1CC1)C(=O)Nc1cccc(c1)C(F)(F)F ZEOWTGPWHLSLOG-UHFFFAOYSA-N 0.000 description 2
- 102000038594 Cdh1/Fizzy-related Human genes 0.000 description 2
- 108091007854 Cdh1/Fizzy-related Proteins 0.000 description 2
- 102100037622 Centromere protein T Human genes 0.000 description 2
- 102100034755 Centrosomal protein of 85 kDa Human genes 0.000 description 2
- 102100031668 Chromodomain Y-like protein Human genes 0.000 description 2
- 102100034665 Clathrin heavy chain 2 Human genes 0.000 description 2
- 102100038447 Claudin-4 Human genes 0.000 description 2
- 108090000601 Claudin-4 Proteins 0.000 description 2
- 102100031048 Coiled-coil domain-containing protein 6 Human genes 0.000 description 2
- 206010009944 Colon cancer Diseases 0.000 description 2
- 102100032951 Condensin complex subunit 2 Human genes 0.000 description 2
- 108010039419 Connective Tissue Growth Factor Proteins 0.000 description 2
- 102100031725 Cortactin-binding protein 2 Human genes 0.000 description 2
- 101710113312 Cortactin-binding protein 2 Proteins 0.000 description 2
- 102100035373 Cyclin-D-binding Myb-like transcription factor 1 Human genes 0.000 description 2
- 102100023263 Cyclin-dependent kinase 10 Human genes 0.000 description 2
- 102100033245 Cyclin-dependent kinase 16 Human genes 0.000 description 2
- 102100026515 Cytochrome P450 2S1 Human genes 0.000 description 2
- 102100039455 Cytochrome b-c1 complex subunit 6, mitochondrial Human genes 0.000 description 2
- 102100027896 Cytochrome b-c1 complex subunit 7 Human genes 0.000 description 2
- 102400000011 Cytochrome b-c1 complex subunit 9 Human genes 0.000 description 2
- 101800000778 Cytochrome b-c1 complex subunit 9 Proteins 0.000 description 2
- 102100028992 Cytochrome c oxidase subunit 6A1, mitochondrial Human genes 0.000 description 2
- 102100037073 Cytoplasmic dynein 1 light intermediate chain 2 Human genes 0.000 description 2
- 102100024812 DNA (cytosine-5)-methyltransferase 3A Human genes 0.000 description 2
- 101710123222 DNA (cytosine-5)-methyltransferase 3B Proteins 0.000 description 2
- 102100021122 DNA damage-binding protein 2 Human genes 0.000 description 2
- 102100029995 DNA ligase 1 Human genes 0.000 description 2
- 238000000018 DNA microarray Methods 0.000 description 2
- 102100034157 DNA mismatch repair protein Msh2 Human genes 0.000 description 2
- 102100040795 DNA primase large subunit Human genes 0.000 description 2
- 102100039606 DNA replication licensing factor MCM3 Human genes 0.000 description 2
- 102100033720 DNA replication licensing factor MCM6 Human genes 0.000 description 2
- 102100033711 DNA replication licensing factor MCM7 Human genes 0.000 description 2
- 102100037373 DNA-(apurinic or apyrimidinic site) endonuclease Human genes 0.000 description 2
- 241000289632 Dasypodidae Species 0.000 description 2
- 102100038587 Death-associated protein kinase 1 Human genes 0.000 description 2
- 102100038606 Death-associated protein kinase 3 Human genes 0.000 description 2
- 102100032501 Death-inducer obliterator 1 Human genes 0.000 description 2
- 102100038199 Desmoplakin Human genes 0.000 description 2
- 102100037126 Developmental pluripotency-associated protein 4 Human genes 0.000 description 2
- 102100034581 Dihydroorotase Human genes 0.000 description 2
- 102100022188 Dihydropyrimidinase-related protein 1 Human genes 0.000 description 2
- 102100024425 Dihydropyrimidinase-related protein 3 Human genes 0.000 description 2
- 102100024361 Disintegrin and metalloproteinase domain-containing protein 9 Human genes 0.000 description 2
- 102100029701 DnaJ homolog subfamily B member 5 Human genes 0.000 description 2
- 102100023283 DnaJ homolog subfamily C member 11 Human genes 0.000 description 2
- 102100030987 E3 SUMO-protein ligase PIAS4 Human genes 0.000 description 2
- 102100034546 E3 ubiquitin-protein ligase FANCL Human genes 0.000 description 2
- 102100022822 E3 ubiquitin-protein ligase RFWD3 Human genes 0.000 description 2
- 102100040341 E3 ubiquitin-protein ligase UBR5 Human genes 0.000 description 2
- 102000017914 EDNRA Human genes 0.000 description 2
- 102100032038 EH domain-containing protein 3 Human genes 0.000 description 2
- 102100039578 ETS translocation variant 4 Human genes 0.000 description 2
- 102100039249 Elongation of very long chain fatty acids protein 6 Human genes 0.000 description 2
- 108050007786 Elongation of very long chain fatty acids protein 6 Proteins 0.000 description 2
- 102100039328 Endoplasmin Human genes 0.000 description 2
- 102100036823 Erlin-2 Human genes 0.000 description 2
- 108700039887 Essential Genes Proteins 0.000 description 2
- 101150057924 Exoc2 gene Proteins 0.000 description 2
- 102100029091 Exportin-2 Human genes 0.000 description 2
- 102100029186 F-box only protein 9 Human genes 0.000 description 2
- 101710199745 F-box only protein 9 Proteins 0.000 description 2
- 102100025637 FACT complex subunit SPT16 Human genes 0.000 description 2
- 102100036118 Far upstream element-binding protein 1 Human genes 0.000 description 2
- 108010039731 Fatty Acid Synthases Proteins 0.000 description 2
- 102100022366 Fatty acyl-CoA reductase 1 Human genes 0.000 description 2
- 101710182389 Fibroblast growth factor receptor 2 Proteins 0.000 description 2
- 102100023599 Fibroblast growth factor-binding protein 3 Human genes 0.000 description 2
- 102100037362 Fibronectin Human genes 0.000 description 2
- 102000003983 Flavoproteins Human genes 0.000 description 2
- 108010057573 Flavoproteins Proteins 0.000 description 2
- 102100020715 Fms-related tyrosine kinase 3 ligand protein Human genes 0.000 description 2
- 101710162577 Fms-related tyrosine kinase 3 ligand protein Proteins 0.000 description 2
- 102100035427 Forkhead box protein O1 Human genes 0.000 description 2
- 102000007338 Fragile X Mental Retardation Protein Human genes 0.000 description 2
- 108010032606 Fragile X Mental Retardation Protein Proteins 0.000 description 2
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 2
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 2
- 102000017707 GABRB3 Human genes 0.000 description 2
- 102100040178 GRB10-interacting GYF protein 1 Human genes 0.000 description 2
- 102000030782 GTP binding Human genes 0.000 description 2
- 108091000058 GTP-Binding Proteins 0.000 description 2
- 102100023448 GTP-binding protein 1 Human genes 0.000 description 2
- 101710102121 GTP-binding protein 1 Proteins 0.000 description 2
- 102100027988 GTP-binding protein Rhes Human genes 0.000 description 2
- 108010001498 Galectin 1 Proteins 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 102100039611 Glutamine synthetase Human genes 0.000 description 2
- 108010036164 Glutathione synthase Proteins 0.000 description 2
- 102100034294 Glutathione synthetase Human genes 0.000 description 2
- 102100033294 Glycerophosphodiester phosphodiesterase 1 Human genes 0.000 description 2
- 101710201236 Glycerophosphodiester phosphodiesterase 1 Proteins 0.000 description 2
- 102100040094 Glycogen phosphorylase, brain form Human genes 0.000 description 2
- 101710096194 Glycogen phosphorylase, brain form Proteins 0.000 description 2
- 102100025303 Glycogenin-2 Human genes 0.000 description 2
- 101710152102 Glycogenin-2 Proteins 0.000 description 2
- 108700023372 Glycosyltransferases Proteins 0.000 description 2
- 102100030648 Glyoxylate reductase/hydroxypyruvate reductase Human genes 0.000 description 2
- 102100021181 Golgi phosphoprotein 3 Human genes 0.000 description 2
- 102100032610 Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas Human genes 0.000 description 2
- 101710110781 Guanylate-binding protein 1 Proteins 0.000 description 2
- 102100039336 HAUS augmin-like complex subunit 4 Human genes 0.000 description 2
- 102100027421 Heat shock cognate 71 kDa protein Human genes 0.000 description 2
- 102000003693 Hedgehog Proteins Human genes 0.000 description 2
- 108090000031 Hedgehog Proteins Proteins 0.000 description 2
- 102100029977 Helicase SKI2W Human genes 0.000 description 2
- 108010087745 Hepatocyte Nuclear Factor 3-beta Proteins 0.000 description 2
- 102100029284 Hepatocyte nuclear factor 3-beta Human genes 0.000 description 2
- 201000005406 Hermansky-Pudlak syndrome 3 Diseases 0.000 description 2
- 102100028716 Hermansky-Pudlak syndrome 3 protein Human genes 0.000 description 2
- 102100028818 Heterogeneous nuclear ribonucleoprotein L Human genes 0.000 description 2
- 102100033998 Heterogeneous nuclear ribonucleoprotein U-like protein 1 Human genes 0.000 description 2
- 108010084674 Heterogeneous-Nuclear Ribonucleoprotein L Proteins 0.000 description 2
- 102100037907 High mobility group protein B1 Human genes 0.000 description 2
- 102100022901 Histone acetyltransferase KAT2A Human genes 0.000 description 2
- 102100027788 Histone-lysine N-methyltransferase KMT5C Human genes 0.000 description 2
- 108700005087 Homeobox Genes Proteins 0.000 description 2
- 102100020759 Homeobox protein Hox-C4 Human genes 0.000 description 2
- 101000691599 Homo sapiens 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 Proteins 0.000 description 2
- 101001069718 Homo sapiens 26S proteasome regulatory subunit 10B Proteins 0.000 description 2
- 101001108583 Homo sapiens 28S rRNA (cytosine-C(5))-methyltransferase Proteins 0.000 description 2
- 101000858479 Homo sapiens 28S ribosomal protein S25, mitochondrial Proteins 0.000 description 2
- 101000866618 Homo sapiens 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase Proteins 0.000 description 2
- 101000691538 Homo sapiens 39S ribosomal protein L12, mitochondrial Proteins 0.000 description 2
- 101000650310 Homo sapiens 39S ribosomal protein L16, mitochondrial Proteins 0.000 description 2
- 101000639842 Homo sapiens 39S ribosomal protein S18a, mitochondrial Proteins 0.000 description 2
- 101000604533 Homo sapiens 5'-nucleotidase domain-containing protein 2 Proteins 0.000 description 2
- 101001127039 Homo sapiens 60S ribosomal protein L38 Proteins 0.000 description 2
- 101000674326 Homo sapiens 60S ribosomal protein L41 Proteins 0.000 description 2
- 101000779382 Homo sapiens A-kinase anchor protein 12 Proteins 0.000 description 2
- 101000580659 Homo sapiens ATP-dependent DNA helicase Q1 Proteins 0.000 description 2
- 101000874173 Homo sapiens ATP-dependent RNA helicase DDX42 Proteins 0.000 description 2
- 101000907886 Homo sapiens ATP-dependent RNA helicase DHX15 Proteins 0.000 description 2
- 101000901948 Homo sapiens ATP-dependent RNA helicase DHX30 Proteins 0.000 description 2
- 101000799140 Homo sapiens Activin receptor type-1 Proteins 0.000 description 2
- 101000755474 Homo sapiens Activity-dependent neuroprotector homeobox protein Proteins 0.000 description 2
- 101000614487 Homo sapiens Adenylate kinase 4, mitochondrial Proteins 0.000 description 2
- 101000797292 Homo sapiens Alpha-actinin-3 Proteins 0.000 description 2
- 101000806863 Homo sapiens Anaphase-promoting complex subunit 7 Proteins 0.000 description 2
- 101000928344 Homo sapiens Ankyrin-2 Proteins 0.000 description 2
- 101000780559 Homo sapiens Apoptosis-enhancing nuclease Proteins 0.000 description 2
- 101000925939 Homo sapiens Armadillo repeat-containing X-linked protein 2 Proteins 0.000 description 2
- 101000761886 Homo sapiens BTB/POZ domain-containing protein 3 Proteins 0.000 description 2
- 101001138033 Homo sapiens Beta-1,3-glucuronyltransferase LARGE2 Proteins 0.000 description 2
- 101000919663 Homo sapiens CCR4-NOT transcription complex subunit 3 Proteins 0.000 description 2
- 101000860047 Homo sapiens COP9 signalosome complex subunit 6 Proteins 0.000 description 2
- 101000860860 Homo sapiens COUP transcription factor 2 Proteins 0.000 description 2
- 101000932896 Homo sapiens CaM kinase-like vesicle-associated protein Proteins 0.000 description 2
- 101000989513 Homo sapiens Calcium-regulated heat-stable protein 1 Proteins 0.000 description 2
- 101000984150 Homo sapiens Calmodulin-2 Proteins 0.000 description 2
- 101000867742 Homo sapiens Caprin-2 Proteins 0.000 description 2
- 101000867841 Homo sapiens Carbonic anhydrase-related protein 11 Proteins 0.000 description 2
- 101000880504 Homo sapiens Centromere protein T Proteins 0.000 description 2
- 101000945822 Homo sapiens Centrosomal protein of 85 kDa Proteins 0.000 description 2
- 101000777795 Homo sapiens Chromodomain Y-like protein Proteins 0.000 description 2
- 101000946482 Homo sapiens Clathrin heavy chain 2 Proteins 0.000 description 2
- 101000777370 Homo sapiens Coiled-coil domain-containing protein 6 Proteins 0.000 description 2
- 101000942617 Homo sapiens Condensin complex subunit 2 Proteins 0.000 description 2
- 101000908138 Homo sapiens Cyclin-dependent kinase 10 Proteins 0.000 description 2
- 101000944357 Homo sapiens Cyclin-dependent kinase 16 Proteins 0.000 description 2
- 101000855328 Homo sapiens Cytochrome P450 2S1 Proteins 0.000 description 2
- 101000746783 Homo sapiens Cytochrome b-c1 complex subunit 6, mitochondrial Proteins 0.000 description 2
- 101001060428 Homo sapiens Cytochrome b-c1 complex subunit 7 Proteins 0.000 description 2
- 101000915989 Homo sapiens Cytochrome c oxidase subunit 6A1, mitochondrial Proteins 0.000 description 2
- 101000954691 Homo sapiens Cytoplasmic dynein 1 light intermediate chain 2 Proteins 0.000 description 2
- 101000909249 Homo sapiens DNA (cytosine-5)-methyltransferase 3B Proteins 0.000 description 2
- 101000863770 Homo sapiens DNA ligase 1 Proteins 0.000 description 2
- 101000611553 Homo sapiens DNA primase large subunit Proteins 0.000 description 2
- 101000963174 Homo sapiens DNA replication licensing factor MCM3 Proteins 0.000 description 2
- 101001018484 Homo sapiens DNA replication licensing factor MCM6 Proteins 0.000 description 2
- 101000872044 Homo sapiens Dermokine Proteins 0.000 description 2
- 101000883444 Homo sapiens Desmoplakin Proteins 0.000 description 2
- 101000881868 Homo sapiens Developmental pluripotency-associated protein 4 Proteins 0.000 description 2
- 101001053501 Homo sapiens Dihydropyrimidinase-related protein 3 Proteins 0.000 description 2
- 101000866011 Homo sapiens DnaJ homolog subfamily B member 5 Proteins 0.000 description 2
- 101000908069 Homo sapiens DnaJ homolog subfamily C member 11 Proteins 0.000 description 2
- 101000848191 Homo sapiens E3 ubiquitin-protein ligase FANCL Proteins 0.000 description 2
- 101000756779 Homo sapiens E3 ubiquitin-protein ligase RFWD3 Proteins 0.000 description 2
- 101000671838 Homo sapiens E3 ubiquitin-protein ligase UBR5 Proteins 0.000 description 2
- 101000921212 Homo sapiens EH domain-containing protein 3 Proteins 0.000 description 2
- 101000813747 Homo sapiens ETS translocation variant 4 Proteins 0.000 description 2
- 101000812663 Homo sapiens Endoplasmin Proteins 0.000 description 2
- 101000740107 Homo sapiens Equilibrative nucleobase transporter 1 Proteins 0.000 description 2
- 101000851719 Homo sapiens Erlin-2 Proteins 0.000 description 2
- 101000770958 Homo sapiens Exportin-2 Proteins 0.000 description 2
- 101000836111 Homo sapiens FACT complex subunit SPT16 Proteins 0.000 description 2
- 101000930770 Homo sapiens Far upstream element-binding protein 1 Proteins 0.000 description 2
- 101000824458 Homo sapiens Fatty acyl-CoA reductase 1 Proteins 0.000 description 2
- 101000827773 Homo sapiens Fibroblast growth factor-binding protein 3 Proteins 0.000 description 2
- 101001027128 Homo sapiens Fibronectin Proteins 0.000 description 2
- 101000877727 Homo sapiens Forkhead box protein O1 Proteins 0.000 description 2
- 101001037070 Homo sapiens GRB10-interacting GYF protein 1 Proteins 0.000 description 2
- 101000578396 Homo sapiens GTP-binding protein Rhes Proteins 0.000 description 2
- 101000998053 Homo sapiens GTP:AMP phosphotransferase AK3, mitochondrial Proteins 0.000 description 2
- 101000822394 Homo sapiens Gamma-aminobutyric acid receptor subunit pi Proteins 0.000 description 2
- 101001010479 Homo sapiens Gastrin-releasing peptide receptor Proteins 0.000 description 2
- 101000888841 Homo sapiens Glutamine synthetase Proteins 0.000 description 2
- 101001040734 Homo sapiens Golgi phosphoprotein 3 Proteins 0.000 description 2
- 101001014590 Homo sapiens Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas Proteins 0.000 description 2
- 101001014594 Homo sapiens Guanine nucleotide-binding protein G(s) subunit alpha isoforms short Proteins 0.000 description 2
- 101001035823 Homo sapiens HAUS augmin-like complex subunit 4 Proteins 0.000 description 2
- 101001080568 Homo sapiens Heat shock cognate 71 kDa protein Proteins 0.000 description 2
- 101000863680 Homo sapiens Helicase SKI2W Proteins 0.000 description 2
- 101000985492 Homo sapiens Hermansky-Pudlak syndrome 3 protein Proteins 0.000 description 2
- 101001017567 Homo sapiens Heterogeneous nuclear ribonucleoprotein U-like protein 1 Proteins 0.000 description 2
- 101001025337 Homo sapiens High mobility group protein B1 Proteins 0.000 description 2
- 101001046967 Homo sapiens Histone acetyltransferase KAT2A Proteins 0.000 description 2
- 101001008824 Homo sapiens Histone-lysine N-methyltransferase KMT5C Proteins 0.000 description 2
- 101001002994 Homo sapiens Homeobox protein Hox-C4 Proteins 0.000 description 2
- 101001030705 Homo sapiens Huntingtin Proteins 0.000 description 2
- 101000852852 Homo sapiens Innate immunity activator protein Proteins 0.000 description 2
- 101001076292 Homo sapiens Insulin-like growth factor II Proteins 0.000 description 2
- 101001033770 Homo sapiens Integrator complex subunit 4 Proteins 0.000 description 2
- 101001013150 Homo sapiens Interstitial collagenase Proteins 0.000 description 2
- 101000960245 Homo sapiens Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial Proteins 0.000 description 2
- 101001091328 Homo sapiens Kelch-like protein 12 Proteins 0.000 description 2
- 101001045824 Homo sapiens Kelch-like protein 3 Proteins 0.000 description 2
- 101001026998 Homo sapiens Ketosamine-3-kinase Proteins 0.000 description 2
- 101001050567 Homo sapiens Kinesin-like protein KIF2C Proteins 0.000 description 2
- 101001044098 Homo sapiens LINE-1 type transposase domain-containing protein 1 Proteins 0.000 description 2
- 101000616300 Homo sapiens Leucine zipper transcription factor-like protein 1 Proteins 0.000 description 2
- 101001014572 Homo sapiens MARCKS-related protein Proteins 0.000 description 2
- 101000578867 Homo sapiens Mis18-binding protein 1 Proteins 0.000 description 2
- 101000764216 Homo sapiens Mitochondrial import receptor subunit TOM40 homolog Proteins 0.000 description 2
- 101000896484 Homo sapiens Mitotic checkpoint protein BUB3 Proteins 0.000 description 2
- 101000992748 Homo sapiens Mortality factor 4-like protein 2 Proteins 0.000 description 2
- 101001014610 Homo sapiens Neuroendocrine secretory protein 55 Proteins 0.000 description 2
- 101000996058 Homo sapiens Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 2 Proteins 0.000 description 2
- 101000578287 Homo sapiens Non-POU domain-containing octamer-binding protein Proteins 0.000 description 2
- 101001000799 Homo sapiens Nuclear pore membrane glycoprotein 210 Proteins 0.000 description 2
- 101000912678 Homo sapiens Nucleolar RNA helicase 2 Proteins 0.000 description 2
- 101000603068 Homo sapiens Nucleolar protein 56 Proteins 0.000 description 2
- 101000597499 Homo sapiens Obg-like ATPase 1 Proteins 0.000 description 2
- 101000721946 Homo sapiens Oral-facial-digital syndrome 1 protein Proteins 0.000 description 2
- 101000613563 Homo sapiens PAS domain-containing serine/threonine-protein kinase Proteins 0.000 description 2
- 101000604540 Homo sapiens PRKCA-binding protein Proteins 0.000 description 2
- 101001134861 Homo sapiens Pericentriolar material 1 protein Proteins 0.000 description 2
- 101000833913 Homo sapiens Peroxisomal acyl-coenzyme A oxidase 3 Proteins 0.000 description 2
- 101000605630 Homo sapiens Phosphatidylinositol 3-kinase catalytic subunit type 3 Proteins 0.000 description 2
- 101000605434 Homo sapiens Phospholipid phosphatase 2 Proteins 0.000 description 2
- 101000582986 Homo sapiens Phospholipid phosphatase-related protein type 3 Proteins 0.000 description 2
- 101000829544 Homo sapiens Polypeptide N-acetylgalactosaminyltransferase 12 Proteins 0.000 description 2
- 101000903686 Homo sapiens Procollagen galactosyltransferase 1 Proteins 0.000 description 2
- 101000797903 Homo sapiens Protein ALEX Proteins 0.000 description 2
- 101000912957 Homo sapiens Protein DEK Proteins 0.000 description 2
- 101000937720 Homo sapiens Protein FAM222B Proteins 0.000 description 2
- 101000995332 Homo sapiens Protein NDRG4 Proteins 0.000 description 2
- 101001074602 Homo sapiens Protein PIMREG Proteins 0.000 description 2
- 101000653788 Homo sapiens Protein S100-A11 Proteins 0.000 description 2
- 101000693024 Homo sapiens Protein arginine N-methyltransferase 7 Proteins 0.000 description 2
- 101000971404 Homo sapiens Protein kinase C iota type Proteins 0.000 description 2
- 101000629617 Homo sapiens Protein sprouty homolog 4 Proteins 0.000 description 2
- 101000601855 Homo sapiens Protocadherin-1 Proteins 0.000 description 2
- 101000797990 Homo sapiens Putative activator of 90 kDa heat shock protein ATPase homolog 2 Proteins 0.000 description 2
- 101000712530 Homo sapiens RAF proto-oncogene serine/threonine-protein kinase Proteins 0.000 description 2
- 101000717389 Homo sapiens RCC1-like G exchanging factor-like protein Proteins 0.000 description 2
- 101000990485 Homo sapiens RNA N6-adenosine-methyltransferase METTL16 Proteins 0.000 description 2
- 101001024635 Homo sapiens RNA cytidine acetyltransferase Proteins 0.000 description 2
- 101001076724 Homo sapiens RNA-binding protein 28 Proteins 0.000 description 2
- 101001076715 Homo sapiens RNA-binding protein 39 Proteins 0.000 description 2
- 101000591115 Homo sapiens RNA-binding protein Musashi homolog 1 Proteins 0.000 description 2
- 101001061807 Homo sapiens Rab-like protein 6 Proteins 0.000 description 2
- 101000999079 Homo sapiens Radiation-inducible immediate-early gene IEX-1 Proteins 0.000 description 2
- 101000709135 Homo sapiens Ral guanine nucleotide dissociation stimulator-like 2 Proteins 0.000 description 2
- 101001060862 Homo sapiens Ras-related protein Rab-31 Proteins 0.000 description 2
- 101001061788 Homo sapiens Ras-related protein Rab-35 Proteins 0.000 description 2
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 2
- 101000582404 Homo sapiens Replication factor C subunit 4 Proteins 0.000 description 2
- 101001055100 Homo sapiens Repressor of RNA polymerase III transcription MAF1 homolog Proteins 0.000 description 2
- 101001112293 Homo sapiens Retinoic acid receptor alpha Proteins 0.000 description 2
- 101001132658 Homo sapiens Retinoic acid receptor gamma Proteins 0.000 description 2
- 101001106322 Homo sapiens Rho GTPase-activating protein 7 Proteins 0.000 description 2
- 101000886098 Homo sapiens Rho guanine nucleotide exchange factor 40 Proteins 0.000 description 2
- 101001095435 Homo sapiens Rhox homeobox family member 2 Proteins 0.000 description 2
- 101001125551 Homo sapiens Ribose-phosphate pyrophosphokinase 1 Proteins 0.000 description 2
- 101000694550 Homo sapiens RuvB-like 1 Proteins 0.000 description 2
- 101000947881 Homo sapiens S-adenosylmethionine synthase isoform type-2 Proteins 0.000 description 2
- 101000707152 Homo sapiens SH2B adapter protein 1 Proteins 0.000 description 2
- 101000724404 Homo sapiens Saccharopine dehydrogenase Proteins 0.000 description 2
- 101000632056 Homo sapiens Septin-9 Proteins 0.000 description 2
- 101000829211 Homo sapiens Serine/arginine repetitive matrix protein 1 Proteins 0.000 description 2
- 101000829212 Homo sapiens Serine/arginine repetitive matrix protein 2 Proteins 0.000 description 2
- 101000576904 Homo sapiens Serine/threonine-protein kinase MRCK beta Proteins 0.000 description 2
- 101000582914 Homo sapiens Serine/threonine-protein kinase PLK4 Proteins 0.000 description 2
- 101001036145 Homo sapiens Serine/threonine-protein kinase greatwall Proteins 0.000 description 2
- 101001001648 Homo sapiens Serine/threonine-protein kinase pim-2 Proteins 0.000 description 2
- 101001123146 Homo sapiens Serine/threonine-protein phosphatase 4 regulatory subunit 1 Proteins 0.000 description 2
- 101000620653 Homo sapiens Serine/threonine-protein phosphatase 5 Proteins 0.000 description 2
- 101001099058 Homo sapiens Serine/threonine-protein phosphatase PGAM5, mitochondrial Proteins 0.000 description 2
- 101000799180 Homo sapiens Short transient receptor potential channel 4-associated protein Proteins 0.000 description 2
- 101000739205 Homo sapiens Small G protein signaling modulator 3 Proteins 0.000 description 2
- 101000825914 Homo sapiens Small nuclear ribonucleoprotein Sm D3 Proteins 0.000 description 2
- 101000908580 Homo sapiens Spliceosome RNA helicase DDX39B Proteins 0.000 description 2
- 101000948265 Homo sapiens Spliceosome-associated protein CWC15 homolog Proteins 0.000 description 2
- 101000707546 Homo sapiens Splicing factor 3A subunit 1 Proteins 0.000 description 2
- 101000616172 Homo sapiens Splicing factor 3B subunit 3 Proteins 0.000 description 2
- 101000628592 Homo sapiens StAR-related lipid transfer protein 7, mitochondrial Proteins 0.000 description 2
- 101000697510 Homo sapiens Stathmin-2 Proteins 0.000 description 2
- 101000740523 Homo sapiens Syntenin-1 Proteins 0.000 description 2
- 101000891092 Homo sapiens TAR DNA-binding protein 43 Proteins 0.000 description 2
- 101000694973 Homo sapiens TATA-binding protein-associated factor 172 Proteins 0.000 description 2
- 101000762938 Homo sapiens TOX high mobility group box family member 4 Proteins 0.000 description 2
- 101000796121 Homo sapiens Thioredoxin-like protein 1 Proteins 0.000 description 2
- 101000649020 Homo sapiens Thyroid receptor-interacting protein 6 Proteins 0.000 description 2
- 101000819111 Homo sapiens Trans-acting T-cell-specific transcription factor GATA-3 Proteins 0.000 description 2
- 101000702364 Homo sapiens Transcription elongation factor SPT5 Proteins 0.000 description 2
- 101000837845 Homo sapiens Transcription factor E3 Proteins 0.000 description 2
- 101000674710 Homo sapiens Transcription initiation factor TFIID subunit 6 Proteins 0.000 description 2
- 101001060442 Homo sapiens Transcriptional regulator QRICH1 Proteins 0.000 description 2
- 101000835093 Homo sapiens Transferrin receptor protein 1 Proteins 0.000 description 2
- 101000755529 Homo sapiens Transforming protein RhoA Proteins 0.000 description 2
- 101000664599 Homo sapiens Tripartite motif-containing protein 2 Proteins 0.000 description 2
- 101000851357 Homo sapiens Troponin T, slow skeletal muscle Proteins 0.000 description 2
- 101000796738 Homo sapiens Tryptase gamma Proteins 0.000 description 2
- 101000625727 Homo sapiens Tubulin beta chain Proteins 0.000 description 2
- 101000788517 Homo sapiens Tubulin beta-2A chain Proteins 0.000 description 2
- 101000834944 Homo sapiens Tubulin epsilon and delta complex protein 2 Proteins 0.000 description 2
- 101000617779 Homo sapiens U1 small nuclear ribonucleoprotein A Proteins 0.000 description 2
- 101000747564 Homo sapiens UBX domain-containing protein 1 Proteins 0.000 description 2
- 101000992235 Homo sapiens UDP-N-acetylglucosamine-peptide N-acetylglucosaminyltransferase 110 kDa subunit Proteins 0.000 description 2
- 101000982047 Homo sapiens Unconventional myosin-XIX Proteins 0.000 description 2
- 101000854707 Homo sapiens VPS35 endosomal protein-sorting factor-like Proteins 0.000 description 2
- 101000787276 Homo sapiens Valine-tRNA ligase, mitochondrial Proteins 0.000 description 2
- 101000804811 Homo sapiens WD repeat and SOCS box-containing protein 1 Proteins 0.000 description 2
- 101000854918 Homo sapiens WD repeat-containing protein 6 Proteins 0.000 description 2
- 101000666063 Homo sapiens WD repeat-containing protein 74 Proteins 0.000 description 2
- 101000782174 Homo sapiens WD repeat-containing protein 82 Proteins 0.000 description 2
- 101000744718 Homo sapiens YTH domain-containing family protein 3 Proteins 0.000 description 2
- 101000784545 Homo sapiens Zinc finger and SCAN domain-containing protein 18 Proteins 0.000 description 2
- 101000964584 Homo sapiens Zinc finger protein 160 Proteins 0.000 description 2
- 101000760207 Homo sapiens Zinc finger protein 331 Proteins 0.000 description 2
- 101000633054 Homo sapiens Zinc finger protein SNAI2 Proteins 0.000 description 2
- 101000818867 Homo sapiens Zinc transporter 9 Proteins 0.000 description 2
- 101001117146 Homo sapiens [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial Proteins 0.000 description 2
- 101000802734 Homo sapiens eIF5-mimic protein 2 Proteins 0.000 description 2
- 101000802094 Homo sapiens mRNA decay activator protein ZFP36L1 Proteins 0.000 description 2
- 101000620751 Homo sapiens mRNA export factor RAE1 Proteins 0.000 description 2
- 101000868892 Homo sapiens pre-rRNA 2'-O-ribose RNA methyltransferase FTSJ3 Proteins 0.000 description 2
- 101000848450 Homo sapiens tRNA (guanine(26)-N(2))-dimethyltransferase Proteins 0.000 description 2
- 102100038562 Huntingtin Human genes 0.000 description 2
- 102100028084 Hyaluronan and proteoglycan link protein 1 Human genes 0.000 description 2
- 101710191341 Hyaluronan and proteoglycan link protein 1 Proteins 0.000 description 2
- 108060003951 Immunoglobulin Proteins 0.000 description 2
- 102100036341 Importin-4 Human genes 0.000 description 2
- 102100037961 Importin-9 Human genes 0.000 description 2
- 102100039813 Inactive tyrosine-protein kinase 7 Human genes 0.000 description 2
- 102100040061 Indoleamine 2,3-dioxygenase 1 Human genes 0.000 description 2
- 101710120843 Indoleamine 2,3-dioxygenase 1 Proteins 0.000 description 2
- 102100036724 Innate immunity activator protein Human genes 0.000 description 2
- 102100039906 Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial Human genes 0.000 description 2
- 108010040082 Junctional Adhesion Molecule A Proteins 0.000 description 2
- 102100022304 Junctional adhesion molecule A Human genes 0.000 description 2
- 101710024993 KIAA1109 Proteins 0.000 description 2
- 108090000484 Kelch-Like ECH-Associated Protein 1 Proteins 0.000 description 2
- 102000004034 Kelch-Like ECH-Associated Protein 1 Human genes 0.000 description 2
- 102100034855 Kelch-like protein 12 Human genes 0.000 description 2
- 102100022101 Kelch-like protein 3 Human genes 0.000 description 2
- 102100033421 Keratin, type I cytoskeletal 18 Human genes 0.000 description 2
- 102100023974 Keratin, type II cytoskeletal 7 Human genes 0.000 description 2
- 108010066327 Keratin-18 Proteins 0.000 description 2
- 108010070507 Keratin-7 Proteins 0.000 description 2
- 102000011782 Keratins Human genes 0.000 description 2
- 108010076876 Keratins Proteins 0.000 description 2
- 102100037378 Ketosamine-3-kinase Human genes 0.000 description 2
- 102100023424 Kinesin-like protein KIF2C Human genes 0.000 description 2
- 102100020679 Krueppel-like factor 6 Human genes 0.000 description 2
- 108010049058 Kruppel-Like Factor 6 Proteins 0.000 description 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
- 108010033796 L-pipecolate dehydrogenase Proteins 0.000 description 2
- 102100021610 LINE-1 type transposase domain-containing protein 1 Human genes 0.000 description 2
- 102100039648 Lactadherin Human genes 0.000 description 2
- 101710191666 Lactadherin Proteins 0.000 description 2
- 102100026519 Lamin-B2 Human genes 0.000 description 2
- 108010085895 Laminin Proteins 0.000 description 2
- 102100021803 Leucine zipper transcription factor-like protein 1 Human genes 0.000 description 2
- 101710099853 Leucine-rich PPR motif-containing protein, mitochondrial Proteins 0.000 description 2
- 102100023342 Leucine-tRNA ligase, mitochondrial Human genes 0.000 description 2
- 102100040705 Low-density lipoprotein receptor-related protein 8 Human genes 0.000 description 2
- 102100023325 M-phase inducer phosphatase 2 Human genes 0.000 description 2
- 102100029450 M1-specific T cell receptor alpha chain Human genes 0.000 description 2
- 102100032514 MARCKS-related protein Human genes 0.000 description 2
- 102100023474 MMS19 nucleotide excision repair protein homolog Human genes 0.000 description 2
- 102100037791 Macrophage migration inhibitory factor Human genes 0.000 description 2
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 description 2
- 102000018697 Membrane Proteins Human genes 0.000 description 2
- 102100027383 Methyl-CpG-binding domain protein 1 Human genes 0.000 description 2
- 101710111887 Methyl-CpG-binding domain protein 1 Proteins 0.000 description 2
- 102100028344 Mis18-binding protein 1 Human genes 0.000 description 2
- 102100026905 Mitochondrial import receptor subunit TOM40 homolog Human genes 0.000 description 2
- 102100021718 Mitotic checkpoint protein BUB3 Human genes 0.000 description 2
- 102100031304 Mortality factor 4-like protein 2 Human genes 0.000 description 2
- 241001529936 Murinae Species 0.000 description 2
- 101000864836 Mus musculus SIN3-HDAC complex-associated factor Proteins 0.000 description 2
- 102000007524 N-Acetylgalactosaminyltransferases Human genes 0.000 description 2
- 108010046220 N-Acetylgalactosaminyltransferases Proteins 0.000 description 2
- 102100040619 N6-adenosine-methyltransferase catalytic subunit Human genes 0.000 description 2
- 101710158306 N6-adenosine-methyltransferase catalytic subunit Proteins 0.000 description 2
- 102100028719 NEDD8-activating enzyme E1 catalytic subunit Human genes 0.000 description 2
- 102100023061 Negative elongation factor B Human genes 0.000 description 2
- 101710147331 Negative elongation factor B Proteins 0.000 description 2
- 102100021877 Neuronal pentraxin receptor Human genes 0.000 description 2
- 102100038816 Neuronatin Human genes 0.000 description 2
- 101710194997 Neuronatin Proteins 0.000 description 2
- 102100034450 Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 2 Human genes 0.000 description 2
- 102100028102 Non-POU domain-containing octamer-binding protein Human genes 0.000 description 2
- 102100032028 Non-receptor tyrosine-protein kinase TYK2 Human genes 0.000 description 2
- 102000014736 Notch Human genes 0.000 description 2
- 108010070047 Notch Receptors Proteins 0.000 description 2
- 102100023904 Nuclear autoantigenic sperm protein Human genes 0.000 description 2
- 101710149564 Nuclear autoantigenic sperm protein Proteins 0.000 description 2
- 101710205482 Nuclear factor 1 A-type Proteins 0.000 description 2
- 102100022165 Nuclear factor 1 B-type Human genes 0.000 description 2
- 101710170464 Nuclear factor 1 B-type Proteins 0.000 description 2
- 101710113455 Nuclear factor 1 C-type Proteins 0.000 description 2
- 101710140810 Nuclear factor 1 X-type Proteins 0.000 description 2
- 102100027582 Nuclear pore complex protein Nup85 Human genes 0.000 description 2
- 102100035570 Nuclear pore membrane glycoprotein 210 Human genes 0.000 description 2
- 102100026100 Nucleolar RNA helicase 2 Human genes 0.000 description 2
- 102100022726 Nucleolar and coiled-body phosphoprotein 1 Human genes 0.000 description 2
- 102100037052 Nucleolar protein 56 Human genes 0.000 description 2
- 102100023258 Nucleoside diphosphate kinase B Human genes 0.000 description 2
- 102100022389 Nucleosome assembly protein 1-like 1 Human genes 0.000 description 2
- 102100025062 Nucleosome-remodeling factor subunit BPTF Human genes 0.000 description 2
- 102100035415 Obg-like ATPase 1 Human genes 0.000 description 2
- 108700026244 Open Reading Frames Proteins 0.000 description 2
- 102100025410 Oral-facial-digital syndrome 1 protein Human genes 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- 102100040902 PAS domain-containing serine/threonine-protein kinase Human genes 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 102100038730 PRKCA-binding protein Human genes 0.000 description 2
- 102100033422 Pericentriolar material 1 protein Human genes 0.000 description 2
- 101710185569 Peroxiredoxin-6 Proteins 0.000 description 2
- 102100026777 Peroxisomal acyl-coenzyme A oxidase 3 Human genes 0.000 description 2
- 102100038811 Peroxisomal sarcosine oxidase Human genes 0.000 description 2
- 102100038329 Phosphatidylinositol 3-kinase catalytic subunit type 3 Human genes 0.000 description 2
- 102100038120 Phospholipid phosphatase 2 Human genes 0.000 description 2
- 102100030383 Phospholipid phosphatase-related protein type 3 Human genes 0.000 description 2
- 102100027330 Phosphoribosylaminoimidazole carboxylase Human genes 0.000 description 2
- 102100038374 Pinin Human genes 0.000 description 2
- 101710173952 Pinin Proteins 0.000 description 2
- 102100035922 Polyamine-modulated factor 1 Human genes 0.000 description 2
- 101710192873 Polyamine-modulated factor 1 Proteins 0.000 description 2
- 101710189219 Polypeptide N-acetylgalactosaminyltransferase 12 Proteins 0.000 description 2
- 102100029522 Pre-mRNA-processing factor 19 Human genes 0.000 description 2
- 102100022982 Procollagen galactosyltransferase 1 Human genes 0.000 description 2
- 102100026113 Protein DEK Human genes 0.000 description 2
- 102100027295 Protein FAM222B Human genes 0.000 description 2
- 102100034432 Protein NDRG4 Human genes 0.000 description 2
- 102100030122 Protein O-GlcNAcase Human genes 0.000 description 2
- 102100036258 Protein PIMREG Human genes 0.000 description 2
- 102100029811 Protein S100-A11 Human genes 0.000 description 2
- 102100030232 Protein SON Human genes 0.000 description 2
- 101710148754 Protein SON Proteins 0.000 description 2
- 102100026297 Protein arginine N-methyltransferase 7 Human genes 0.000 description 2
- 102100036352 Protein disulfide-isomerase Human genes 0.000 description 2
- 102100021557 Protein kinase C iota type Human genes 0.000 description 2
- 102100026845 Protein sprouty homolog 4 Human genes 0.000 description 2
- 102100037551 Protocadherin-1 Human genes 0.000 description 2
- 102100032319 Putative activator of 90 kDa heat shock protein ATPase homolog 2 Human genes 0.000 description 2
- 102100024551 Putative methyltransferase NSUN5C Human genes 0.000 description 2
- 102100033479 RAF proto-oncogene serine/threonine-protein kinase Human genes 0.000 description 2
- 102100027504 RANBP2-like and GRIP domain-containing protein 8 Human genes 0.000 description 2
- 101710172027 RANBP2-like and GRIP domain-containing protein 8 Proteins 0.000 description 2
- 102100020784 RCC1-like G exchanging factor-like protein Human genes 0.000 description 2
- 102100030522 RNA N6-adenosine-methyltransferase METTL16 Human genes 0.000 description 2
- 102000009572 RNA Polymerase II Human genes 0.000 description 2
- 108010009460 RNA Polymerase II Proteins 0.000 description 2
- 102100037011 RNA cytidine acetyltransferase Human genes 0.000 description 2
- 102000044126 RNA-Binding Proteins Human genes 0.000 description 2
- 101710105008 RNA-binding protein Proteins 0.000 description 2
- 102100027512 RNA-binding protein 12 Human genes 0.000 description 2
- 101710203308 RNA-binding protein 12 Proteins 0.000 description 2
- 102100029250 RNA-binding protein 14 Human genes 0.000 description 2
- 101710203307 RNA-binding protein 14 Proteins 0.000 description 2
- 102100025872 RNA-binding protein 28 Human genes 0.000 description 2
- 102100025858 RNA-binding protein 39 Human genes 0.000 description 2
- 102100038152 RNA-binding protein 5 Human genes 0.000 description 2
- 101710133259 RNA-binding protein 5 Proteins 0.000 description 2
- 102100034026 RNA-binding protein Musashi homolog 1 Human genes 0.000 description 2
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
- 238000010240 RT-PCR analysis Methods 0.000 description 2
- 102100029618 Rab-like protein 6 Human genes 0.000 description 2
- 102100036900 Radiation-inducible immediate-early gene IEX-1 Human genes 0.000 description 2
- 102100032786 Ral guanine nucleotide dissociation stimulator-like 2 Human genes 0.000 description 2
- 102100038473 Ran GTPase-activating protein 1 Human genes 0.000 description 2
- 101710160162 Ran GTPase-activating protein 1 Proteins 0.000 description 2
- 102100027838 Ras-related protein Rab-31 Human genes 0.000 description 2
- 102100029568 Ras-related protein Rab-35 Human genes 0.000 description 2
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 2
- 102100030542 Replication factor C subunit 4 Human genes 0.000 description 2
- 102100026898 Repressor of RNA polymerase III transcription MAF1 homolog Human genes 0.000 description 2
- 102100035528 Ret finger protein-like 3 Human genes 0.000 description 2
- 101710183525 Ret finger protein-like 3 Proteins 0.000 description 2
- 102100023606 Retinoic acid receptor alpha Human genes 0.000 description 2
- 102100033912 Retinoic acid receptor gamma Human genes 0.000 description 2
- 102100021446 Rho GTPase-activating protein 7 Human genes 0.000 description 2
- 102100039653 Rho guanine nucleotide exchange factor 40 Human genes 0.000 description 2
- 102100025290 Ribonuclease H1 Human genes 0.000 description 2
- 102100029508 Ribose-phosphate pyrophosphokinase 1 Human genes 0.000 description 2
- 102000002278 Ribosomal Proteins Human genes 0.000 description 2
- 108010000605 Ribosomal Proteins Proteins 0.000 description 2
- 108090000986 Ribosomal protein L10 Proteins 0.000 description 2
- 102000003926 Ribosomal protein L18 Human genes 0.000 description 2
- 108090000343 Ribosomal protein L18 Proteins 0.000 description 2
- 102000004339 Ribosomal protein S2 Human genes 0.000 description 2
- 108090000904 Ribosomal protein S2 Proteins 0.000 description 2
- 102100027160 RuvB-like 1 Human genes 0.000 description 2
- 102100035947 S-adenosylmethionine synthase isoform type-2 Human genes 0.000 description 2
- 102100031770 SH2B adapter protein 1 Human genes 0.000 description 2
- 108091007597 SLC56A1 Proteins 0.000 description 2
- 102100028294 Saccharopine dehydrogenase Human genes 0.000 description 2
- 102100030058 Secreted frizzled-related protein 1 Human genes 0.000 description 2
- 102100026077 Selenocysteine insertion sequence-binding protein 2 Human genes 0.000 description 2
- 101710166136 Selenocysteine insertion sequence-binding protein 2 Proteins 0.000 description 2
- 102100023840 Selenoprotein H Human genes 0.000 description 2
- 101710095008 Selenoprotein H Proteins 0.000 description 2
- 101710118835 Sentrin-specific protease Proteins 0.000 description 2
- 102100028024 Septin-9 Human genes 0.000 description 2
- 102100023664 Serine/arginine repetitive matrix protein 1 Human genes 0.000 description 2
- 102100023657 Serine/arginine repetitive matrix protein 2 Human genes 0.000 description 2
- 102100029703 Serine/arginine-rich splicing factor 5 Human genes 0.000 description 2
- 101710123514 Serine/arginine-rich splicing factor 5 Proteins 0.000 description 2
- 102100025347 Serine/threonine-protein kinase MRCK beta Human genes 0.000 description 2
- 102100030267 Serine/threonine-protein kinase PLK4 Human genes 0.000 description 2
- 102100039278 Serine/threonine-protein kinase greatwall Human genes 0.000 description 2
- 102100036120 Serine/threonine-protein kinase pim-2 Human genes 0.000 description 2
- 102100028618 Serine/threonine-protein phosphatase 4 regulatory subunit 1 Human genes 0.000 description 2
- 102100022346 Serine/threonine-protein phosphatase 5 Human genes 0.000 description 2
- 102100038901 Serine/threonine-protein phosphatase PGAM5, mitochondrial Human genes 0.000 description 2
- 102100037797 Serine/threonine/tyrosine-interacting protein Human genes 0.000 description 2
- 102100034106 Short transient receptor potential channel 4-associated protein Human genes 0.000 description 2
- 102100027843 Sideroflexin-1 Human genes 0.000 description 2
- 102100037275 Small G protein signaling modulator 3 Human genes 0.000 description 2
- 108020004459 Small interfering RNA Proteins 0.000 description 2
- 102100022775 Small nuclear ribonucleoprotein Sm D3 Human genes 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- 102100030992 Sorting nexin-1 Human genes 0.000 description 2
- 101710103909 Sorting nexin-1 Proteins 0.000 description 2
- 102100022378 Sorting nexin-2 Human genes 0.000 description 2
- 101710103884 Sorting nexin-2 Proteins 0.000 description 2
- 102100021915 Sperm-associated antigen 5 Human genes 0.000 description 2
- 101710098571 Sperm-associated antigen 5 Proteins 0.000 description 2
- 102100024690 Spliceosome RNA helicase DDX39B Human genes 0.000 description 2
- 102100036029 Spliceosome-associated protein CWC15 homolog Human genes 0.000 description 2
- 102100031713 Splicing factor 3A subunit 1 Human genes 0.000 description 2
- 102100021816 Splicing factor 3B subunit 3 Human genes 0.000 description 2
- 102100026760 StAR-related lipid transfer protein 7, mitochondrial Human genes 0.000 description 2
- 102100028051 Stathmin-2 Human genes 0.000 description 2
- 108010027912 Sulfite Oxidase Proteins 0.000 description 2
- 102000043440 Sulfite oxidase Human genes 0.000 description 2
- 102100039485 Symplekin Human genes 0.000 description 2
- 102100029452 T cell receptor alpha chain constant Human genes 0.000 description 2
- 108091008874 T cell receptors Proteins 0.000 description 2
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 2
- 102100040347 TAR DNA-binding protein 43 Human genes 0.000 description 2
- 102100028639 TATA-binding protein-associated factor 172 Human genes 0.000 description 2
- 102100040296 TATA-box-binding protein Human genes 0.000 description 2
- 102100026749 TOX high mobility group box family member 4 Human genes 0.000 description 2
- 108010010057 TYK2 Kinase Proteins 0.000 description 2
- 102100027802 Target of rapamycin complex subunit LST8 Human genes 0.000 description 2
- 101710115678 Target of rapamycin complex subunit LST8 Proteins 0.000 description 2
- 102100036497 Telomeric repeat-binding factor 1 Human genes 0.000 description 2
- 101710098080 Teratocarcinoma-derived growth factor Proteins 0.000 description 2
- 102100035115 Testin Human genes 0.000 description 2
- 102100031344 Thioredoxin-interacting protein Human genes 0.000 description 2
- 101710114149 Thioredoxin-interacting protein Proteins 0.000 description 2
- 102100031373 Thioredoxin-like protein 1 Human genes 0.000 description 2
- 108010022394 Threonine synthase Proteins 0.000 description 2
- 108010029287 Threonine-tRNA ligase Proteins 0.000 description 2
- 108010046722 Thrombospondin 1 Proteins 0.000 description 2
- 102100036034 Thrombospondin-1 Human genes 0.000 description 2
- 102100028099 Thyroid receptor-interacting protein 6 Human genes 0.000 description 2
- 102100021386 Trans-acting T-cell-specific transcription factor GATA-3 Human genes 0.000 description 2
- 102100030402 Transcription elongation factor SPT5 Human genes 0.000 description 2
- 102100028507 Transcription factor E3 Human genes 0.000 description 2
- 102100021170 Transcription initiation factor TFIID subunit 6 Human genes 0.000 description 2
- 102100022011 Transcription intermediary factor 1-alpha Human genes 0.000 description 2
- 108700029229 Transcriptional Regulatory Elements Proteins 0.000 description 2
- 102100027895 Transcriptional regulator QRICH1 Human genes 0.000 description 2
- 102100029446 Transcriptional-regulating factor 1 Human genes 0.000 description 2
- 101710130537 Transcriptional-regulating factor 1 Proteins 0.000 description 2
- 102100026144 Transferrin receptor protein 1 Human genes 0.000 description 2
- 102100022387 Transforming protein RhoA Human genes 0.000 description 2
- 102100031016 Transgelin-2 Human genes 0.000 description 2
- 108050006805 Transgelin-2 Proteins 0.000 description 2
- 108700019146 Transgenes Proteins 0.000 description 2
- 102100033055 Transketolase Human genes 0.000 description 2
- 102100032503 Transmembrane 9 superfamily member 2 Human genes 0.000 description 2
- 101710127170 Transmembrane 9 superfamily member 2 Proteins 0.000 description 2
- 102100025378 Transmembrane protein KIAA1109 Human genes 0.000 description 2
- 102100028746 Transportin-3 Human genes 0.000 description 2
- 102100038799 Tripartite motif-containing protein 2 Human genes 0.000 description 2
- 102100033632 Tropomyosin alpha-1 chain Human genes 0.000 description 2
- 101710128188 Tropomyosin alpha-1 chain Proteins 0.000 description 2
- 102100036471 Tropomyosin beta chain Human genes 0.000 description 2
- 101710186456 Tropomyosin beta chain Proteins 0.000 description 2
- 102100036860 Troponin T, slow skeletal muscle Human genes 0.000 description 2
- 102100032761 Tryptase gamma Human genes 0.000 description 2
- 102100024717 Tubulin beta chain Human genes 0.000 description 2
- 102100026157 Tubulin epsilon and delta complex protein 2 Human genes 0.000 description 2
- 102100033725 Tumor necrosis factor receptor superfamily member 16 Human genes 0.000 description 2
- 102100022013 U1 small nuclear ribonucleoprotein A Human genes 0.000 description 2
- 102100040201 UBX domain-containing protein 1 Human genes 0.000 description 2
- 102100038834 UTP-glucose-1-phosphate uridylyltransferase Human genes 0.000 description 2
- 101710088074 UTP-glucose-1-phosphate uridylyltransferase 2 Proteins 0.000 description 2
- 102100021017 Ubiquitin carboxyl-terminal hydrolase 5 Human genes 0.000 description 2
- 102100023341 Ubiquitin-40S ribosomal protein S27a Human genes 0.000 description 2
- 102100030424 Ubiquitin-associated protein 2 Human genes 0.000 description 2
- 101710101250 Ubiquitin-associated protein 2 Proteins 0.000 description 2
- 102100026769 Unconventional myosin-XIX Human genes 0.000 description 2
- 108010072685 Uracil-DNA Glycosidase Proteins 0.000 description 2
- 102100037111 Uracil-DNA glycosylase Human genes 0.000 description 2
- 102100020777 VPS35 endosomal protein-sorting factor-like Human genes 0.000 description 2
- 102100025609 Valine-tRNA ligase, mitochondrial Human genes 0.000 description 2
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 2
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 2
- 102100039037 Vascular endothelial growth factor A Human genes 0.000 description 2
- 102100037814 Vigilin Human genes 0.000 description 2
- 108010022133 Voltage-Dependent Anion Channel 1 Proteins 0.000 description 2
- 102100035334 WD repeat and SOCS box-containing protein 1 Human genes 0.000 description 2
- 108010020277 WD repeat containing planar cell polarity effector Proteins 0.000 description 2
- 102100020706 WD repeat-containing protein 6 Human genes 0.000 description 2
- 102100038091 WD repeat-containing protein 74 Human genes 0.000 description 2
- 102100036550 WD repeat-containing protein 82 Human genes 0.000 description 2
- 101001053511 Xenopus tropicalis Dihydropyrimidinase-related protein 3 Proteins 0.000 description 2
- 102100039674 YTH domain-containing family protein 3 Human genes 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 102100028956 Zinc finger Ran-binding domain-containing protein 2 Human genes 0.000 description 2
- 101710102922 Zinc finger Ran-binding domain-containing protein 2 Proteins 0.000 description 2
- 102100020915 Zinc finger and SCAN domain-containing protein 18 Human genes 0.000 description 2
- 102100040815 Zinc finger protein 160 Human genes 0.000 description 2
- 102100040030 Zinc finger protein 195 Human genes 0.000 description 2
- 101710145530 Zinc finger protein 195 Proteins 0.000 description 2
- 102100039979 Zinc finger protein 212 Human genes 0.000 description 2
- 101710143830 Zinc finger protein 212 Proteins 0.000 description 2
- 102100021359 Zinc finger protein 263 Human genes 0.000 description 2
- 101710143812 Zinc finger protein 263 Proteins 0.000 description 2
- 102100026334 Zinc finger protein 275 Human genes 0.000 description 2
- 102100026316 Zinc finger protein 281 Human genes 0.000 description 2
- 101710143983 Zinc finger protein 281 Proteins 0.000 description 2
- 102100029570 Zinc finger protein SNAI2 Human genes 0.000 description 2
- 102100021421 Zinc transporter 9 Human genes 0.000 description 2
- 102100024148 [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial Human genes 0.000 description 2
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 210000003050 axon Anatomy 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 108091008324 binding proteins Proteins 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 108010046616 cdc25 Phosphatases Proteins 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 108010022820 collapsin response mediator protein-1 Proteins 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- 239000012228 culture supernatant Substances 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 230000003436 cytoskeletal effect Effects 0.000 description 2
- 230000001086 cytosolic effect Effects 0.000 description 2
- 102000004419 dihydrofolate reductase Human genes 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 230000002222 downregulating effect Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 102100035859 eIF5-mimic protein 2 Human genes 0.000 description 2
- 210000001900 endoderm Anatomy 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- 108010072251 fetal Alzheimer antigen Proteins 0.000 description 2
- 210000003754 fetus Anatomy 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- BRZYSWJRSDMWLG-CAXSIQPQSA-N geneticin Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](C(C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-CAXSIQPQSA-N 0.000 description 2
- 210000001654 germ layer Anatomy 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000013595 glycosylation Effects 0.000 description 2
- 238000006206 glycosylation reaction Methods 0.000 description 2
- 108010092427 high density lipoprotein binding protein Proteins 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 102000018358 immunoglobulin Human genes 0.000 description 2
- 230000016784 immunoglobulin production Effects 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 239000000411 inducer Substances 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 108010052219 lamin B2 Proteins 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 102100034702 mRNA decay activator protein ZFP36L1 Human genes 0.000 description 2
- 102100022885 mRNA export factor RAE1 Human genes 0.000 description 2
- 210000004962 mammalian cell Anatomy 0.000 description 2
- 230000010311 mammalian development Effects 0.000 description 2
- 108010082117 matrigel Proteins 0.000 description 2
- 210000003716 mesoderm Anatomy 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 108010065551 mouse Zinc finger protein 275 Proteins 0.000 description 2
- 210000003061 neural cell Anatomy 0.000 description 2
- 108010001839 neuronal pentraxin receptor Proteins 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 210000004940 nucleus Anatomy 0.000 description 2
- 108010035632 ornithine decarboxylase antizyme inhibitor Proteins 0.000 description 2
- 201000003455 orofaciodigital syndrome I Diseases 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 108010044156 peptidyl-prolyl cis-trans isomerase b Proteins 0.000 description 2
- 230000008823 permeabilization Effects 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 108010035774 phosphoribosylaminoimidazole carboxylase Proteins 0.000 description 2
- 102000030592 phosphoserine aminotransferase Human genes 0.000 description 2
- 108010088694 phosphoserine aminotransferase Proteins 0.000 description 2
- 102100032318 pre-rRNA 2'-O-ribose RNA methyltransferase FTSJ3 Human genes 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000002062 proliferating effect Effects 0.000 description 2
- GPTFURBXHJWNHR-UHFFFAOYSA-N protopine Chemical compound C1=C2C(=O)CC3=CC=C4OCOC4=C3CN(C)CCC2=CC2=C1OCO2 GPTFURBXHJWNHR-UHFFFAOYSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 108010052833 ribonuclease HI Proteins 0.000 description 2
- 108090000327 ribosomal protein L21 Proteins 0.000 description 2
- 108010025325 ribosomal protein L32 Proteins 0.000 description 2
- 108010088974 ribosomal protein S15a Proteins 0.000 description 2
- 108010011179 ribosomal protein S27a Proteins 0.000 description 2
- 102000004337 ribosomal protein S5 Human genes 0.000 description 2
- 108090000902 ribosomal protein S5 Proteins 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 102100034541 tRNA (guanine(26)-N(2))-dimethyltransferase Human genes 0.000 description 2
- 102100029783 tRNA pseudouridine synthase A Human genes 0.000 description 2
- 101710194143 tRNA pseudouridine synthase A Proteins 0.000 description 2
- 239000011269 tar Substances 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- 231100000167 toxic agent Toxicity 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 108010071511 transcriptional intermediary factor 1 Proteins 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000010474 transient expression Effects 0.000 description 2
- 230000014621 translational initiation Effects 0.000 description 2
- 108010048891 transportin SR Proteins 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 230000004614 tumor growth Effects 0.000 description 2
- 230000003827 upregulation Effects 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 210000004325 uterine smooth muscle cell Anatomy 0.000 description 2
- 108010037501 vesicular transport factor p115 Proteins 0.000 description 2
- 239000013603 viral vector Substances 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- JBFQOLHAGBKPTP-NZATWWQASA-N (2s)-2-[[(2s)-4-carboxy-2-[[3-carboxy-2-[[(2s)-2,6-diaminohexanoyl]amino]propanoyl]amino]butanoyl]amino]-4-methylpentanoic acid Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)C(CC(O)=O)NC(=O)[C@@H](N)CCCCN JBFQOLHAGBKPTP-NZATWWQASA-N 0.000 description 1
- UOYQOJGTLUOLDS-GEMLJDPKSA-N (2s)-2-amino-5-[[(2r)-1-(carboxymethylamino)-1-oxo-3-sulfanylpropan-2-yl]amino]-5-oxopentanoic acid;selenium Chemical compound [Se].OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O UOYQOJGTLUOLDS-GEMLJDPKSA-N 0.000 description 1
- LAQPKDLYOBZWBT-NYLDSJSYSA-N (2s,4s,5r,6r)-5-acetamido-2-{[(2s,3r,4s,5s,6r)-2-{[(2r,3r,4r,5r)-5-acetamido-1,2-dihydroxy-6-oxo-4-{[(2s,3s,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}hexan-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-4-hydroxy-6-[(1r,2r)-1,2,3-trihydrox Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]([C@@H](NC(C)=O)C=O)[C@@H]([C@H](O)CO)O[C@H]1[C@H](O)[C@@H](O[C@]2(O[C@H]([C@H](NC(C)=O)[C@@H](O)C2)[C@H](O)[C@H](O)CO)C(O)=O)[C@@H](O)[C@@H](CO)O1 LAQPKDLYOBZWBT-NYLDSJSYSA-N 0.000 description 1
- 108010029190 1-Phosphatidylinositol 4-Kinase Proteins 0.000 description 1
- 102000001556 1-Phosphatidylinositol 4-Kinase Human genes 0.000 description 1
- 108020004463 18S ribosomal RNA Proteins 0.000 description 1
- INAPMGSXUVUWAF-UOTPTPDRSA-N 1D-myo-inositol 1-phosphate Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](OP(O)(O)=O)[C@H](O)[C@@H]1O INAPMGSXUVUWAF-UOTPTPDRSA-N 0.000 description 1
- 102100024830 2-(3-amino-3-carboxypropyl)histidine synthase subunit 2 Human genes 0.000 description 1
- FALRKNHUBBKYCC-UHFFFAOYSA-N 2-(chloromethyl)pyridine-3-carbonitrile Chemical compound ClCC1=NC=CC=C1C#N FALRKNHUBBKYCC-UHFFFAOYSA-N 0.000 description 1
- 208000010543 22q11.2 deletion syndrome Diseases 0.000 description 1
- 102100036734 26S proteasome non-ATPase regulatory subunit 10 Human genes 0.000 description 1
- BIDWUUDRRVHZLQ-UHFFFAOYSA-N 3-ethyl-3-(2-ethylhexoxymethyl)oxetane Chemical compound CCCCC(CC)COCC1(CC)COC1 BIDWUUDRRVHZLQ-UHFFFAOYSA-N 0.000 description 1
- COCMHKNAGZHBDZ-UHFFFAOYSA-N 4-carboxy-3-[3-(dimethylamino)-6-dimethylazaniumylidenexanthen-9-yl]benzoate Chemical compound C=12C=CC(=[N+](C)C)C=C2OC2=CC(N(C)C)=CC=C2C=1C1=CC(C([O-])=O)=CC=C1C(O)=O COCMHKNAGZHBDZ-UHFFFAOYSA-N 0.000 description 1
- 102100033400 4F2 cell-surface antigen heavy chain Human genes 0.000 description 1
- 102100025643 60S ribosomal protein L12 Human genes 0.000 description 1
- 101710187298 60S ribosomal protein L12 Proteins 0.000 description 1
- 102100033824 A-kinase anchor protein 12 Human genes 0.000 description 1
- 102100026445 A-kinase anchor protein 17A Human genes 0.000 description 1
- 108010005465 AC133 Antigen Proteins 0.000 description 1
- 102000005908 AC133 Antigen Human genes 0.000 description 1
- 102100040190 ADP-ribosylation factor-binding protein GGA2 Human genes 0.000 description 1
- 102100028814 ATP synthase mitochondrial F1 complex assembly factor 1 Human genes 0.000 description 1
- 102100027787 ATP synthase subunit g, mitochondrial Human genes 0.000 description 1
- 102100021407 ATP-dependent RNA helicase DDX18 Human genes 0.000 description 1
- 102100035972 ATPase GET3 Human genes 0.000 description 1
- 101710196038 Actin-10 Proteins 0.000 description 1
- 102100023989 Actin-related protein 2 Human genes 0.000 description 1
- 102100021636 Actin-related protein 2/3 complex subunit 2 Human genes 0.000 description 1
- 102100033892 Actin-related protein 2/3 complex subunit 5 Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108010045938 Adaptor Protein Complex gamma Subunits Proteins 0.000 description 1
- 102100030446 Adenosine 5'-monophosphoramidase HINT1 Human genes 0.000 description 1
- 101710142940 Adenosine deaminase 2 Proteins 0.000 description 1
- 101710136834 Adenylyl cyclase-associated protein Proteins 0.000 description 1
- 101710096343 Adhesion G protein-coupled receptor L1 Proteins 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 102100037995 Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B Human genes 0.000 description 1
- 208000012186 Alzheimer disease 3 Diseases 0.000 description 1
- 101710113670 Anaerobic glycerol-3-phosphate dehydrogenase subunit A Proteins 0.000 description 1
- 101710113668 Anaerobic glycerol-3-phosphate dehydrogenase subunit C Proteins 0.000 description 1
- 108010049777 Ankyrins Proteins 0.000 description 1
- 102000008102 Ankyrins Human genes 0.000 description 1
- 102000000412 Annexin Human genes 0.000 description 1
- 108050008874 Annexin Proteins 0.000 description 1
- 101000686547 Arabidopsis thaliana 30S ribosomal protein S1, chloroplastic Proteins 0.000 description 1
- 241000384062 Armadillo Species 0.000 description 1
- 102100033261 Aspartyl aminopeptidase Human genes 0.000 description 1
- 102100024747 Band 4.1-like protein 1 Human genes 0.000 description 1
- 102100029963 Beta-galactoside alpha-2,6-sialyltransferase 2 Human genes 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 102100034808 CCAAT/enhancer-binding protein alpha Human genes 0.000 description 1
- 101710150565 CDK5 regulatory subunit-associated protein 2 Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102100025580 Calmodulin-1 Human genes 0.000 description 1
- 102000007590 Calpain Human genes 0.000 description 1
- 108010032088 Calpain Proteins 0.000 description 1
- 102000003895 Calpain-1 Human genes 0.000 description 1
- 108090000236 Calpain-1 Proteins 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 102000004031 Carboxy-Lyases Human genes 0.000 description 1
- 108090000489 Carboxy-Lyases Proteins 0.000 description 1
- 108010031425 Casein Kinases Proteins 0.000 description 1
- 102000005403 Casein Kinases Human genes 0.000 description 1
- 108090000994 Catalytic RNA Proteins 0.000 description 1
- 102000053642 Catalytic RNA Human genes 0.000 description 1
- 102100021391 Cationic amino acid transporter 3 Human genes 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 102100025064 Cellular tumor antigen p53 Human genes 0.000 description 1
- 102100023309 Centrosomal protein of 152 kDa Human genes 0.000 description 1
- 206010008723 Chondrodystrophy Diseases 0.000 description 1
- 102400000676 Chondromodulin-1 Human genes 0.000 description 1
- 101800004542 Chondromodulin-1 Proteins 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 102100028284 Collagen alpha-1(XXVI) chain Human genes 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 102100033843 Condensin complex subunit 1 Human genes 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 102100032202 Cornulin Human genes 0.000 description 1
- 206010066946 Craniofacial dysostosis Diseases 0.000 description 1
- 102100029375 Crk-like protein Human genes 0.000 description 1
- 201000006526 Crouzon syndrome Diseases 0.000 description 1
- 101710110922 Cyclin-D-binding Myb-like transcription factor 1 Proteins 0.000 description 1
- 102100039683 Cyclin-G-associated kinase Human genes 0.000 description 1
- 101710113457 Cyclin-G-associated kinase Proteins 0.000 description 1
- 102100024458 Cyclin-dependent kinase inhibitor 2A Human genes 0.000 description 1
- 108010068682 Cyclophilins Proteins 0.000 description 1
- 102000001493 Cyclophilins Human genes 0.000 description 1
- 102100023419 Cystic fibrosis transmembrane conductance regulator Human genes 0.000 description 1
- 102100039925 Cytochrome b-c1 complex subunit 10 Human genes 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 108010024491 DNA Methyltransferase 3A Proteins 0.000 description 1
- 101710137105 DNA damage-binding protein 2 Proteins 0.000 description 1
- 102100024829 DNA polymerase delta catalytic subunit Human genes 0.000 description 1
- 230000033616 DNA repair Effects 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 101710109420 DNA-(apurinic or apyrimidinic site) endonuclease Proteins 0.000 description 1
- 102100027642 DNA-binding protein inhibitor ID-2 Human genes 0.000 description 1
- 101710081796 Death-inducer obliterator 1 Proteins 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 102100021215 Denticleless protein homolog Human genes 0.000 description 1
- 102100033582 Dermokine Human genes 0.000 description 1
- 108700029231 Developmental Genes Proteins 0.000 description 1
- 101000756636 Dictyostelium discoideum Major actin Proteins 0.000 description 1
- 108091000126 Dihydroorotase Proteins 0.000 description 1
- 101800001224 Disintegrin Proteins 0.000 description 1
- 101710116121 Disintegrin and metalloproteinase domain-containing protein 9 Proteins 0.000 description 1
- 101100521338 Drosophila melanogaster prominin-like gene Proteins 0.000 description 1
- 102100021236 Dynamin-1 Human genes 0.000 description 1
- 102100024827 Dynamin-1-like protein Human genes 0.000 description 1
- 101710191253 E3 SUMO-protein ligase PIAS4 Proteins 0.000 description 1
- 102100026246 E3 ubiquitin-protein ligase NRDP1 Human genes 0.000 description 1
- 101150062404 EDNRA gene Proteins 0.000 description 1
- 102100039368 ER lumen protein-retaining receptor 2 Human genes 0.000 description 1
- 102100027126 Echinoderm microtubule-associated protein-like 2 Human genes 0.000 description 1
- 241000258955 Echinodermata Species 0.000 description 1
- 102100035087 Ectoderm-neural cortex protein 1 Human genes 0.000 description 1
- 108010024882 Electron Transport Complex III Proteins 0.000 description 1
- 102000015782 Electron Transport Complex III Human genes 0.000 description 1
- 102100024125 Embryonal Fyn-associated substrate Human genes 0.000 description 1
- 102100038537 Endogenous retrovirus group K member 24 Pro protein Human genes 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 108700041152 Endoplasmic Reticulum Chaperone BiP Proteins 0.000 description 1
- 102100021451 Endoplasmic reticulum chaperone BiP Human genes 0.000 description 1
- 102100027117 Engulfment and cell motility protein 2 Human genes 0.000 description 1
- 102100029775 Eukaryotic translation initiation factor 1 Human genes 0.000 description 1
- 102100021699 Eukaryotic translation initiation factor 3 subunit B Human genes 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 1
- 108090000381 Fibroblast growth factor 4 Proteins 0.000 description 1
- 102100028072 Fibroblast growth factor 4 Human genes 0.000 description 1
- 241000714188 Friend murine leukemia virus Species 0.000 description 1
- 108090000839 GABA-A Receptors Proteins 0.000 description 1
- 102000004300 GABA-A Receptors Human genes 0.000 description 1
- 102000017700 GABRP Human genes 0.000 description 1
- 102000001534 GDP dissociation inhibitor Human genes 0.000 description 1
- 102100040196 GRB10-interacting GYF protein 2 Human genes 0.000 description 1
- 102100022084 GRIP1-associated protein 1 Human genes 0.000 description 1
- 102100022506 Gamma-aminobutyric acid receptor subunit pi Human genes 0.000 description 1
- 102100030916 Gamma-soluble NSF attachment protein Human genes 0.000 description 1
- 102100032862 General transcription factor IIH subunit 4 Human genes 0.000 description 1
- 102100028701 General vesicular transport factor p115 Human genes 0.000 description 1
- BPDVTFBJZNBHEU-HGNGGELXSA-N Glu-Ala-His Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 BPDVTFBJZNBHEU-HGNGGELXSA-N 0.000 description 1
- 102000058062 Glucose Transporter Type 3 Human genes 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 108010058940 Glutamyl Aminopeptidase Proteins 0.000 description 1
- 102000006485 Glutamyl Aminopeptidase Human genes 0.000 description 1
- 102100033044 Glutathione peroxidase 2 Human genes 0.000 description 1
- 101710119052 Glutathione peroxidase 2 Proteins 0.000 description 1
- 108010051724 Glycine-tRNA Ligase Proteins 0.000 description 1
- 101710127406 Glycoprotein 5 Proteins 0.000 description 1
- 102000051366 Glycosyltransferases Human genes 0.000 description 1
- 102000019220 Glycyl-tRNA synthetases Human genes 0.000 description 1
- 101710200205 Glyoxylate reductase/hydroxypyruvate reductase Proteins 0.000 description 1
- 102100034190 Glypican-1 Human genes 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
- 108010092964 Guanine Nucleotide Dissociation Inhibitors Proteins 0.000 description 1
- 102100039335 HAUS augmin-like complex subunit 5 Human genes 0.000 description 1
- 101150112743 HSPA5 gene Proteins 0.000 description 1
- 101710089250 Heat shock 70 kDa protein 5 Proteins 0.000 description 1
- 102100031624 Heat shock protein 105 kDa Human genes 0.000 description 1
- 101710195459 Histidine triad nucleotide-binding protein Proteins 0.000 description 1
- 102100039236 Histone H3.3 Human genes 0.000 description 1
- 108091016367 Histone-lysine N-methyltransferase EHMT2 Proteins 0.000 description 1
- 102100034826 Homeobox protein Meis2 Human genes 0.000 description 1
- 102100025449 Homeobox protein SIX5 Human genes 0.000 description 1
- 101710189526 Homeobox protein SIX5 Proteins 0.000 description 1
- 101000909233 Homo sapiens 2-(3-amino-3-carboxypropyl)histidine synthase subunit 2 Proteins 0.000 description 1
- 101001136581 Homo sapiens 26S proteasome non-ATPase regulatory subunit 10 Proteins 0.000 description 1
- 101000600756 Homo sapiens 3-phosphoinositide-dependent protein kinase 1 Proteins 0.000 description 1
- 101000718019 Homo sapiens A-kinase anchor protein 17A Proteins 0.000 description 1
- 101001037082 Homo sapiens ADP-ribosylation factor-binding protein GGA2 Proteins 0.000 description 1
- 101000789413 Homo sapiens ATP synthase mitochondrial F1 complex assembly factor 1 Proteins 0.000 description 1
- 101000936950 Homo sapiens ATP synthase subunit g, mitochondrial Proteins 0.000 description 1
- 101001041703 Homo sapiens ATP-dependent RNA helicase DDX18 Proteins 0.000 description 1
- 101001074983 Homo sapiens ATPase GET3 Proteins 0.000 description 1
- 101000975766 Homo sapiens Actin-related protein 2 Proteins 0.000 description 1
- 101000754220 Homo sapiens Actin-related protein 2/3 complex subunit 2 Proteins 0.000 description 1
- 101000925555 Homo sapiens Actin-related protein 2/3 complex subunit 5 Proteins 0.000 description 1
- 101000720051 Homo sapiens Adenosine deaminase 2 Proteins 0.000 description 1
- 101000959588 Homo sapiens Adhesion G protein-coupled receptor L1 Proteins 0.000 description 1
- 101000951413 Homo sapiens Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B Proteins 0.000 description 1
- 101000927708 Homo sapiens Aspartyl aminopeptidase Proteins 0.000 description 1
- 101000908754 Homo sapiens Band 4.1-like protein 1 Proteins 0.000 description 1
- 101000863891 Homo sapiens Beta-galactoside alpha-2,6-sialyltransferase 2 Proteins 0.000 description 1
- 101000945515 Homo sapiens CCAAT/enhancer-binding protein alpha Proteins 0.000 description 1
- 101000882873 Homo sapiens CDK5 regulatory subunit-associated protein 2 Proteins 0.000 description 1
- 101000984164 Homo sapiens Calmodulin-1 Proteins 0.000 description 1
- 101000721661 Homo sapiens Cellular tumor antigen p53 Proteins 0.000 description 1
- 101000908174 Homo sapiens Centrosomal protein of 152 kDa Proteins 0.000 description 1
- 101000860862 Homo sapiens Collagen alpha-1(XXVI) chain Proteins 0.000 description 1
- 101000710846 Homo sapiens Condensin complex subunit 1 Proteins 0.000 description 1
- 101001067929 Homo sapiens Core histone macro-H2A.1 Proteins 0.000 description 1
- 101000920981 Homo sapiens Cornulin Proteins 0.000 description 1
- 101000919315 Homo sapiens Crk-like protein Proteins 0.000 description 1
- 101000804518 Homo sapiens Cyclin-D-binding Myb-like transcription factor 1 Proteins 0.000 description 1
- 101000907783 Homo sapiens Cystic fibrosis transmembrane conductance regulator Proteins 0.000 description 1
- 101000607479 Homo sapiens Cytochrome b-c1 complex subunit 10 Proteins 0.000 description 1
- 101000909242 Homo sapiens DNA (cytosine-5)-methyltransferase 3A Proteins 0.000 description 1
- 101001041466 Homo sapiens DNA damage-binding protein 2 Proteins 0.000 description 1
- 101001134036 Homo sapiens DNA mismatch repair protein Msh2 Proteins 0.000 description 1
- 101000909198 Homo sapiens DNA polymerase delta catalytic subunit Proteins 0.000 description 1
- 101000806846 Homo sapiens DNA-(apurinic or apyrimidinic site) endonuclease Proteins 0.000 description 1
- 101000956149 Homo sapiens Death-associated protein kinase 3 Proteins 0.000 description 1
- 101000869896 Homo sapiens Death-inducer obliterator 1 Proteins 0.000 description 1
- 101000968287 Homo sapiens Denticleless protein homolog Proteins 0.000 description 1
- 101000832769 Homo sapiens Disintegrin and metalloproteinase domain-containing protein 9 Proteins 0.000 description 1
- 101000817604 Homo sapiens Dynamin-1 Proteins 0.000 description 1
- 101000909218 Homo sapiens Dynamin-1-like protein Proteins 0.000 description 1
- 101000692706 Homo sapiens E3 ubiquitin-protein ligase NRDP1 Proteins 0.000 description 1
- 101100225546 Homo sapiens EHMT2 gene Proteins 0.000 description 1
- 101000812465 Homo sapiens ER lumen protein-retaining receptor 2 Proteins 0.000 description 1
- 101001057942 Homo sapiens Echinoderm microtubule-associated protein-like 2 Proteins 0.000 description 1
- 101000877456 Homo sapiens Ectoderm-neural cortex protein 1 Proteins 0.000 description 1
- 101001053896 Homo sapiens Embryonal Fyn-associated substrate Proteins 0.000 description 1
- 101001064121 Homo sapiens Endogenous retrovirus group K member 24 Env polyprotein Proteins 0.000 description 1
- 101000893923 Homo sapiens Endogenous retrovirus group K member 24 Gag polyprotein Proteins 0.000 description 1
- 101000995911 Homo sapiens Endogenous retrovirus group K member 24 Np9 protein Proteins 0.000 description 1
- 101000956196 Homo sapiens Endogenous retrovirus group K member 24 Pro protein Proteins 0.000 description 1
- 101000967336 Homo sapiens Endothelin-1 receptor Proteins 0.000 description 1
- 101001057855 Homo sapiens Engulfment and cell motility protein 2 Proteins 0.000 description 1
- 101000967216 Homo sapiens Eosinophil cationic protein Proteins 0.000 description 1
- 101001012787 Homo sapiens Eukaryotic translation initiation factor 1 Proteins 0.000 description 1
- 101000896557 Homo sapiens Eukaryotic translation initiation factor 3 subunit B Proteins 0.000 description 1
- 101000892677 Homo sapiens Fermitin family homolog 2 Proteins 0.000 description 1
- 101000846888 Homo sapiens Fibrillin-3 Proteins 0.000 description 1
- 101001052035 Homo sapiens Fibroblast growth factor 2 Proteins 0.000 description 1
- 101000827688 Homo sapiens Fibroblast growth factor receptor 2 Proteins 0.000 description 1
- 101001037074 Homo sapiens GRB10-interacting GYF protein 2 Proteins 0.000 description 1
- 101000900683 Homo sapiens GRIP1-associated protein 1 Proteins 0.000 description 1
- 101001042451 Homo sapiens Galectin-1 Proteins 0.000 description 1
- 101000702693 Homo sapiens Gamma-soluble NSF attachment protein Proteins 0.000 description 1
- 101000655406 Homo sapiens General transcription factor IIH subunit 4 Proteins 0.000 description 1
- 101001010442 Homo sapiens Glyoxylate reductase/hydroxypyruvate reductase Proteins 0.000 description 1
- 101001014668 Homo sapiens Glypican-3 Proteins 0.000 description 1
- 101001035821 Homo sapiens HAUS augmin-like complex subunit 5 Proteins 0.000 description 1
- 101000866478 Homo sapiens Heat shock protein 105 kDa Proteins 0.000 description 1
- 101001035966 Homo sapiens Histone H3.3 Proteins 0.000 description 1
- 101001047006 Homo sapiens Histone acetyltransferase KAT2B Proteins 0.000 description 1
- 101000877312 Homo sapiens Histone-lysine N-methyltransferase EHMT2 Proteins 0.000 description 1
- 101001019057 Homo sapiens Homeobox protein Meis2 Proteins 0.000 description 1
- 101001046870 Homo sapiens Hypoxia-inducible factor 1-alpha Proteins 0.000 description 1
- 101000852543 Homo sapiens Importin-4 Proteins 0.000 description 1
- 101000599453 Homo sapiens Importin-9 Proteins 0.000 description 1
- 101000606465 Homo sapiens Inactive tyrosine-protein kinase 7 Proteins 0.000 description 1
- 101000962413 Homo sapiens Inositol polyphosphate-5-phosphatase A Proteins 0.000 description 1
- 101000840572 Homo sapiens Insulin-like growth factor-binding protein 4 Proteins 0.000 description 1
- 101001050282 Homo sapiens Jupiter microtubule associated homolog 2 Proteins 0.000 description 1
- 101001006887 Homo sapiens Kelch-like protein 21 Proteins 0.000 description 1
- 101000966742 Homo sapiens Leucine-rich PPR motif-containing protein, mitochondrial Proteins 0.000 description 1
- 101000624540 Homo sapiens Leucine-tRNA ligase, mitochondrial Proteins 0.000 description 1
- 101001036258 Homo sapiens Little elongation complex subunit 2 Proteins 0.000 description 1
- 101001039207 Homo sapiens Low-density lipoprotein receptor-related protein 8 Proteins 0.000 description 1
- 101000977270 Homo sapiens MMS19 nucleotide excision repair protein homolog Proteins 0.000 description 1
- 101001019104 Homo sapiens Mediator of RNA polymerase II transcription subunit 14 Proteins 0.000 description 1
- 101001057156 Homo sapiens Melanoma-associated antigen C2 Proteins 0.000 description 1
- 101000967192 Homo sapiens Metastasis-associated protein MTA3 Proteins 0.000 description 1
- 101001116774 Homo sapiens Methionine-R-sulfoxide reductase B2, mitochondrial Proteins 0.000 description 1
- 101000590830 Homo sapiens Monocarboxylate transporter 1 Proteins 0.000 description 1
- 101000969812 Homo sapiens Multidrug resistance-associated protein 1 Proteins 0.000 description 1
- 101001128460 Homo sapiens Myosin light polypeptide 6 Proteins 0.000 description 1
- 101001116520 Homo sapiens Myotubularin-related protein 11 Proteins 0.000 description 1
- 101001111187 Homo sapiens NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial Proteins 0.000 description 1
- 101000573300 Homo sapiens NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial Proteins 0.000 description 1
- 101000837517 Homo sapiens NEDD8-activating enzyme E1 catalytic subunit Proteins 0.000 description 1
- 101000962052 Homo sapiens Neurobeachin-like protein 2 Proteins 0.000 description 1
- 101001111338 Homo sapiens Neurofilament heavy polypeptide Proteins 0.000 description 1
- 101000577541 Homo sapiens Neuronal regeneration-related protein Proteins 0.000 description 1
- 101001109620 Homo sapiens Nucleolar and coiled-body phosphoprotein 1 Proteins 0.000 description 1
- 101000979629 Homo sapiens Nucleoside diphosphate kinase A Proteins 0.000 description 1
- 101000979623 Homo sapiens Nucleoside diphosphate kinase B Proteins 0.000 description 1
- 101001041245 Homo sapiens Ornithine decarboxylase Proteins 0.000 description 1
- 101001121326 Homo sapiens Oxidative stress-induced growth inhibitor 2 Proteins 0.000 description 1
- 101000651906 Homo sapiens Paired amphipathic helix protein Sin3a Proteins 0.000 description 1
- 101000651908 Homo sapiens Paired amphipathic helix protein Sin3b Proteins 0.000 description 1
- 101000818376 Homo sapiens Palmitoyltransferase ZDHHC17 Proteins 0.000 description 1
- 101000619708 Homo sapiens Peroxiredoxin-6 Proteins 0.000 description 1
- 101000689394 Homo sapiens Phospholipid scramblase 4 Proteins 0.000 description 1
- 101001081953 Homo sapiens Phosphoribosylaminoimidazole carboxylase Proteins 0.000 description 1
- 101000872170 Homo sapiens Polycomb complex protein BMI-1 Proteins 0.000 description 1
- 101000912686 Homo sapiens Probable ATP-dependent RNA helicase DDX23 Proteins 0.000 description 1
- 101000734702 Homo sapiens Proline-, glutamic acid- and leucine-rich protein 1 Proteins 0.000 description 1
- 101000705766 Homo sapiens Proteasome activator complex subunit 3 Proteins 0.000 description 1
- 101001050220 Homo sapiens Proteasome adapter and scaffold protein ECM29 Proteins 0.000 description 1
- 101000892338 Homo sapiens Protein AF1q Proteins 0.000 description 1
- 101000933252 Homo sapiens Protein BEX3 Proteins 0.000 description 1
- 101000585728 Homo sapiens Protein O-GlcNAcase Proteins 0.000 description 1
- 101000652172 Homo sapiens Protein Smaug homolog 1 Proteins 0.000 description 1
- 101000878687 Homo sapiens Protein cramped-like Proteins 0.000 description 1
- 101001072202 Homo sapiens Protein disulfide-isomerase Proteins 0.000 description 1
- 101001133607 Homo sapiens Protein kinase C and casein kinase substrate in neurons protein 3 Proteins 0.000 description 1
- 101000958299 Homo sapiens Protein lyl-1 Proteins 0.000 description 1
- 101000822312 Homo sapiens Protein transport protein Sec24C Proteins 0.000 description 1
- 101000591312 Homo sapiens Putative MORF4 family-associated protein 1-like protein UPP Proteins 0.000 description 1
- 101000979900 Homo sapiens Putative methyltransferase NSUN5C Proteins 0.000 description 1
- 101000996935 Homo sapiens Putative oxidoreductase GLYR1 Proteins 0.000 description 1
- 101000779418 Homo sapiens RAC-alpha serine/threonine-protein kinase Proteins 0.000 description 1
- 101100086726 Homo sapiens RCC2 gene Proteins 0.000 description 1
- 101000841682 Homo sapiens RING finger protein unkempt homolog Proteins 0.000 description 1
- 101000746142 Homo sapiens RNA polymerase-associated protein CTR9 homolog Proteins 0.000 description 1
- 101001077488 Homo sapiens RNA-binding protein Raly Proteins 0.000 description 1
- 101001130290 Homo sapiens Rab GTPase-binding effector protein 1 Proteins 0.000 description 1
- 101000893674 Homo sapiens Ras GTPase-activating protein-binding protein 2 Proteins 0.000 description 1
- 101000579702 Homo sapiens Replication factor C subunit 1 Proteins 0.000 description 1
- 101001132652 Homo sapiens Retinoic acid receptor responder protein 2 Proteins 0.000 description 1
- 101000856728 Homo sapiens Rho GDP-dissociation inhibitor 1 Proteins 0.000 description 1
- 101000581122 Homo sapiens Rho-related GTP-binding protein RhoD Proteins 0.000 description 1
- 101001104307 Homo sapiens Ribonuclease 7 Proteins 0.000 description 1
- 101000832674 Homo sapiens SURP and G-patch domain-containing protein 2 Proteins 0.000 description 1
- 101000702544 Homo sapiens SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5 Proteins 0.000 description 1
- 101000687737 Homo sapiens SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 1 Proteins 0.000 description 1
- 101000702542 Homo sapiens SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 Proteins 0.000 description 1
- 101000654679 Homo sapiens Semaphorin-5B Proteins 0.000 description 1
- 101000654674 Homo sapiens Semaphorin-6A Proteins 0.000 description 1
- 101000753197 Homo sapiens Sodium/potassium-transporting ATPase subunit alpha-2 Proteins 0.000 description 1
- 101000617818 Homo sapiens Solute carrier organic anion transporter family member 4A1 Proteins 0.000 description 1
- 101000707770 Homo sapiens Splicing factor 3B subunit 2 Proteins 0.000 description 1
- 101000651299 Homo sapiens Sprouty-related, EVH1 domain-containing protein 2 Proteins 0.000 description 1
- 101000685323 Homo sapiens Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial Proteins 0.000 description 1
- 101000800571 Homo sapiens T-box transcription factor T Proteins 0.000 description 1
- 101000714144 Homo sapiens Telomeric repeat-binding factor 1 Proteins 0.000 description 1
- 101000596825 Homo sapiens Testin Proteins 0.000 description 1
- 101000837626 Homo sapiens Thyroid hormone receptor alpha Proteins 0.000 description 1
- 101000638427 Homo sapiens Tonsoku-like protein Proteins 0.000 description 1
- 101000796673 Homo sapiens Transformation/transcription domain-associated protein Proteins 0.000 description 1
- 101000629913 Homo sapiens Translocon-associated protein subunit beta Proteins 0.000 description 1
- 101000766332 Homo sapiens Tribbles homolog 1 Proteins 0.000 description 1
- 101000713575 Homo sapiens Tubulin beta-3 chain Proteins 0.000 description 1
- 101000801254 Homo sapiens Tumor necrosis factor receptor superfamily member 16 Proteins 0.000 description 1
- 101000987017 Homo sapiens Tumor protein p53-inducible protein 11 Proteins 0.000 description 1
- 101000807306 Homo sapiens Ubiquitin-like modifier-activating enzyme 1 Proteins 0.000 description 1
- 101000608672 Homo sapiens Uveal autoantigen with coiled-coil domains and ankyrin repeats Proteins 0.000 description 1
- 101000818832 Homo sapiens Zinc finger protein 608 Proteins 0.000 description 1
- 102100035957 Huntingtin-interacting protein 1 Human genes 0.000 description 1
- 108050003304 Huntingtin-interacting protein 1 Proteins 0.000 description 1
- 102100022875 Hypoxia-inducible factor 1-alpha Human genes 0.000 description 1
- 101710125768 Importin-4 Proteins 0.000 description 1
- 101710125765 Importin-9 Proteins 0.000 description 1
- 101710099452 Inactive tyrosine-protein kinase 7 Proteins 0.000 description 1
- 108010055912 Inhibitor of Differentiation Protein 2 Proteins 0.000 description 1
- 102000009617 Inorganic Pyrophosphatase Human genes 0.000 description 1
- 108010009595 Inorganic Pyrophosphatase Proteins 0.000 description 1
- 102100039253 Inositol polyphosphate-5-phosphatase A Human genes 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 108090001117 Insulin-Like Growth Factor II Proteins 0.000 description 1
- 102000004369 Insulin-like growth factor-binding protein 4 Human genes 0.000 description 1
- 102100029224 Insulin-like growth factor-binding protein 4 Human genes 0.000 description 1
- 108090000969 Insulin-like growth factor-binding protein 4 Proteins 0.000 description 1
- 102100039134 Integrator complex subunit 4 Human genes 0.000 description 1
- 108010064593 Intercellular Adhesion Molecule-1 Proteins 0.000 description 1
- 102100037795 Interleukin-6 receptor subunit beta Human genes 0.000 description 1
- 101710152369 Interleukin-6 receptor subunit beta Proteins 0.000 description 1
- 108090001007 Interleukin-8 Proteins 0.000 description 1
- 108010044467 Isoenzymes Proteins 0.000 description 1
- 208000009289 Jackson-Weiss syndrome Diseases 0.000 description 1
- 108010025815 Kanamycin Kinase Proteins 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- 102100038204 Large neutral amino acids transporter small subunit 1 Human genes 0.000 description 1
- 241000713666 Lentivirus Species 0.000 description 1
- 108010071170 Leucine-tRNA ligase Proteins 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 102100039420 Little elongation complex subunit 2 Human genes 0.000 description 1
- 108010015340 Low Density Lipoprotein Receptor-Related Protein-1 Proteins 0.000 description 1
- 102100027434 Luc7-like protein 3 Human genes 0.000 description 1
- 101710133040 Luc7-like protein 3 Proteins 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 108091054455 MAP kinase family Proteins 0.000 description 1
- 102000043136 MAP kinase family Human genes 0.000 description 1
- 102100028397 MAP kinase-activated protein kinase 3 Human genes 0.000 description 1
- 108010041980 MAP-kinase-activated kinase 3 Proteins 0.000 description 1
- 102000034655 MIF Human genes 0.000 description 1
- 101710134025 MMS19 nucleotide excision repair protein homolog Proteins 0.000 description 1
- 229910015837 MSH2 Inorganic materials 0.000 description 1
- 108010048043 Macrophage Migration-Inhibitory Factors Proteins 0.000 description 1
- 206010064912 Malignant transformation Diseases 0.000 description 1
- 101001129124 Mannheimia haemolytica Outer membrane lipoprotein 1 Proteins 0.000 description 1
- 102100034820 Mediator of RNA polymerase II transcription subunit 14 Human genes 0.000 description 1
- 102100027252 Melanoma-associated antigen C2 Human genes 0.000 description 1
- 102000005741 Metalloproteases Human genes 0.000 description 1
- 108010006035 Metalloproteases Proteins 0.000 description 1
- 102100040617 Metastasis-associated protein MTA3 Human genes 0.000 description 1
- 101000859568 Methanobrevibacter smithii (strain ATCC 35061 / DSM 861 / OCM 144 / PS) Carbamoyl-phosphate synthase Proteins 0.000 description 1
- 102100024862 Methionine-R-sulfoxide reductase B2, mitochondrial Human genes 0.000 description 1
- 102000009664 Microtubule-Associated Proteins Human genes 0.000 description 1
- 108010020004 Microtubule-Associated Proteins Proteins 0.000 description 1
- 102000012870 Minichromosome Maintenance Complex Component 4 Human genes 0.000 description 1
- 108010079786 Minichromosome Maintenance Complex Component 4 Proteins 0.000 description 1
- 108010079754 Minichromosome Maintenance Complex Component 6 Proteins 0.000 description 1
- 102000012942 Minichromosome Maintenance Complex Component 6 Human genes 0.000 description 1
- 241000713869 Moloney murine leukemia virus Species 0.000 description 1
- 102100034068 Monocarboxylate transporter 1 Human genes 0.000 description 1
- YXOLAZRVSSWPPT-UHFFFAOYSA-N Morin Chemical compound OC1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 YXOLAZRVSSWPPT-UHFFFAOYSA-N 0.000 description 1
- 102100021339 Multidrug resistance-associated protein 1 Human genes 0.000 description 1
- 241000180709 Murine type C retrovirus Species 0.000 description 1
- 101001019055 Mus musculus Homeobox protein Meis1 Proteins 0.000 description 1
- 101001067395 Mus musculus Phospholipid scramblase 1 Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 108700031745 MutS Homolog 2 Proteins 0.000 description 1
- 102000047831 Myeloid Ecotropic Viral Integration Site 1 Human genes 0.000 description 1
- 108060008487 Myosin Proteins 0.000 description 1
- 102000003505 Myosin Human genes 0.000 description 1
- 102100031829 Myosin light polypeptide 6 Human genes 0.000 description 1
- 102100024963 Myotubularin-related protein 11 Human genes 0.000 description 1
- 108010081735 N-Ethylmaleimide-Sensitive Proteins Proteins 0.000 description 1
- 102000004868 N-Methyl-D-Aspartate Receptors Human genes 0.000 description 1
- 108090001041 N-Methyl-D-Aspartate Receptors Proteins 0.000 description 1
- BAWFJGJZGIEFAR-NNYOXOHSSA-O NAD(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-O 0.000 description 1
- 102100023964 NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial Human genes 0.000 description 1
- 102100026360 NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial Human genes 0.000 description 1
- 108700037255 NEDD8-activating enzyme E1 catalytic subunit Proteins 0.000 description 1
- 101150090182 NELL2 gene Proteins 0.000 description 1
- 108010081372 NM23 Nucleoside Diphosphate Kinases Proteins 0.000 description 1
- 102000005238 NM23 Nucleoside Diphosphate Kinases Human genes 0.000 description 1
- 101150065592 NME2 gene Proteins 0.000 description 1
- 102000034570 NR1 subfamily Human genes 0.000 description 1
- 108020001305 NR1 subfamily Proteins 0.000 description 1
- 102000038100 NR2 subfamily Human genes 0.000 description 1
- 108020002076 NR2 subfamily Proteins 0.000 description 1
- 108010032605 Nerve Growth Factor Receptors Proteins 0.000 description 1
- 102100039235 Neurobeachin-like protein 2 Human genes 0.000 description 1
- 108010088373 Neurofilament Proteins Proteins 0.000 description 1
- 102000008763 Neurofilament Proteins Human genes 0.000 description 1
- 102100024007 Neurofilament heavy polypeptide Human genes 0.000 description 1
- 208000002537 Neuronal Ceroid-Lipofuscinoses Diseases 0.000 description 1
- 102100028745 Neuronal regeneration-related protein Human genes 0.000 description 1
- 108010084810 Neurotransmitter Transport Proteins Proteins 0.000 description 1
- 102000005665 Neurotransmitter Transport Proteins Human genes 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- 108010035916 Nuclear Matrix-Associated Proteins Proteins 0.000 description 1
- 102000008297 Nuclear Matrix-Associated Proteins Human genes 0.000 description 1
- 102000007999 Nuclear Proteins Human genes 0.000 description 1
- 108010089610 Nuclear Proteins Proteins 0.000 description 1
- 101710202583 Nuclear pore complex protein NUP85 Proteins 0.000 description 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 101710123727 Nucleolar and coiled-body phosphoprotein 1 Proteins 0.000 description 1
- 102100023252 Nucleoside diphosphate kinase A Human genes 0.000 description 1
- 101710192961 Nucleosome assembly protein 1-like 1 Proteins 0.000 description 1
- 101710147982 Nucleosome assembly protein 1;1 Proteins 0.000 description 1
- 101000761187 Odontomachus monticola U-poneritoxin(01)-Om1a Proteins 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108010053291 Oncogene Protein v-akt Proteins 0.000 description 1
- 108010078627 Oncogene Protein v-crk Proteins 0.000 description 1
- 102000016451 Ornithine decarboxylase antizyme 2 Human genes 0.000 description 1
- 108050006091 Ornithine decarboxylase antizyme 2 Proteins 0.000 description 1
- 208000004286 Osteochondrodysplasias Diseases 0.000 description 1
- 102100040557 Osteopontin Human genes 0.000 description 1
- 101710160107 Outer membrane protein A Proteins 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 102100026317 Oxidative stress-induced growth inhibitor 2 Human genes 0.000 description 1
- 238000002944 PCR assay Methods 0.000 description 1
- 101150099424 PDIA4 gene Proteins 0.000 description 1
- 101150048468 PODXL gene Proteins 0.000 description 1
- 102000025443 POZ domain binding proteins Human genes 0.000 description 1
- 108091014659 POZ domain binding proteins Proteins 0.000 description 1
- 102100027333 Paired amphipathic helix protein Sin3b Human genes 0.000 description 1
- 102100021061 Palmitoyltransferase ZDHHC17 Human genes 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 108010077524 Peptide Elongation Factor 1 Proteins 0.000 description 1
- 108010044843 Peptide Initiation Factors Proteins 0.000 description 1
- 102000005877 Peptide Initiation Factors Human genes 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 108010092528 Phosphate Transport Proteins Proteins 0.000 description 1
- 102000016462 Phosphate Transport Proteins Human genes 0.000 description 1
- 102000007982 Phosphoproteins Human genes 0.000 description 1
- 108010089430 Phosphoproteins Proteins 0.000 description 1
- 108010022181 Phosphopyruvate Hydratase Proteins 0.000 description 1
- 102000012288 Phosphopyruvate Hydratase Human genes 0.000 description 1
- 108010064071 Phosphorylase Kinase Proteins 0.000 description 1
- 102000014750 Phosphorylase Kinase Human genes 0.000 description 1
- 102000009097 Phosphorylases Human genes 0.000 description 1
- 108010073135 Phosphorylases Proteins 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 102100038411 Platelet glycoprotein V Human genes 0.000 description 1
- 101710195077 Platelet glycoprotein V Proteins 0.000 description 1
- 108091026813 Poly(ADPribose) Proteins 0.000 description 1
- 102100033566 Polycomb complex protein BMI-1 Human genes 0.000 description 1
- 108010068086 Polyubiquitin Proteins 0.000 description 1
- 102100037935 Polyubiquitin-C Human genes 0.000 description 1
- 102000004257 Potassium Channel Human genes 0.000 description 1
- 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 1
- 108010036933 Presenilin-1 Proteins 0.000 description 1
- 102100026136 Probable ATP-dependent RNA helicase DDX23 Human genes 0.000 description 1
- 102100028772 Proline dehydrogenase 1, mitochondrial Human genes 0.000 description 1
- 102100034729 Proline-, glutamic acid- and leucine-rich protein 1 Human genes 0.000 description 1
- 102100021923 Prolow-density lipoprotein receptor-related protein 1 Human genes 0.000 description 1
- 108010059712 Pronase Proteins 0.000 description 1
- 102100032258 Prostaglandin reductase 1 Human genes 0.000 description 1
- 102100031298 Proteasome activator complex subunit 3 Human genes 0.000 description 1
- 102100023080 Proteasome adapter and scaffold protein ECM29 Human genes 0.000 description 1
- 102100040665 Protein AF1q Human genes 0.000 description 1
- 102100025955 Protein BEX3 Human genes 0.000 description 1
- 102100032706 Protein Jade-1 Human genes 0.000 description 1
- 101710173740 Protein Jade-1 Proteins 0.000 description 1
- 102000003923 Protein Kinase C Human genes 0.000 description 1
- 101710081801 Protein O-GlcNAcase Proteins 0.000 description 1
- 108010059000 Protein Phosphatase 1 Proteins 0.000 description 1
- 102000005569 Protein Phosphatase 1 Human genes 0.000 description 1
- 102100039972 Protein RCC2 Human genes 0.000 description 1
- 102100030591 Protein Smaug homolog 1 Human genes 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 101710150593 Protein beta Proteins 0.000 description 1
- 102100038012 Protein cramped-like Human genes 0.000 description 1
- 102100037089 Protein disulfide-isomerase A4 Human genes 0.000 description 1
- 102100037088 Protein disulfide-isomerase A5 Human genes 0.000 description 1
- 101710106234 Protein disulfide-isomerase A5 Proteins 0.000 description 1
- 102100034315 Protein kinase C and casein kinase substrate in neurons protein 3 Human genes 0.000 description 1
- 102100038231 Protein lyl-1 Human genes 0.000 description 1
- 102100022538 Protein transport protein Sec24C Human genes 0.000 description 1
- 108010014608 Proto-Oncogene Proteins c-kit Proteins 0.000 description 1
- 102000016971 Proto-Oncogene Proteins c-kit Human genes 0.000 description 1
- 101710097451 Putative G-protein coupled receptor Proteins 0.000 description 1
- 102100034096 Putative MORF4 family-associated protein 1-like protein UPP Human genes 0.000 description 1
- 101710123132 Putative methyltransferase NSUN5C Proteins 0.000 description 1
- 102100034301 Putative oxidoreductase GLYR1 Human genes 0.000 description 1
- 102100039117 Putative vomeronasal receptor-like protein 4 Human genes 0.000 description 1
- 102000009609 Pyrophosphatases Human genes 0.000 description 1
- 108010009413 Pyrophosphatases Proteins 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 102100033810 RAC-alpha serine/threonine-protein kinase Human genes 0.000 description 1
- 102100029455 RING finger protein unkempt homolog Human genes 0.000 description 1
- 102220581868 RNA N6-adenosine-methyltransferase METTL16_R12A_mutation Human genes 0.000 description 1
- 102100025052 RNA-binding protein Raly Human genes 0.000 description 1
- 102100031523 Rab GTPase-binding effector protein 1 Human genes 0.000 description 1
- 102000014113 Rabaptin-5 Human genes 0.000 description 1
- 108050003998 Rabaptin-5 Proteins 0.000 description 1
- 102100040857 Ras GTPase-activating protein-binding protein 2 Human genes 0.000 description 1
- 102000003901 Ras GTPase-activating proteins Human genes 0.000 description 1
- 108090000231 Ras GTPase-activating proteins Proteins 0.000 description 1
- 101000595041 Rattus norvegicus Podocalyxin Proteins 0.000 description 1
- 101100433158 Rattus norvegicus Zc3hav1 gene Proteins 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 102100028270 Replication factor C subunit 1 Human genes 0.000 description 1
- 206010038910 Retinitis Diseases 0.000 description 1
- 201000000582 Retinoblastoma Diseases 0.000 description 1
- 102100033914 Retinoic acid receptor responder protein 2 Human genes 0.000 description 1
- 101710202172 Rho GDP-dissociation inhibitor Proteins 0.000 description 1
- 102100025642 Rho GDP-dissociation inhibitor 1 Human genes 0.000 description 1
- 238000011579 SCID mouse model Methods 0.000 description 1
- 102000000395 SH3 domains Human genes 0.000 description 1
- 108050008861 SH3 domains Proteins 0.000 description 1
- 102000012987 SLC1A5 Human genes 0.000 description 1
- 108060002241 SLC1A5 Proteins 0.000 description 1
- 108091006788 SLC20A1 Proteins 0.000 description 1
- 108091006792 SLC20A2 Proteins 0.000 description 1
- 108091006298 SLC2A3 Proteins 0.000 description 1
- 108091006313 SLC3A2 Proteins 0.000 description 1
- 108091006248 SLC7 Cationic Amino Acid Transporter Proteins 0.000 description 1
- 108091006230 SLC7A3 Proteins 0.000 description 1
- 108091006232 SLC7A5 Proteins 0.000 description 1
- 102100024541 SURP and G-patch domain-containing protein 2 Human genes 0.000 description 1
- 102100031028 SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5 Human genes 0.000 description 1
- 102100024777 SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 1 Human genes 0.000 description 1
- 102100031029 SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 Human genes 0.000 description 1
- 101100189627 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) PTC5 gene Proteins 0.000 description 1
- 101710192308 Sal-like protein 2 Proteins 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 101100082911 Schizosaccharomyces pombe (strain 972 / ATCC 24843) ppp1 gene Proteins 0.000 description 1
- 102000009203 Sema domains Human genes 0.000 description 1
- 108050000099 Sema domains Proteins 0.000 description 1
- 102000014105 Semaphorin Human genes 0.000 description 1
- 108050003978 Semaphorin Proteins 0.000 description 1
- 102100032780 Semaphorin-5B Human genes 0.000 description 1
- 102100032795 Semaphorin-6A Human genes 0.000 description 1
- 101710143039 Serine/threonine/tyrosine-interacting protein Proteins 0.000 description 1
- 102000007365 Sialoglycoproteins Human genes 0.000 description 1
- 108010032838 Sialoglycoproteins Proteins 0.000 description 1
- 108010051611 Signal Recognition Particle Proteins 0.000 description 1
- 102000013598 Signal recognition particle Human genes 0.000 description 1
- 102100037082 Signal recognition particle 14 kDa protein Human genes 0.000 description 1
- 101710089523 Signal recognition particle 14 kDa protein Proteins 0.000 description 1
- 102100034803 Small nuclear ribonucleoprotein-associated protein N Human genes 0.000 description 1
- 102100029797 Sodium-dependent phosphate transporter 1 Human genes 0.000 description 1
- 102100032419 Sodium-dependent phosphate transporter 2 Human genes 0.000 description 1
- 102100021955 Sodium/potassium-transporting ATPase subunit alpha-2 Human genes 0.000 description 1
- 102100022004 Solute carrier organic anion transporter family member 4A1 Human genes 0.000 description 1
- 101710168942 Sphingosine-1-phosphate phosphatase 1 Proteins 0.000 description 1
- 102100031436 Splicing factor 3B subunit 2 Human genes 0.000 description 1
- 102100027650 Sprouty-related, EVH1 domain-containing protein 2 Human genes 0.000 description 1
- 238000012896 Statistical algorithm Methods 0.000 description 1
- 241000030560 Styx Species 0.000 description 1
- 108010012901 Succinate Dehydrogenase Proteins 0.000 description 1
- 102000019259 Succinate Dehydrogenase Human genes 0.000 description 1
- 102100023155 Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial Human genes 0.000 description 1
- 101710138921 Symplekin Proteins 0.000 description 1
- 108010083130 Syntenins Proteins 0.000 description 1
- 102100033130 T-box transcription factor T Human genes 0.000 description 1
- 108010044281 TATA-Box Binding Protein Proteins 0.000 description 1
- 108010033711 Telomeric Repeat Binding Protein 1 Proteins 0.000 description 1
- 206010043276 Teratoma Diseases 0.000 description 1
- 206010049808 Thanatophoric dwarfism Diseases 0.000 description 1
- 102000006601 Thymidine Kinase Human genes 0.000 description 1
- 108020004440 Thymidine kinase Proteins 0.000 description 1
- 102100028702 Thyroid hormone receptor alpha Human genes 0.000 description 1
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical class IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 description 1
- 102100031224 Tonsoku-like protein Human genes 0.000 description 1
- 102000006288 Transcription Factor TFIIH Human genes 0.000 description 1
- 108010083256 Transcription Factor TFIIH Proteins 0.000 description 1
- 102100037116 Transcription elongation factor 1 homolog Human genes 0.000 description 1
- 102000000887 Transcription factor STAT Human genes 0.000 description 1
- 108050007918 Transcription factor STAT Proteins 0.000 description 1
- 101710177718 Transcription intermediary factor 1-beta Proteins 0.000 description 1
- 102000004338 Transferrin Human genes 0.000 description 1
- 108090000901 Transferrin Proteins 0.000 description 1
- 108010043652 Transketolase Proteins 0.000 description 1
- 102100026229 Translocon-associated protein subunit beta Human genes 0.000 description 1
- 102100026387 Tribbles homolog 1 Human genes 0.000 description 1
- 102100036790 Tubulin beta-3 chain Human genes 0.000 description 1
- 102100027873 Tumor protein p53-inducible protein 11 Human genes 0.000 description 1
- 108010086857 U5 Small Nuclear Ribonucleoprotein Proteins 0.000 description 1
- 102000006837 U5 Small Nuclear Ribonucleoprotein Human genes 0.000 description 1
- 102000003436 UBA3 Human genes 0.000 description 1
- 108060008744 UBA3 Proteins 0.000 description 1
- LFTYTUAZOPRMMI-NESSUJCYSA-N UDP-N-acetyl-alpha-D-galactosamine Chemical compound O1[C@H](CO)[C@H](O)[C@H](O)[C@@H](NC(=O)C)[C@H]1O[P@](O)(=O)O[P@](O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C(NC(=O)C=C2)=O)O1 LFTYTUAZOPRMMI-NESSUJCYSA-N 0.000 description 1
- 101710117112 UDP-N-acetylglucosamine-peptide N-acetylglucosaminyltransferase 110 kDa subunit Proteins 0.000 description 1
- LFTYTUAZOPRMMI-UHFFFAOYSA-N UNPD164450 Natural products O1C(CO)C(O)C(O)C(NC(=O)C)C1OP(O)(=O)OP(O)(=O)OCC1C(O)C(O)C(N2C(NC(=O)C=C2)=O)O1 LFTYTUAZOPRMMI-UHFFFAOYSA-N 0.000 description 1
- 108010091546 Ubiquitin-Activating Enzymes Proteins 0.000 description 1
- 102000018478 Ubiquitin-Activating Enzymes Human genes 0.000 description 1
- 108010066496 Ubiquitin-Specific Proteases Proteins 0.000 description 1
- 102000018390 Ubiquitin-Specific Proteases Human genes 0.000 description 1
- 102100037160 Ubiquitin-like modifier-activating enzyme 1 Human genes 0.000 description 1
- 102100039543 Uveal autoantigen with coiled-coil domains and ankyrin repeats Human genes 0.000 description 1
- 102100021164 Vasodilator-stimulated phosphoprotein Human genes 0.000 description 1
- 102100035054 Vesicle-fusing ATPase Human genes 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 101710202136 Voltage-dependent anion-selective channel Proteins 0.000 description 1
- 108050001627 Voltage-dependent anion-selective channel protein 1 Proteins 0.000 description 1
- 101710146924 Zinc finger protein 331 Proteins 0.000 description 1
- 102100021354 Zinc finger protein 608 Human genes 0.000 description 1
- OGQICQVSFDPSEI-UHFFFAOYSA-N Zorac Chemical compound N1=CC(C(=O)OCC)=CC=C1C#CC1=CC=C(SCCC2(C)C)C2=C1 OGQICQVSFDPSEI-UHFFFAOYSA-N 0.000 description 1
- 102100023895 Zyxin Human genes 0.000 description 1
- 108010023249 Zyxin Proteins 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 208000008919 achondroplasia Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009858 acid secretion Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 208000021841 acute erythroid leukemia Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 108010048418 alpha Subunit Hypoxia-Inducible Factor 1 Proteins 0.000 description 1
- 102000009120 alpha Subunit Hypoxia-Inducible Factor 1 Human genes 0.000 description 1
- VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 1
- 230000002491 angiogenic effect Effects 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 230000001640 apoptogenic effect Effects 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- AQLMHYSWFMLWBS-UHFFFAOYSA-N arsenite(1-) Chemical compound O[As](O)[O-] AQLMHYSWFMLWBS-UHFFFAOYSA-N 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- 230000000599 auto-anti-genic effect Effects 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 108010081355 beta 2-Microglobulin Proteins 0.000 description 1
- 102000015736 beta 2-Microglobulin Human genes 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 238000010256 biochemical assay Methods 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 101150103980 ced-12 gene Proteins 0.000 description 1
- 230000012292 cell migration Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000017455 cell-cell adhesion Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000005754 cellular signaling Effects 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 210000001612 chondrocyte Anatomy 0.000 description 1
- 230000010428 chromatin condensation Effects 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 238000011281 clinical therapy Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 230000005757 colony formation Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 108010048032 cyclophilin B Proteins 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 210000004292 cytoskeleton Anatomy 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000013075 data extraction Methods 0.000 description 1
- 230000032459 dedifferentiation Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 108700041286 delta Proteins 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- FOOBQHKMWYGHCE-UHFFFAOYSA-N diphthamide Chemical compound C[N+](C)(C)C(C(N)=O)CCC1=NC=C(CC(N)C([O-])=O)N1 FOOBQHKMWYGHCE-UHFFFAOYSA-N 0.000 description 1
- BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 description 1
- 108010007093 dispase Proteins 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 210000003981 ectoderm Anatomy 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000006862 enzymatic digestion Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 208000015756 familial Alzheimer disease Diseases 0.000 description 1
- 230000004720 fertilization Effects 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- FVTCRASFADXXNN-SCRDCRAPSA-N flavin mononucleotide Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-SCRDCRAPSA-N 0.000 description 1
- 239000003269 fluorescent indicator Substances 0.000 description 1
- 238000001215 fluorescent labelling Methods 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000011223 gene expression profiling Methods 0.000 description 1
- 238000012239 gene modification Methods 0.000 description 1
- 230000008570 general process Effects 0.000 description 1
- 230000004077 genetic alteration Effects 0.000 description 1
- 231100000118 genetic alteration Toxicity 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 230000005017 genetic modification Effects 0.000 description 1
- 235000013617 genetically modified food Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 102000045442 glycosyltransferase activity proteins Human genes 0.000 description 1
- 108700014210 glycosyltransferase activity proteins Proteins 0.000 description 1
- 230000002710 gonadal effect Effects 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 239000003630 growth substance Substances 0.000 description 1
- ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 108010008429 immunoglobulin-binding factors Proteins 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 108060004006 inositol polyphosphate 5-phosphatase Proteins 0.000 description 1
- 102000030582 inositol polyphosphate 5-phosphatase Human genes 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229940068935 insulin-like growth factor 2 Drugs 0.000 description 1
- 230000002608 insulinlike Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000004692 intercellular junction Anatomy 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 108010076401 isopeptidase Proteins 0.000 description 1
- 108010029560 keratinocyte growth factor receptor Proteins 0.000 description 1
- 208000025014 late infantile neuronal ceroid lipofuscinosis Diseases 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 108010004145 leukotriene B4 12-hydroxydehydrogenase Proteins 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000001638 lipofection Methods 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 108010031117 low density lipoprotein receptor-related protein 8 Proteins 0.000 description 1
- 208000003747 lymphoid leukemia Diseases 0.000 description 1
- 108010089256 lysyl-aspartyl-glutamyl-leucine Proteins 0.000 description 1
- 230000010874 maintenance of protein location Effects 0.000 description 1
- 230000036212 malign transformation Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 125000000311 mannosyl group Chemical group C1([C@@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 239000003226 mitogen Substances 0.000 description 1
- 230000002297 mitogenic effect Effects 0.000 description 1
- 150000002762 monocarboxylic acid derivatives Chemical class 0.000 description 1
- 238000004264 monolayer culture Methods 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- 235000007708 morin Nutrition 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005044 neurofilament Anatomy 0.000 description 1
- 108090001075 neuroligin 2 Proteins 0.000 description 1
- 102000004872 neuroligin 2 Human genes 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- 230000000683 nonmetastatic effect Effects 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 239000002853 nucleic acid probe Substances 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 101150031080 nup85 gene Proteins 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000002515 oligonucleotide synthesis Methods 0.000 description 1
- 230000005868 ontogenesis Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 150000002891 organic anions Chemical class 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 102000004401 podocalyxin Human genes 0.000 description 1
- 108090000917 podocalyxin Proteins 0.000 description 1
- 210000000557 podocyte Anatomy 0.000 description 1
- 229920000729 poly(L-lysine) polymer Polymers 0.000 description 1
- 229920002791 poly-4-hydroxybutyrate Polymers 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000029279 positive regulation of transcription, DNA-dependent Effects 0.000 description 1
- 108020001213 potassium channel Proteins 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 108020004930 proline dehydrogenase Proteins 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 239000012268 protein inhibitor Substances 0.000 description 1
- 229940121649 protein inhibitor Drugs 0.000 description 1
- 108010005709 protein kinase C kinase Proteins 0.000 description 1
- 230000007026 protein scission Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 238000011536 re-plating Methods 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
- 102000037983 regulatory factors Human genes 0.000 description 1
- 108091008025 regulatory factors Proteins 0.000 description 1
- 230000032537 response to toxin Effects 0.000 description 1
- 102000003702 retinoic acid receptors Human genes 0.000 description 1
- 108090000064 retinoic acid receptors Proteins 0.000 description 1
- 201000009410 rhabdomyosarcoma Diseases 0.000 description 1
- 108010074916 ribophorin Proteins 0.000 description 1
- 108020004418 ribosomal RNA Proteins 0.000 description 1
- 108091092562 ribozyme Proteins 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 101150015999 sec24 gene Proteins 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 239000012679 serum free medium Substances 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 108010006908 signal sequence receptor Proteins 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- FZHAPNGMFPVSLP-UHFFFAOYSA-N silanamine Chemical compound [SiH3]N FZHAPNGMFPVSLP-UHFFFAOYSA-N 0.000 description 1
- 239000004055 small Interfering RNA Substances 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 108010039827 snRNP Core Proteins Proteins 0.000 description 1
- 210000004989 spleen cell Anatomy 0.000 description 1
- 206010062920 spondyloepiphyseal dysplasia Diseases 0.000 description 1
- 201000002962 spondyloepiphyseal dysplasia with congenital joint dislocations Diseases 0.000 description 1
- 230000010473 stable expression Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229940014800 succinic anhydride Drugs 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000004114 suspension culture Methods 0.000 description 1
- 229960000565 tazarotene Drugs 0.000 description 1
- ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 description 1
- 201000003896 thanatophoric dysplasia Diseases 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 208000008732 thymoma Diseases 0.000 description 1
- 239000005495 thyroid hormone Substances 0.000 description 1
- 229940036555 thyroid hormone Drugs 0.000 description 1
- 102000004217 thyroid hormone receptors Human genes 0.000 description 1
- 108090000721 thyroid hormone receptors Proteins 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 239000012581 transferrin Substances 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 210000000143 trophectoderm cell Anatomy 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 108010054220 vasodilator-stimulated phosphoprotein Proteins 0.000 description 1
- 201000000866 velocardiofacial syndrome Diseases 0.000 description 1
- 230000008189 vertebrate development Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 210000004340 zona pellucida Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Definitions
- International Patent Publication WO 99/20741 describes methods and materials for the growth of primate-derived primordial stem cells.
- International Patent Publication WO 01/51616 provides techniques for growth and differentiation of human pluripotent stem cells.
- An article by Xu et al. (Nature Biotechnology 19:971 , 2001) describes feeder-free growth of undifferentiated human embryonic stem cells.
- Lebkowski et al. (Cancer J. 7 Suppl. 2:S83, 2001) discuss the culture, differentiation, and genetic modification of human embryonic stem cell for regenerative medicine applications.
- These publications report exemplary culture methods for propagating human embryonic stem cells in an undifferentiated state, and their use in preparing cells for human therapy.
- Markers for identifying undifferentiated pluripotent stem cells include SSEA-4, Tra-1-60, and Tra-1-81 (Thomson et al. and Gearhart et al., supra). They also express human telomerase reverse transcriptase, and the POU transcription factor Oct 3/4 (WO 01/51616; Amit et al., Dev. Biol. 227:271 , 2000; Xu et al., supra).
- Fan et al. (Dev. Biol. 210:481 , 1999) propose that forced expression of the homeobox-containing gene Pern blocks differentiation of embryonic stem cells.
- Abdel-Rahman et al. (Hum. Reprod. 10:2787,
- the following disclosure provides new markers and marker combinations that are effective means to identify, characterize, qualify, and control differentiation of pluripotent cells.
- This invention identifies a number of genes that are up- or down-regulated during the course of differentiation of early-stage pluripotent stem cells obtained from primates, exemplified by human embryonic stem cells. As a consequence, the genes are differentially expressed in undifferentiated versus differentiated cells. This property confers special benefit on these genes for identification, characterization, culturing, differentiation, and manipulation of stem cells and their progeny, and other cells that express the same markers.
- One aspect of this invention is a system for assessing a culture of undifferentiated primate pluripotent stem (pPS) cells or their progeny, in which expression of one or more of the identified markers listed in the disclosure is detected or measured.
- the level of expression can be measured in isolation or compared with any suitable standard, such as undifferentiated pPS cells maintained under specified conditions, progeny at a certain stage of differentiation, or stable end-stage differentiated cells, such as may be obtained from the ATCC.
- any suitable standard such as undifferentiated pPS cells maintained under specified conditions, progeny at a certain stage of differentiation, or stable end-stage differentiated cells, such as may be obtained from the ATCC.
- the marker(s) are up- or down-regulated during differentiation, presence of the markers is correlated with the presence or proportion of undifferentiated or differentiated cells in the population.
- An exemplary (non-limiting) combination suitable for qualifying cultures of pPS cells are markers of the undifferentiated phenotype selected from Cripto, gastrin-releasing peptide (GRP) receptor, podocalyxin-like protein, hTERT and/Oct 3/4 (POU domain, class 5 transcription factor), in various combinations.
- GFP gastrin-releasing peptide
- Other cell markers can be measured in conjunction, including any of the newly described differentiation markers listed in this disclosure, or traditional pPS cell markers like SSEA-4 and Tra-1-60.
- markers of various differentiated cell phenotypes can be assayed as a measure of contaminating cells.
- Early stage cell types include stromal cells (marked by CD44 and Vimentin), fibroblasts, mesenchymal cells, and embryoid body cells.
- the markers can be detected or quantified at the mRNA level by PCR amplification, at the protein or enzyme product level by antibody assay, or by any suitable technique.
- the marker system of this invention can be used for quantifying the proportion of undifferentiated pPS cells or differentiated cells in the culture; for assessing the ability of a culture system or component thereof (such as a soluble factor, culture medium, or feeder cell) to maintain pPS cells in an undifferentiated state; for assessing the ability of a culture system or component thereof to cause differentiation of pPS cells into a culture of lineage-restricted precursor cells or terminally differentiated cells; or for any other worthwhile purpose.
- This invention includes kits and the use of specific reagents in order to measure the expression of the markers whenever appropriate.
- This invention also provides a system assessing the growth characteristics of a cell population by detecting or measuring expression of one or more of the differentially expressed marker genes identified in this disclosure. This can be applied not only to various types of pPS cells and progenitor cells in various stages of differentiation, but also to clinical samples from a disease condition associated with abnormal cell growth. Renewed expression of markers of a relatively undifferentiated phenotype may be diagnostic of disease conditions such as cancer, and can serve as a means by which to target therapeutic agents to the disease site.
- the marker system can also be used to regulate gene expression.
- Transcriptional control elements for the markers will cause an operatively linked encoding region to be expressed preferentially in undifferentiated or differentiated cells.
- the encoding sequence can be a reporter gene (such as a gene that causes the cells to emit fluorescence), a positive selection marker (such as a drug resistance gene), or a negative selection marker.
- Vector constructs comprising recombinant elements linked in this fashion can be used to positively select or deplete undifferentiated, differentiated, or cancerous cells from a mixed population or in vivo, depending on the nature of the effector gene and whether transcription is up- or down-regulated during differentiation. They can also be used to monitor culture conditions of pPS cells, differentiation conditions, or for drug screening.
- the marker system of this invention can also be used to sort differentiated cells from less differentiated cells.
- the marker can be used directly for cell separation by adsorption using an antibody or lectin, or by fluorescence activated cell sorting. Alternatively, these separation techniques can be effected using a transcription promoter from the marker gene in a promoter-reporter construct.
- the marker system of this invention can be used to map differentiation pathways or influence differentiation. Markers suited for this purpose may act as transcription regulators, or encode products that enhance cell interaction in some fashion.
- pPS cells or their differentiated progeny are genetically altered to increase expression of one or more of the identified genes using a transgene, or to decrease expression, for example, using an antisense or siRNA construct.
- gene products involved in cell interaction or signaling can be added directly to the culture medium. The effect of this can be to help maintain the transfected cell in the undifferentiated state, promote differentiation in general, or direct differentiation down a particular pathway.
- Another aspect of the invention are methods for identifying these and other genes that are up- or down-regulated upon differentiation of any cell type.
- the methods involve comparing expression libraries obtained from the cells before and after differentiation, by sequencing transcripts in each of the libraries, and identifying genes that have statistically significant differences in the relative number of transcripts (as a percentage of transcripts in each library) at a confidence level of 67%, 95%, or 98%.
- the method can be enhanced by creating assemblies in which different sequences are counted for the same transcript if they are known to correspond to a single transcript according to previously compiled data.
- differentially expressed markers identified in this disclosure are 39 nucleotide sequences which are not present in their entirety in the UniGene database. These are listed in this disclosure as SEQ. ID NOs:1 to 39.
- This invention includes novel nucleic acids consisting of or containing any of these sequences or the complementary sequences, and novel fragments thereof.
- This invention also includes novel polypeptides encoded in these sequences (made either by expressing the nucleic acid or by peptide synthesis), antibodies specific for the polypeptides (made by conventional techniques or through a commercial service), and use of these nucleic acids, peptides, and antibodies for any industrial application.
- culture conditions and other cell manipulations identified using the marker system of this invention that are suitable for maintaining or proliferating pPS cells without allowing differentiation, or causing them to differentiate in a certain fashion.
- Culture conditions tested and validated according to this invention are illustrated in the example section.
- Figure 1 shows the profile of genes preferentially expressed in undifferentiated pluripotent stem cells, upon preliminary differentiation of the cells by culturing in retinoic acid or DMSO. Level of gene expression at the mRNA level was measured by real-time PCR assay. Any of the genes showing substantial down-regulation upon differentiation can be used to characterize the undifferentiated cell population, and culture methods suitable for maintaining them in an undifferentiated state.
- Figure 2 shows the level of expression of five genes in hES cells, compared with fully differentiated cells. This five-marker panel provides robust qualification of the undifferentiated phenotype.
- Figure 3 show results of an experiment in which hES cells of the H1 line were maintained for multiple passages in different media.
- Medium conditioned with feeder cells provides factors effective to allow hES cells to proliferate in culture without differentiating.
- culturing in unconditioned medium leads to decreased percentage of cells expressing CD9, and the classic hES cell marker SSEA-4.
- Figure 4 illustrates the sensitivity of hTERT, Oct 3/4, Cripto, GRP receptor, and podocalyxin-like protein (measured by real-time PCR) as a means of determining the degree of differentiation of the cells. After multiple passages in unconditioned medium, all five markers show expression that has been downregulated by 10 to 10 4 -fold.
- Figure 6 shows results of an experiment in which different media were tested for their ability to promote growth of hES cells without proliferation. The test media were not preconditioned, but supplemented with 8-40 ng/mL bFGF, with or without stem cell factor, Flt3 ligand, or LIF.
- Effective combinations of factors were identified by following the undifferentiated phenotype using the markers of this invention. Alterations in expression profiles were temporary and reversible, showing that the cells are still undifferentiated.
- Figure 7 shows analysis of the undifferentiated hES cell markers SSEA-4, TRA 1-60 and Oct-4 by antibody staining and flow cytometry. Oct-4 is detected by permeabilizing the cells before staining.
- Figure 8 shows the results of the immunocytochemical analysis for stromal cell markers CD44, STRO-1 and Vimentin, which label cells in the hES cell culture that have undergone differentiation.
- Figure 9 shows the relative gene expression levels for cell populations in which undifferentiated hES cells were mixed with BJ fibroblasts in increasing amounts.
- pluripotent stem cells to differentiate spontaneously has made it challenging for investigators to work with these cells. Consistent cultures of undifferentiated stem cells are required to compare results obtained from multiple experiments performed within or between laboratories. Unfortunately, morphological characterization is subjective and especially difficult for cultures that often contain 10-20% differentiated cells. Nevertheless, having a set of standardized criteria will be important in qualifying these cells for use in clinical therapy.
- the marker system identified in this disclosure provides the basis for establishing these standards.
- 148,453 different transcripts were amplified and sequenced from undifferentiated human embryonic stem cells, and three types of progeny.
- 532 genes were identified having substantially higher EST counts in undifferentiated cells, and 142 genes were identified having substantially higher EST counts after differentiation.
- Other differentially expressed genes were identified by microarray analysis of undifferentiated cells, compared with cells at the beginning of the differentiation process.
- the system provided by this invention can be used not only to qualify populations of undifferentiated cells, but in other powerful ways of maintaining and manipulating cells described later in this disclosure- Culture systems have been identified and protocols have been developed to expand cultures of undifferentiated cells and produce commercially viable quantities of cells for use in research, drug screening, and regenerative medicine.
- pPS cells are pluripotent cells that have the characteristic of being capable under appropriate conditions of producing progeny of several different cell types that are derivatives of all of the three germinal layers (endoderm, mesoderm, and ectoderm), according to a standard art-accepted test, such as the ability to form a teratoma in 8-12 week old SCID mice.
- the term includes both established lines of stem cells of various kinds, and cells obtained from primary tissue that are pluripotent in the manner described.
- the pPS cells are not embryonal carcinoma (EC) cells, and are not derived from a malignant source. It is desirable (but not always necessary) that the cells be euploid.
- Exemplary pPS cells are obtained from embryonic or fetal tissue at any time after fertilization.
- hES cells Human Embryonic Stem cells
- hES cell cultures are described as "undifferentiated” when a substantial proportion (at least 20%, and possibly over 50% or 80%) of stem cells and their derivatives in the population display morphological characteristics of undifferentiated cells, distinguishing them from differentiated cells of embryo or adult origin. It is understood that colonies of undifferentiated cells within the population will often be surrounded by neighboring cells that are differentiated.
- the proportion of cells displaying the undifferentiated phenotype will fluctuate as the cells proliferate and are passaged from one culture to another.
- Cells are recognized as proliferating in an undifferentiated state when they go through at least 4 passages and/or 8 population doublings while retaining at least about 50%, or the same proportion of cells bearing characteristic markers or morphological characteristics of undifferentiated cells.
- a "differentiated cell” is a cell that has progressed down a developmental pathway, and includes lineage-committed progenitor cells and terminally differentiated cells.
- Feeer cells or feeders are terms used to describe cells of one type that are co-cultured with cells of another type, to provide an environment in which the cells of the second type can grow.
- hES cell populations are said to be "essentially free” of feeder cells if the cells have been grown through at least one round after splitting in which fresh feeder cells are not added to support the growth of pPS cells.
- embryoid bodies refers to aggregates of differentiated and undifferentiated cells that appear when pPS cells overgrow in monolayer cultures, or are maintained in suspension cultures. Embryoid bodies are a mixture of different cell types, typically from several germ layers, distinguishable by morphological criteria and cell markers detectable by immunocytochemistry.
- a cell “marker” is any phenotypic feature of a cell that can be used to characterize it or discriminate it from other cell types.
- a marker of this invention may be a protein (including secreted, cell surface, or internal proteins; either synthesized or taken up by the cell); a nucleic acid (such as an mRNA, or enzymatically active nucleic acid molecule) or a polysaccharide. Included are determinants of any such cell components that are detectable by antibody, lectin, probe or nucleic acid amplification reaction that are specific for the cell type of interest.
- the markers can also be identified by a biochemical or enzyme assay that depend on the function of the gene product.
- a marker is said to be "preferentially expressed” in an undifferentiated or differentiated cell population, if it is expressed at a level that is at least 10 times higher (in terms of total gene product measured in an antibody or PCR assay) or 10 times more frequently (in terms of positive cells in the population). Markers that are expressed 100, 1 ,000, or 10,000 times higher or more frequently are increasingly more preferred.
- polynucleotide and nucleic acid refer to a polymeric form of nucleotides of any length.
- polynucleotide refers interchangeably to double- and single-stranded molecules. Unless otherwise specified, any embodiment of the invention that is a polynucleotide encompasses both a double-stranded form, and each of the two complementary single-stranded forms known or predicted to make up the double-stranded form.
- a cell is said to be "genetically altered” or “transfected” when a polynucleotide has been transferred into the cell by any suitable means of artificial manipulation, or where the cell is a progeny of the originally altered cell that has inherited the polynucleotide.
- control element or "control sequence” is a nucleotide sequence involved in an interaction of molecules that contributes to the functional regulation of a polynucleotide, including replication, duplication, transcription, splicing, translation, or degradation of the polynucleotide.
- Operatively linked refers to an operative relationship between genetic elements, in which the function of one element influences the function of another element.
- an expressible encoding sequence may be operatively linked to a promoter that drives gene transcription.
- antibody as used in this disclosure refers to both polyclonal and monoclonal antibody.
- the ambit of the term deliberately encompasses not only intact immunoglobulin molecules, but also such fragments and derivatives of immunoglobulin molecules that retain a desired binding specificity.
- the markers are suitable for identifying, characterizing, and manipulating related types of undifferentiated pluripotent cells. They are also suitable for use with pluripotent cells obtained from primary embryonic tissue, without first establishing an undifferentiated cell line. It is contemplated that the markers described in this application will in general be useful for other types of pluripotent cells, including embryonic germ cells (U.S. Patents 6,090,622 and 6,251 ,671), and ES and EG cells from other mammalian species, such as non-human primates.
- Embryonic stem cells can be isolated from blastocysts of members of primate species (U.S. Patent 5,843,780; Thomson et al., Proc. Natl. Acad. Sci. USA 92:7844, 1995). Human embryonic stem cells
- hES cells can be prepared from human blastocyst cells using the techniques described by Thomson et al. (U.S. Patent 6,200,806; Science 282:1145, 1998; Curr. Top. Dev. Biol. 38:133 ff., 1998) and Reubinoff et al, Nature Biotech. 18:399, 2000.
- Equivalent cell types to hES ceils include their pluripotent derivatives, such as primitive ectoderm-like (EPL) cells, outlined in WO 01/51610 (Bresagen). hES cells can be obtained from human preimplantation embryos.
- in vitro fertilized (IVF) embryos can be used, or one-cell human embryos can be expanded to the blastocyst stage (Bongso et al., Hum Reprod 4: 706, 1989). Embryos are cultured to the blastocyst stage in G1.2 and G2.2 medium (Gardner et al., Fertil. Steril. 69:84, 1998). The zona pellucida is removed from developed blastocysts by brief exposure to pronase (Sigma).
- the inner cell masses are isolated by immunosurgery, in which blastocysts are exposed to a 1 :50 dilution of rabbit anti-human spleen cell antiserum for 30 min, then washed for 5 min three times in DMEM, and exposed to a 1 :5 dilution of Guinea pig complement (Gibco) for 3 min (Solter et al., Proc. Natl. Acad. Sci. USA 72:5099, 1975). After two further washes in DMEM, lysed trophectoderm cells are removed from the intact inner cell mass (ICM) by gentle pipetting, and the ICM plated on mEF feeder layers.
- ICM inner cell mass
- inner cell mass derived outgrowths are dissociated into clumps, either by exposure to calcium and magnesium-free phosphate-buffered saline (PBS) with 1 mM EDTA, by exposure to dispase or trypsin, or by mechanical dissociation with a micropipette; and then replated on mEF in fresh medium.
- PBS calcium and magnesium-free phosphate-buffered saline
- EDTA calcium and magnesium-free phosphate-buffered saline
- dispase or trypsin or by mechanical dissociation with a micropipette
- ES-like morphology is characterized as compact colonies with apparently high nucleus to cytoplasm ratio and prominent nucleoli.
- ES cells are then routinely split every 1-2 weeks by brief trypsinization, exposure to Dulbecco's PBS (containing 2 mM EDTA), exposure to type IV collagenase (-200 U/mL; Gibco) or by selection of individual colonies by micropipette. Clump sizes of about 50 to 100 cells are optimal.
- Propagation ofpPS Cells in an Undifferentiated State pPS cells can be propagated continuously in culture, using culture conditions that promote proliferation without promoting differentiation.
- Exemplary serum-containing ES medium is made with 80% DMEM (such as Knock-Out DMEM, Gibco), 20% of either defined fetal bovine serum (FBS, Hyclone) or serum replacement (US 20020076747 A1 , Life Technologies Inc.), 1% non-essential amino acids, 1 mM L-glutamine, and 0.1 mM ⁇ -mercaptoethanol.
- FBS defined fetal bovine serum
- FBS defined fetal bovine serum
- serum replacement US 20020076747 A1 , Life Technologies Inc.
- human bFGF is added to 4 ng/mL (WO 99/20741 , Geron Corp.).
- ES cells are cultured on a layer of feeder cells, typically fibroblasts derived from embryonic or fetal tissue. Embryos are harvested from a CF1 mouse at 13 days of pregnancy, transferred to 2 mL trypsin/EDTA, finely minced, and incubated 5 min at 37°C. 10% FBS is added, debris is allowed to settle, and the cells are propagated in 90% DMEM, 10% FBS, and 2 mM glutamine. To prepare a feeder cell layer, cells are irradiated to inhibit proliferation but permit synthesis of factors that support ES cells (-4000 rads ⁇ -irradiation). Culture plates are coated with 0.5% gelatin overnight, plated with 375,000 irradiated mEFs per well, and used 5 h to 4 days after plating. The medium is replaced with fresh hES medium just before seeding pPS cells.
- feeder cells typically fibroblasts derived from embryonic or fetal tissue. Embryos are harvested from a CF1 mouse at 13
- pPS cells can be maintained in an undifferentiated state even without feeder cells.
- the environment for feeder-free cultures includes a suitable culture substrate, particularly an extracellular matrix such as Matrigel® or laminin.
- the pPS cells are plated at >15,000 cells cm “2 (optimally 90,000 cm “2 to 170,000 cm “2 ).
- enzymatic digestion is halted before cells become completely dispersed (say, -5 min with collagenase IV).
- Clumps of -10 to 2,000 cells are then plated directly onto the substrate without further dispersal.
- the cells can be harvested without enzymes before the plate reaches confluence by incubating -5 min in a solution of 0.5 mM EDTA in PBS.
- the cells After washing from the culture vessel, the cells are plated into a new culture without further dispersal.
- confluent human embryonic stem cells cultured in the absence of feeders are removed from the plates by incubating with a solution of 0.05% (wt/vol) trypsin (Gibco) and 0.053 mM EDTA for 5-15 min at 37 9 C.
- the remaining cells in the plate are removed and the cells are triturated into a suspension comprising single cells and small clusters, and then plated at densities of 50,000-200,000 cells cm '2 to promote survival and limit differentiation.
- Feeder-free cultures are supported by a nutrient medium containing factors that support proliferation of the cells without differentiation. Such factors may be introduced into the medium by culturing the medium with cells secreting such factors, such as irradiated (-4,000 rad) primary mouse embryonic fibroblasts, telomerized mouse fibroblasts, or fibroblast-like cells derived from pPS cells.
- Medium can be conditioned by plating the feeders at a density of -5-6 x 10 4 cm "2 in a serum free medium such as KO DMEM supplemented with 20% serum replacement and 4 ng/mL bFGF.
- a serum free medium such as KO DMEM supplemented with 20% serum replacement and 4 ng/mL bFGF.
- Medium that has been conditioned for 1-2 days is supplemented with further bFGF, and used to support pPS cell culture for 1-2 days.
- ligands for the FGF-2 or FGF-4 receptor can be added that help support proliferation without differentiation
- factors such as ligands for the FGF-2 or FGF-4 receptor, ligands for c-kit (such as stem cell factor), ligands for receptors associated with gp130, insulin, transferrin, lipids, cholesterol, nucleosides, pyruvate, and a reducing agent such as ⁇ -mercaptoethanol.
- ligands for the FGF-2 or FGF-4 receptor such as stem cell factor
- ligands for receptors associated with gp130 such as insulin, transferrin, lipids, cholesterol, nucleosides, pyruvate
- a reducing agent such as ⁇ -mercaptoethanol.
- ES cells Under the microscope, ES cells appear with high nuclear/cytoplasmic ratios, prominent nucleoli, and compact colony formation with poorly discernable cell junctions.
- Conventional markers for hES cells are stage-specific embryonic antigen (SSEA) 3 and 4, and markers detectable using antibodies Tra-1-60 and Tra-1-81 (Thomson et al., Science 282:1145, 1998).
- SSEA stage-specific embryonic antigen
- Differentiation of pPS cells in vitro results in the loss of SSEA-4, Tra-1-60, and Tra-1-81 expression, and increased expression of SSEA-1.
- Expression libraries were made from ES cells (WO 01/51616), embryoid bodies (WO 01/51616), and cells differentiated towards the hepatocyte (WO 01/81549) or neural cell (WO 01/88104) lineage.
- mRNA was reverse transcribed and amplified, producing expressed sequence tags (ESTs) occurring in frequency proportional to the level of expression in the cell type being analyzed.
- the ESTs were subjected to automatic sequencing, and counted according to the corresponding unique (non-redundant) transcript. A total of 148,453 non-redundant transcripts were represented in each of the 4 libraries. Genes were then identified as having a differential expression pattern if the number of EST counts of the transcript was statistically different between the libraries being compared.
- mRNA from each of the cell types was analyzed for binding to a broad-specificity EST-based microarray, performed according to the method described in WO 01/51616. .
- Genes were identified as having a differential expression pattern if they showed a comparatively different signal on the microarray. Significant expression differences determined by EST sequencing, microarray analysis, or other observations were confirmed by real-time PCR analysis.
- the mRNA was amplified by PCR using specific forward and reverse primers designed from the GenBank sequence, and the amplification product was detected using labeled sequence-specific probes. The number of amplification cycles required to reach a threshold amount was then compared between different libraries. Distinguishing markers fall into several categories. Those of particular interest include the following:
- the encoded genes may be involved in differentiation down restricted lineages. Markers can also be classified according to the function of the gene product or its location in the cell. Where not already indicated, protein gene products can be predicted by referencing public information according to the GenBank accession number, or by translating the open reading frame after the translation start signal though the genetic code. Features of the markers listed can be determined by the descriptors give in the tables below, or by using the accession number or sequence data to reference public information. Marker groups of particular interest include the following:
- Secreted proteins of interest, for example, because they can be detected by immunoassay of the culture supernatant, and may transmit signals to neighboring cells.
- Secreted proteins typically have an N-terminal signal peptides, and may have glycosylation sites.
- Surface membrane proteins of interest, for example, because they can be used for cell- surface labeling and affinity separation, or because they act as receptors for signal transduction. They may have glycosylation sites and a membrane spanning region. A Markov model for predicting transmembrane protein topology is described by Krogh et al., J. Mol Biol. 305:567, 2001. • Enzymes with relevant function.
- Glycosyltransferases decorate the cell membrane with distinguishing carbohydrate epitopes that may play a role in cellular adhesion or localization.
- the markers provided in this disclosure can be used as a means to identify both undifferentiated and differentiated cells — either a population as a whole, or as individual cells within a population. This can be used to evaluate the expansion or maintenance of pre-existing cell populations, or to characterize the pluripotent nature (or lineage commitment) of newly obtained populations.
- markers in a test cell will provide evidence of undifferentiated or differentiated phenotype, according to the expression pattern listed later in this disclosure.
- a plurality of markers (such as any 2, 3, 4, 5, 6, 8, 10, 12, 15, or 20 markers from Tables 2-3 or 5-9) will provide a more detailed assessment of the characteristics of the cell.
- Expression of genes that are down-regulated and/or lack of expression of genes that are up-regulated upon differentiation correlates with a differentiated phenotype.
- Expression of genes that are up-regulated and/or lack of expression of genes that are down-regulated upon differentiation correlates with an undifferentiated phenotype.
- the markers newly identified in this disclosure may be analyzed together (with or without markers that were previously known) in any combination effective for characterizing the cell status or phenotype.
- markers are provided elsewhere in this disclosure.
- combinations of markers like Cripto, gastrin-releasing peptide (GRP) receptor, podocalyxin-like protein (PODXL), and human telomerase reverse transcriptase (hTERT) are effective, either alone, or in combination with cell surface markers like SSEA-3, SSEA-4, Tra-1-60 and Tra-1-81 , or intracellular markers like Oct 3/4.
- GFP gastrin-releasing peptide
- PODXL podocalyxin-like protein
- hTERT human telomerase reverse transcriptase
- any marker can be used that is characteristic of contaminating cells that may be present.
- early stage non-specific hES cell differentiation generates cells having characteristics of stromal cells, fibroblasts, mesenchymal cells, embryoid body cells, and other cell types.
- stromal cells fibroblasts, mesenchymal cells, embryoid body cells, and other cell types.
- a combination of markers characteristic of several types of cells can be used, as long as they are preferentially expressed in differentiated cells.
- Tissue-specific markers can be detected using any suitable immunological technique — such as flow cytochemistry for cell-surface markers, or immunocytochemistry (for example, of fixed cells or tissue sections) for intracellular or cell-surface markers.
- a cell-surface antigen is defined as positive if a significantly detectable amount of antibody will bind to the antigen in a standard immunocytochemistry or flow cytometry assay, optionally after fixation of the cells, and optionally using a labeled secondary antibody or other conjugate to amplify labeling.
- tissue-specific gene products can also be detected at the mRNA level by Northern blot analysis, dot-blot hybridization analysis, or by reverse transcriptase initiated polymerase chain reaction (RT-PCR) using sequence-specific primers in standard amplification methods. See U.S. Patent No. 5,843,780 for further details. Sequence data for particular markers listed in this disclosure can be obtained from public databases such as GenBank.
- Reagents for conducting these assays can be packaged in kit form, optionally with instructions for the use of the reagents in the characterization or monitoring of pPS cells, or their differentiated progeny.
- Stem cells regulate their own replenishment and serve as a source of cells that can differentiate into defined cell lineages. Cancer cells also have the ability to self-renew, but lack of regulation results in uncontrolled cellular proliferation. Three key signaling pathways, Wnt, Sonic hedgehog (Shh), and Notch, are known growth regulators of tumor cells. The genomics data provided in this disclosure indicate that all three of these pathways are active in hES cells.
- this disclosure provides a system for evaluating clinical conditions associated with abnormal cell growth, such as hyperplasia or cancers of various kinds. Markers meeting the desired criteria include those contained in Tables 2, 5, 7 and 9.
- each marker of interest is determined at the mRNA or protein level using a suitable assay system such as those described earlier; and then the expression is correlated with the clinical condition that the patient is suspected of having. As before, combinations of multiple markers may be more effective in doing the assessment. Presence of a particular marker may also provide a means by which a toxic agent or other therapeutic drug may be targeted to the disease site.
- the markers of this invention can be used to evaluate a human or non-human subject who has been treated with a cell population or tissue generated by differentiating pPS cells.
- a histological sample taken at or near the site of administration, or a site to which the cells would be expected to migrate, could be harvested at a time subsequent to treatment, and then assayed to assess whether any of the administered cells had reverted to the undifferentiated phenotype.
- Reagents for conducting diagnostic tests such as nucleotide probes or primers, or specific antibody, can be packaged in kit form, optionally with instructions for the use of the reagents in the determination of a disease condition.
- the markers and marker combinations of this invention provide a system for monitoring undifferentiated pPS cells and their differentiated progeny in culture.
- This system can be used as a quality control, to compare the characteristics of undifferentiated pPS cells between different passages or different batches. It can also be used to assess a change in culture conditions, to determine the effect of the change on the undifferentiated cell phenotype.
- a decrease in the level of expression of an undifferentiated marker because of the alteration by 3-, 10-, 25-, 100- and 1000-fold is progressively less preferred.
- Corresponding increases in marker expression may be more beneficial.
- Moderate decreases in marker expression may be quite acceptable within certain boundaries, if the cells retain their ability to form progeny of all three germ layers is retained, and/or the level of the undifferentiated marker is relatively restored when culture conditions are returned to normal.
- the markers of this invention can be used to evaluate different feeder cells, extracellular matrixes, base media, additives to the media, culture vessels, or other features of the culture as illustrated in WO 99/20741 and PCT application PCT/US02/28200. Illustrations of this technique are provided below in Example 6 ( Figures 3 to 6).
- the markers of this invention can also be used to monitor and optimize conditions for differentiating cells. Improved differentiation procedures will lead to higher or more rapid expression of markers for the differentiated phenotype, and/or lower or more rapid decrease in expression of markers for the undifferentiated phenotype.
- Differential expression of the markers listed in this disclosure indicates that each marker is controlled by a transcriptional regulatory element (such as a promoter) that is tissue specific, causing higher levels of expression in undifferentiated cells compared with differentiated cells, or vice versa.
- a transcriptional regulatory element such as a promoter
- tissue specific such as tissue specific
- the corresponding transcriptional regulatory element is combined with a heterologous encoding region to drive expression of the encoding region, then the expression pattern in different cell types will mimic that of the marker gene.
- Minimum promoter sequences of many of the genes listed in this disclosure are known and further described elsewhere. Where a promoter has not been fully characterized, specific transcription can usually be driven by taking the 500 base pairs immediately upstream of the translation start signal for the marker in the corresponding genomic clone.
- a recombinant vector is constructed in which the specific promoter of interest is operatively linked to the encoding region in such a manner that it drives transcription of the encoding region upon transfection into a suitable host cell.
- Suitable vector systems for transient expression include those based on adenovirus and certain types of plasmids.
- Vectors for long-term expression include those based on plasmid lipofection or electroporation, episomal vectors, retrovirus, and lentivirus.
- tissue-specific promoters is expression of a reporter gene.
- Suitable reporters include fluorescence markers such as green fluorescent protein, luciferase, or enzymatic markers such as alkaline phosphatase and ⁇ -galactosidase.
- Other reporters such as a blood group glycosyltransferase (WO 02/074935), or Invitrogen's pDisplayTM, create a cell surface epitope that can be counterstained with labeled specific antibody or lectin.
- pPS cells labeled with reporters can be used to follow the differentiation process directly, the presence or absence of the reporter correlating with the undifferentiated or differentiated phenotype, depending on the specificity of the promoter. This in turn can be used to follow or optimize culture conditions for undifferentiated pPS cells, or differentiation protocols.
- cells containing promoter-reporter constructs can be used for drug screening, in which a test compound is combined with the cell, and expression or suppression of the promoter is correlated with an effect attributable to the compound.
- tissue-specific promoters Another application of tissue-specific promoters is expression of a positive or negative drug selection marker.
- Antibiotic resistance genes such as neomycin phosphotransferase, expressed under control of a tissue-specific promoter, can be used to positively select for undifferentiated or differentiated cells in a medium containing the corresponding drug (geneticin), by choosing a promoter with the appropriate specificity.
- Toxin genes genes that mediate apoptosis, or genes that convert a prodrug into a toxic compound (such as thymidine kinase) can be used to negatively select against contaminating undifferentiated or differentiated cells in a population of the opposite phenotype (WO 02/42445;
- Promoters specific for the undifferentiated cell phenotype can also be used as a means for targeting cancer cells — using the promoter to drive expression of a gene that is toxic to the cell (WO 98/14593, WO 02/42468), or to drive a replication gene in a viral vector (WO 00/46355).
- adenoviral vector in which the GRPR promoter (AY032865) drives the E1a gene should specifically lyse cancer cells in the manner described in Majumdar et al., Gene Ther. 8:568, 2001.
- tissue-specific promoters of this invention will come readily to the mind of the skilled reader.
- Differentially expressed markers are also a means by which mixed cell populations can be separated into populations that are more homogeneous. This can be accomplished directly by selecting a marker of the undifferentiated or differentiated phenotype, which is itself expressed on the cell surface, or otherwise causes expression of a unique cell-surface epitope. The epitope is then used as a handle by which the marked cells can be physically separated from the unmarked cells. For example, marked cells can be aggregated or adsorbed to a solid support using an antibody or lectin that is specific for the epitope. Alternatively, the marker can be used to attach a fluorescently labeled antibody or lectin, and then the cell suspension can be subject to fluorescence-activated cell sorting.
- tissue-specific promoter chosen based on its expression pattern (as described in the last section), and use it to drive transcription of a gene suitable for separating the cells.
- the marker from which the promoter is chosen need not itself be a cell surface protein.
- the promoter can drive expression of a fluorescent gene, such as GFP, and then cells having the marked phenotype can be separated by FACS.
- the promoter drives expression of a heterologous gene that causes expression of a cell-surface epitope. The epitope is then used for adsorption-based separation, or to attach a fluorescent label, as already described.
- the differentially expressed genes of this invention are caused to increase or decrease their expression level, in order to either inhibit or promote the differentiation process.
- Suitable genes are those that are believed in the normal case of ontogeny to be active in maintaining the undifferentiated state, active in the general process of differentiation, or active in differentiation into particular cell lineages. Markers of interest for this application are the following:
- Forkhead box 01 A (FOX01A); Zic family member 3 (ZIC3); Hypothetical protein FLJ20582; Forkhead box H1 (FOXH1); Zinc finger protein, Hsal2; KRAB-zinc finger protein SZF1-1 ; Zinc finger protein of cerebellum ZIC2; and Coup transcription factor 2 (COUP-TF2).
- Other candidates include those marked in Tables 5 and 6 with the symbol "®", and other factors with zinc fingers or nucleic acid binding activity.
- One way of manipulating gene expression is to induce a transient or stable genetic alteration in the cells using a suitable vector, such as those already listed.
- a suitable vector such as those already listed.
- Lets at Geron Corp. have determined that the following constitutive promoters are effective in undifferentiated hES cells: for transient expression CMV, SV40, EF1 ⁇ , UbC, and PGK; for stable expression, SV40, EF1 ⁇ , UbC, MND and PGK.
- Expressing a gene associated with the undifferentiated phenotype may assist the cells to stay undifferentiated in the absence of some of the elements usually required in the culture environment.
- Expressing a gene associated with the differentiated phenotype may promote early differentiation, and/or initiate a cascade of events beneficial for obtaining a desired cell population. Maintaining or causing expression of a gene of either type early in the differentiation process may in some instances help guide differentiation down a particular pathway.
- Another way of manipulating gene expression is to alter transcription from the endogenous gene.
- One means of accomplishing this is to introduce factors that specifically influence transcription through the endogenous promoter.
- Another means suitable for down-regulating expression at the protein level is to genetically alter the cells with a nucleic acid that removes the mRNA or otherwise inhibits translation (for example, a hybridizing antisense molecule, ribozyme, or small interfering RNA).
- Dominant-negative mutants of the target factor can reduce the functional effect of the gene product.
- Targeting a particular factor associated with the undifferentiated phenotype in this fashion can be used to promote differentiation. In some instances, this can lead to de-repression of genes associated with a particular cell type.
- the gene product is a soluble protein or peptide that influences cell interaction or signal transduction (for example, cytokines like osteopontin and Cripto)
- cytokines like osteopontin and Cripto
- Products that maintain the undifferentiated phenotype can then be withdrawn from the culture medium to initiate differentiation; and products that promote differentiation can be withdrawn once the process is complete. Since differentiation is a multi-step process, changing the level of gene product on a permanent basis may cause multiple effects. In some instances, it may be advantageous to affect gene expression in a temporary fashion at each sequential step in the pathway, in case the same factor plays different effects at different steps of differentiation.
- function of transcription factors can be evaluated by changing expression of individual genes, or by invoking a high throughput analysis, using cDNAs obtained from a suitable library such as exemplified in Example 1.
- Cells that undergo an alteration of interest can be cloned and pulled from multi-well plates, and the responsible gene identified by PCR amplification.
- the effect of up- or down-regulating expression of a particular gene can be determined by evaluating the cell for morphological characteristics, and the expression of other characteristic markers. Besides the markers listed later in this disclosure, the reader may want to follow the effect on particular cell types, using markers for later-stage or terminally differentiated cells. Tissue-specific markers suitable for this purpose are listed in WO 01/81549 (hepatocytes), WO 01/88104 (neural cells), PCT/US02/20998 (osteoblasts and mesenchymal cells), PCT/US02/22245 (cardiomyocytes), PCT/US02/39091 (hematopoietic cells), PCT/US02/39089 (islet cells), and PCT/US02/39090 (chondrocytes). Such markers can be analyzed by PCR amplification, fluorescence labeling, or immunocytochemistry, as already described. Promoter-reporter constructs based on the same markers can facilitate analysis when expression is being altered in a high throughput protocol.
- Example 1 An EST database of undifferentiated hES cells and their differentiated progeny cDNA libraries were prepared from human embryonic stem (hES) cells cultured in undifferentiated form. cDNA libraries were also prepared from progeny, subject to non-specific differentiation as embryoid bodies (EBs), or taken through the preliminary stages of established differentiation protocols for neurons (preNEU) or hepatocytes (preHEP). The hES cell lines H1 , H7, and H9 were maintained under feeder-free conditions.
- EBs embryoid bodies
- preNEU embryoid bodies
- preHEP hepatocytes
- EBs were prepared as follows. Confluent plates of undifferentiated hES cells were treated briefly with collagenase IV, and scraped to obtain small clusters of cells.
- KO DMEM fetal bovine serum in place of 20% SR, and not preconditioned
- low adhesion 6-well plates Costar
- PreHEP cells were prepared based on the hepatocyte differentiation protocol described in WO 01/81549. Confluent wells of undifferentiated cells were prepared, and medium was changed to KO DMEM plus 20% SR + 1% DMSO. The medium was changed every 24 h, and cells were used for preparation of cytoplasmic RNA on day 5 of DMSO treatment.
- PreNEU cells were prepared based on the neural differentiation protocol described in
- hES cells of the H7 line (p29) were used to generate EBs as described above except that 10 ⁇ M all-trans RA was included in the differentiation medium. After 4 days in suspension, EBs were transferred to culture plate precoated with poly-L-lysine and laminin. After plating, the medium was changed to EPFI medium. Cells were used for the preparation of cytoplasmic RNA after 3 days of growth in EPFI.
- Partial 5' end sequences (an expressed sequence tag, or EST) were determined by conventional means for independent clones derived from each cDNA library. Overlapping ESTs were assembled into conjoined sequences.
- Candidate markers were selected from a database based on the imputed level of gene expression. The frequency of ESTs for any particular gene correlates with the abundance of that mRNA in the cells used to generate the cDNA library. Thus, a comparison of frequencies of ESTs among the libraries indicates the relative abundance of the associated mRNA in the different cell types.
- Candidate molecular markers were selected from the expressed gene (EST) database from their greater abundance in undifferentiated hES cells, relative to differentiated hES cells. Genes were identified as having a differential expression pattern (being up- or down-regulated) during the differentiation process, if the count of ESTs sequenced in the undifferentiated cells was substantially different from the sum of ESTs in the three differentiated libraries.
- Oct 3/4 a POU domain-containing transcription factor
- hTERT telomerase reverse transcriptase
- Other genes suitable for characterizing or manipulating the undifferentiated phenotype are those that are down- regulated upon differentiation with a significance of p ⁇ 0.05, as determined by the Fisher Exact Test (explained below). 193 genes were found to have 4-fold more ESTs in hES cells, relative to each of the three cell types.
- GRP-R Gastrin-releasing peptide receptor
- EST frequency queries Three genes were observed from EST frequency queries that were of particular interest as potentially useful markers of hES cells. They were Teratocarcinoma-derived growth factor (Cripto), Podocalyxin-like (PODXL), and gastrin-releasing peptide receptor (GRPR). These genes were not only more abundant in undifferentiated cells, relative to differentiated hES cells, but also encoded for proteins expressed on the surface of cells. Surface markers have the added advantage that they could be easily detected with immunological reagents. ESTs for Cripto and GRPR were quite restricted to hES cells, with one or zero ESTs, respectively, scored in any of the differentiated cells.
- Cripto Teratocarcinoma-derived growth factor
- PODXL Podocalyxin-like
- GRPR gastrin-releasing peptide receptor
- PODXL ESTs were detected in all 4-cell types, but substantially fewer (2.5X -12X) in differentiated cells. All three markers retained a detectable level of expression in differentiated cultures of hES cells. There may be a low level of expression of these markers in differentiated cells, or the expression detected may be due to a small proportion of undifferentiated cells in the population. GABA(A) receptor, Lefty B, Osteopontin, Thy-1 co-transcribed, and Solute carrier 21 are other significant markers of the undifferentiated phenotype. 0 By similar reasoning, genes that show a higher frequency of ESTs in differentiated cells can be used as specific markers for differentiation.
- ESTs that are 2-fold more abundant in the sum of all three differentiated cell types (EBs, preHEP and preNEU cells) and with a p-value ⁇ 0.05 as determined by the Fisher Exact Test, compared with undifferentiated hES cells are candidate markers for differentiation down multiple pathways.
- ESTs that are relatively abundant in only one of the differentiated cell types are 5 candidate markers for tissue-specific differentiation. The following markers are of particular interest:
- H2A histone family member Y 1 5 5 14 (H2AFY), transcript variant 3, mRNA
- Rho-related BTB domain 0 10 7 13 containing 3 RHOBTB3
- the es value is substantially >1 for genes marking the undifferentiated phenotype, and ⁇ 1 for genes indicating differentiation.
- Pool A contains the sequences derived from the undifferentiated hES cells and Pool B contains the sequences from the other three cell types (EB, preHep, preNeu).
- N is equal to the number of sequences derived from the undifferentiated hES cells (37,081) and M is equal to the sum of all ESTs from the three differentiated cell types (111 ,372).
- genes with p ⁇ 0.05 are considered to be differentially represented.
- markers identified with the symbol "®” may play a role in the regulation of gene transcription.
- VEGF vascular endothelial growth factor
- GTPBG3 mitochondrial GTP binding protein
- NDRG4 NDRG family member 4
- PCTK1 PCTAIRE protein kinase 1
- TDGF1 teratocarcinoma-derived growth factor 1
- HNRPL nuclear ribonucleoprotein L
- GTPBP1 GTP binding protein 1
- GA_36707 NM_021627 sentrin-specific protease (SENP2) 4 0 1 0 5 es 12.01 p 0.02
- DAPK1 death-associated protein kinase 1
- GA 38084 NM_015658 DKFZP564C186 protein (DKFZP564C186) 13 5 3 5 26 es 3.00 p 0.01
- GA_38225 NMJD07152 zinc finger protein 195 (ZNF195) 4 0 2 0 6 es 6.01 p 0.04
- GA_38238 AL133439 mRNA full length insert cDNA clone EUROIMAGE 4 0 2 0 6 es 6.01 p 0.04
- GATA3 GATA binding protein 3
- VDAC1 voltage-dependent anion channel 1
- GABA gamma-aminobutyric acid
- IGFBP3 insulin-like growth factor binding protein 3
- Example 3 Microarray analysis for other differentially expressed genes
- the level of gene expression was tested at the mRNA level in microarrays.
- Genes were selected from the non-redundant set of gene assemblies from the four cDNA libraries described in Example 1 , based on their novelty and possible interest as markers.
- An additional 7,000 sequence-verified clones were obtained from Research Genetics (Huntsville AL) and incorporated into an array with a control set of -200 known housekeeping genes. Each clone was grown overnight in 96-well format and DNA purified using the Qiagen 96-well DNA kit. The DNA templates were PCR amplified in 100 ⁇ L reactions. PCR product was then purified using the ArrayltTM PCR Purification Kit (Telechem, Sunnyvale CA) according to manufacturer instructions.
- PreNeu preNeu
- PreHep DMSO treated cells
- S, EB, RA-treated, and D SO-treated cells (10 ⁇ g, 15 ⁇ g, and 20 ⁇ g for sensitivity) was then reverse transcriptase labeled with Cy3 or Cy5 fluorophores, and competitively hybridized to the microarrays overnight at 42°C in 50% formarmide and Sigma hybridization buffer.
- Undifferentiated ES RNA was directly and indirectly compared with RNA from all other cell types. Experiments were repeated at least 5 times each, and dye reversed.
- Stratagene Universal Human Reference RNA Cat. #740000
- Arrays were washed repeatedly and scanned using a GenePixTM 4000A microarray scanner (Axon Instruments, Fremont CA).
- GABA gamma-aminobutyric acid
- RNASEH1 ribonuclease H1
- RASD2 NM_014310 RASD family, member 2 (RASD2) -2.72 -3.13 NMJ312467 tryptase gamma 1 (TPSG1) -2.63 -2.55
- rhodopsin opsin 2, rod pigment
- NM_012407 protein kinase C alpha binding protein -5.44 -2.56 (PRKCABP)
- GA_7286 NM_020119 likely ortholog of rat zinc-finger antiviral 2.5 3.55 1 0 0 0 protein (ZAP)
- TaqmanTM RT-PCR was performed under the following conditions: 1 x RT Master Mix (ABI),
- RNA was isolated by a guanidinium isothiocyanate method (RNAeasyTM kit, Qiagen) according to manufacturer's instructions, and subsequently DNAse treated (DNAfreeTM kit, Ambion). Gene-specific primers and probes were designed
- Probe oligonucleotides were synthesized with the fluorescent indicators 6-carboxyfluorescein (FAM) and 6-carboxy-tetramethylrhodamine (TAMRA) at the 5' and 3' ends, respectively. Relative quantitation of gene expression between multiple samples was achieved by normalization against endogenous18S ribosomal RNA (primer and probe from ABI) using the ⁇ C T method of quantitation (ABI). Fold change in expression level was calculated as 2 " ⁇ CT .
- FAM 6-carboxyfluorescein
- TAMRA 6-carboxy-tetramethylrhodamine
- the table below shows the results of this analysis. Since the cells have been cultured in RA and DMSO for a short period, they are at the early stages of differentiation, and the difference in expression level is less dramatic than it would be after further differentiation. Of particular interest for following or modulating the differentiation process are markers that show modified expression within the first week of differentiation by more than 2-fold (*), 5-fold (* * ), 10-fold (***), or 100-fold (****).
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Developmental Biology & Embryology (AREA)
- Reproductive Health (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- Gynecology & Obstetrics (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Neurology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0520847A GB2415781B (en) | 2003-03-13 | 2004-03-13 | Genes that are up- or down-regulated during differentiation of human embryonic stem cells |
EP04757690A EP1608738A4 (en) | 2003-03-13 | 2004-03-13 | Genes that are up- or down-regulated during differentiation of human embryonic stem cells |
US10/804,822 US20060134636A1 (en) | 2003-03-13 | 2004-03-19 | Standardization of growth conditions for human embryonic stem cells intended for use in regenerative medicine |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/388,578 | 2003-03-13 | ||
US10/388,578 US20030224411A1 (en) | 2003-03-13 | 2003-03-13 | Genes that are up- or down-regulated during differentiation of human embryonic stem cells |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/804,822 Continuation-In-Part US20060134636A1 (en) | 2003-03-13 | 2004-03-19 | Standardization of growth conditions for human embryonic stem cells intended for use in regenerative medicine |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004083406A2 true WO2004083406A2 (en) | 2004-09-30 |
WO2004083406A3 WO2004083406A3 (en) | 2005-03-31 |
Family
ID=29584638
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/008883 WO2004083406A2 (en) | 2003-03-13 | 2004-03-13 | Genes that are up- or down-regulated during differentiation of human embryonic stem cells |
Country Status (5)
Country | Link |
---|---|
US (2) | US20030224411A1 (en) |
EP (1) | EP1608738A4 (en) |
GB (1) | GB2415781B (en) |
SG (1) | SG151119A1 (en) |
WO (1) | WO2004083406A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007102787A1 (en) * | 2006-03-06 | 2007-09-13 | Agency For Science, Technology & Research | Human embryonic stem cell methods and podxl expression |
Families Citing this family (125)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8153424B2 (en) * | 2001-10-03 | 2012-04-10 | Wisconsin Alumni Research Foundation | Method of in vitro differentiation of neural stem cells, motor neurons and dopamine neurons from primate embryonic stem cells |
US7588937B2 (en) * | 2001-10-03 | 2009-09-15 | Wisconsin Alumni Research Foundation | Method of in vitro differentiation of neural stem cells, motor neurons and dopamine neurons from primate embryonic stem cells |
CN100549163C (en) | 2002-12-16 | 2009-10-14 | 技术研究及发展基金有限公司 | The stem cell culture for preparing the method for no feeder cell, no allogenic human embryo stem cell and use this method preparation |
US7153650B2 (en) * | 2003-03-13 | 2006-12-26 | Geron Corporation | Marker system for preparing and characterizing high-quality human embryonic stem cells |
US20030224411A1 (en) * | 2003-03-13 | 2003-12-04 | Stanton Lawrence W. | Genes that are up- or down-regulated during differentiation of human embryonic stem cells |
BR122018071808B8 (en) | 2003-11-06 | 2020-06-30 | Seattle Genetics Inc | conjugate |
US7985585B2 (en) | 2004-07-09 | 2011-07-26 | Viacyte, Inc. | Preprimitive streak and mesendoderm cells |
US8647873B2 (en) * | 2004-04-27 | 2014-02-11 | Viacyte, Inc. | PDX1 expressing endoderm |
US20050266554A1 (en) * | 2004-04-27 | 2005-12-01 | D Amour Kevin A | PDX1 expressing endoderm |
WO2007059007A2 (en) | 2005-11-14 | 2007-05-24 | Cythera, Inc. | Markers of definitive endoderm |
US7625753B2 (en) * | 2003-12-23 | 2009-12-01 | Cythera, Inc. | Expansion of definitive endoderm cells |
AU2004309421B2 (en) | 2003-12-23 | 2011-04-21 | Viacyte, Inc. | Definitive endoderm |
US7541185B2 (en) * | 2003-12-23 | 2009-06-02 | Cythera, Inc. | Methods for identifying factors for differentiating definitive endoderm |
KR101200133B1 (en) | 2004-06-01 | 2012-11-13 | 제넨테크, 인크. | Antibody drug conjugates and methods |
EP2267116B1 (en) | 2004-07-13 | 2017-05-31 | Asterias Biotherapeutics, Inc. | Growth medium for primate embryonic stem cells |
CA2576872C (en) * | 2004-08-13 | 2013-11-12 | University Of Georgia Research Foundation, Inc. | Compositions and methods for self-renewal and differentiation in human embryonic stem cells |
CA2580141C (en) | 2004-09-23 | 2013-12-10 | Genentech, Inc. | Cysteine engineered antibodies and conjugates |
US20100111856A1 (en) | 2004-09-23 | 2010-05-06 | Herman Gill | Zirconium-radiolabeled, cysteine engineered antibody conjugates |
US8080420B2 (en) | 2004-10-22 | 2011-12-20 | University Of Central Florida Research Foundation, Inc. | Methods and products for biasing cellular development |
EP1859055B2 (en) * | 2005-03-04 | 2014-05-28 | Cellartis AB | Use of panel of pairs of primers complementary to reporter genes of cell differentiation |
CN101233226B (en) | 2005-06-22 | 2017-08-11 | 阿斯特利亚斯生物治疗股份公司 | The suspension culture of human embryo stem cell |
US9062289B2 (en) | 2005-06-22 | 2015-06-23 | Asterias Biotherapeutics, Inc. | Differentiation of primate pluripotent stem cells to cardiomyocyte-lineage cells |
AU2006286149B2 (en) | 2005-08-29 | 2012-09-13 | Technion Research And Development Foundation Ltd. | Media for culturing stem cells |
DK2674485T3 (en) * | 2005-10-27 | 2019-08-26 | Viacyte Inc | PDX-1 EXPRESSING DORSAL AND VENTRAL FORTARM ENDODERM |
CA2640185A1 (en) * | 2006-01-24 | 2007-08-02 | Christopher J. Centeno | Mesenchymal stem cell isolation and transplantation method and system to be used in a clinical setting |
JPWO2007088971A1 (en) * | 2006-02-03 | 2009-06-25 | メッセンジャー・スケープ株式会社 | Genes that can be used for cancer prognosis |
US11254916B2 (en) | 2006-03-02 | 2022-02-22 | Viacyte, Inc. | Methods of making and using PDX1-positive pancreatic endoderm cells |
US7695965B2 (en) | 2006-03-02 | 2010-04-13 | Cythera, Inc. | Methods of producing pancreatic hormones |
CA2644468C (en) * | 2006-03-02 | 2022-02-01 | Cythera, Inc. | Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production |
JP5693004B2 (en) * | 2006-07-28 | 2015-04-01 | チルドレンズ メモリアル ホスピタル | Method for suppressing malignancy of tumor cells using microenvironment of human embryonic stem cells |
US8106004B2 (en) * | 2006-07-28 | 2012-01-31 | Children's Memorial Hospital | Methods of inhibiting tumor cell aggressiveness using the microenvironment of human embryonic stem cells |
DK2733203T3 (en) | 2006-08-02 | 2019-02-04 | Technion Res & Dev Foundation | PROCEDURES FOR EXPANSION OF EMBRYONAL STEM CELLS IN A SUSPENSION CULTURE |
JP4998874B2 (en) * | 2006-09-21 | 2012-08-15 | 独立行政法人理化学研究所 | Determination method of inflammatory diseases |
WO2008048647A1 (en) * | 2006-10-17 | 2008-04-24 | Cythera, Inc. | Modulation of the phosphatidylinositol-3-kinase pathway in the differentiation of human embryonic stem cells |
CN101688239A (en) * | 2007-02-12 | 2010-03-31 | 约翰·霍普金斯大学 | The early detection of colorectal carcinoma and prognosis |
US9095562B2 (en) * | 2007-07-05 | 2015-08-04 | Regenerative Sciences, Inc. | Methods and compositions for optimized expansion and implantation of mesenchymal stem cells |
US7695963B2 (en) | 2007-09-24 | 2010-04-13 | Cythera, Inc. | Methods for increasing definitive endoderm production |
CN101945994A (en) | 2007-12-19 | 2011-01-12 | 再生科学有限责任公司 | Compositions and methods to promote implantation and engrafment of stem cells |
CN102026546A (en) | 2008-03-14 | 2011-04-20 | 再生科学有限责任公司 | Compositions and methods for cartilage repair |
EP3293255A1 (en) | 2008-03-27 | 2018-03-14 | Asterias Biotherapeutics, Inc. | Differentiation of primate pluripotent stem cells to hematopoietic lineage cells |
ES2932850T3 (en) | 2008-11-14 | 2023-01-27 | Viacyte Inc | Encapsulation of pancreatic cells derived from human pluripotent stem cells |
JP2012510874A (en) | 2008-12-05 | 2012-05-17 | リジェネレイティブ サイエンシーズ, エルエルシー | Methods and compositions for promoting repair of avascular tissue |
US20100168022A1 (en) * | 2008-12-11 | 2010-07-01 | Centeno Christopher J | Use of In-Vitro Culture to Design or Test Personalized Treatment Regimens |
KR100950195B1 (en) * | 2009-03-20 | 2010-03-29 | 서울대학교산학협력단 | Method for isolation of umbilical cord blood derived-pluripotent stem cell expressing znf281 |
EP2448966B1 (en) | 2009-07-03 | 2018-11-14 | Avipep Pty Ltd | Immuno-conjugates and methods for producing them |
IN2012DN03025A (en) | 2009-09-09 | 2015-07-31 | Ct Se Llc | |
US9113950B2 (en) | 2009-11-04 | 2015-08-25 | Regenerative Sciences, Llc | Therapeutic delivery device |
EP4166652A1 (en) | 2009-11-12 | 2023-04-19 | Technion Research & Development Foundation Ltd. | Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state |
WO2011075786A1 (en) | 2009-12-23 | 2011-06-30 | Avipep Pty Ltd | Immuno-conjugates and methods for producing them 2 |
SG184440A1 (en) | 2010-04-08 | 2012-11-29 | Univ Edinburgh | Chondrogenic progenitor cells, protocol for derivation of cells and uses thereof |
BR112012026213B1 (en) | 2010-04-15 | 2021-12-28 | Medimmune Limited | PYRROLOBENZODIAZEPINE COMPOUNDS, CONJUGATE THEREOF, PHARMACEUTICAL COMPOSITION INCLUDING CONJUGATE AND USE THEREOF FOR TREATMENT OF A PROLIFERATIVE DISEASE |
WO2011130624A2 (en) | 2010-04-16 | 2011-10-20 | Immune Disease Institute, Inc. | Sustained polypeptide expression from synthetic, modified rnas and uses thereof |
CA2799540A1 (en) | 2010-06-08 | 2011-12-15 | Genentech, Inc. | Cysteine engineered antibodies and conjugates |
WO2012037456A1 (en) | 2010-09-17 | 2012-03-22 | President And Fellows Of Harvard College | Functional genomics assay for characterizing pluripotent stem cell utility and safety |
JP5889912B2 (en) | 2010-11-17 | 2016-03-22 | ジェネンテック, インコーポレイテッド | Alaninyl maytansinol antibody conjugate |
WO2012135253A1 (en) | 2011-03-29 | 2012-10-04 | Geron Corporation | Enriched populations of cardiomyocyte lineage cells from pluripotent stem cells |
AU2012245073B2 (en) | 2011-04-21 | 2016-02-11 | Garvan Institute Of Medical Research | Modified variable domain molecules and methods for producing and using them b |
CA2833212C (en) | 2011-05-12 | 2020-06-09 | Genentech, Inc. | Multiple reaction monitoring lc-ms/ms method to detect therapeutic antibodies in animal samples using framework signature peptides |
US20120301889A1 (en) * | 2011-05-20 | 2012-11-29 | City Of Hope | Method and reagents for identifying pluripotent stem cells |
US9133438B2 (en) | 2011-06-29 | 2015-09-15 | Biorestorative Therapies, Inc. | Brown fat cell compositions and methods |
KR101877598B1 (en) | 2011-10-14 | 2018-07-11 | 메디뮨 리미티드 | Pyrrolobenzodiazepines and conjugates thereof |
WO2013106677A1 (en) | 2012-01-13 | 2013-07-18 | The General Hospital Corporation | Isolated human lung progenitor cells and uses thereof |
WO2013130093A1 (en) | 2012-03-02 | 2013-09-06 | Genentech, Inc. | Biomarkers for treatment with anti-tubulin chemotherapeutic compounds |
ES2703151T3 (en) | 2012-10-12 | 2019-03-07 | Adc Therapeutics Sa | Pyrrolobenzodiazepine antibody conjugates |
HUE035694T2 (en) | 2012-10-12 | 2018-05-28 | Adc Therapeutics Sa | Pyrrolobenzodiazepine-anti-cd22 antibody conjugates |
SI2906296T1 (en) | 2012-10-12 | 2018-06-29 | Adc Therapeutics Sa | Pyrrolobenzodiazepine-antibody conjugates |
NZ707486A (en) | 2012-10-12 | 2018-09-28 | Adc Therapeutics Sa | Pyrrolobenzodiazepine - anti-psma antibody conjugates |
PT2839860T (en) | 2012-10-12 | 2019-07-29 | Medimmune Ltd | Pyrrolobenzodiazepines and conjugates thereof |
ES2660029T3 (en) | 2012-10-12 | 2018-03-20 | Medimmune Limited | Antibody-pyrrolobenzodiazepine conjugates |
EP2906250B1 (en) | 2012-10-12 | 2018-05-30 | ADC Therapeutics SA | Pyrrolobenzodiazepine-anti-psma antibody conjugates |
EA031585B1 (en) | 2012-12-21 | 2019-01-31 | Медимьюн Лимитед | Pyrrolobenzodiazepines and conjugates thereof |
CN105246894A (en) | 2012-12-21 | 2016-01-13 | 斯皮罗根有限公司 | Unsymmetrical pyrrolobenzodiazepines-dimers for use in the treatment of proliferative and autoimmune diseases |
JP6444902B2 (en) | 2013-03-13 | 2018-12-26 | メドイミューン・リミテッドMedImmune Limited | Pyrrolobenzodiazepine and its conjugates |
NZ710745A (en) | 2013-03-13 | 2019-03-29 | Genentech Inc | Pyrrolobenzodiazepines and conjugates thereof |
CN105142674B (en) | 2013-03-13 | 2018-11-13 | 麦迪穆有限责任公司 | Pyrrolobenzodiazepines Zhuo and its conjugate |
ES2957410T3 (en) | 2013-04-19 | 2024-01-18 | Biorestorative Therapies Inc | Stem cells derived from human brown adipose tissue and their uses |
CN106414718A (en) | 2013-06-11 | 2017-02-15 | 哈佛学院校长同事会 | Improved production of recombinant von willebrand factor in a bioreactor |
AU2014307080B2 (en) | 2013-08-12 | 2018-06-07 | Genentech, Inc. | 1-(chloromethyl)-2,3-dihydro-1H-benzo(E)indole dimer antibody-drug conjugate compounds, and methods of use and treatment |
WO2015052535A1 (en) | 2013-10-11 | 2015-04-16 | Spirogen Sàrl | Pyrrolobenzodiazepine-antibody conjugates |
GB201317982D0 (en) | 2013-10-11 | 2013-11-27 | Spirogen Sarl | Pyrrolobenzodiazepines and conjugates thereof |
EP3054983B1 (en) | 2013-10-11 | 2019-03-20 | Medimmune Limited | Pyrrolobenzodiazepine-antibody conjugates |
EP3054985B1 (en) | 2013-10-11 | 2018-12-26 | Medimmune Limited | Pyrrolobenzodiazepine-antibody conjugates |
CA2928952A1 (en) | 2013-12-16 | 2015-06-25 | Genentech, Inc. | Peptidomimetic compounds and antibody-drug conjugates thereof |
JP6895254B2 (en) | 2013-12-16 | 2021-06-30 | ジェネンテック, インコーポレイテッド | Peptidomimetic compounds and their antibodies-drug conjugates |
CA2929565A1 (en) | 2013-12-16 | 2015-06-25 | Genentech, Inc. | 1-(chloromethyl)-2,3-dihydro-1h-benzo[e]indole dimer antibody-drug conjugate compounds, and methods of use and treatment |
US10188746B2 (en) | 2014-09-10 | 2019-01-29 | Medimmune Limited | Pyrrolobenzodiazepines and conjugates thereof |
GB201416112D0 (en) | 2014-09-12 | 2014-10-29 | Medimmune Ltd | Pyrrolobenzodiazepines and conjugates thereof |
EP3191134B1 (en) | 2014-09-12 | 2019-11-20 | Genentech, Inc. | Anthracycline disulfide intermediates, antibody-drug conjugates and methods |
US10077318B2 (en) | 2014-09-12 | 2018-09-18 | Genentech, Inc. | Cysteine engineered antibodies and conjugates |
MA40575A (en) | 2014-09-17 | 2016-03-24 | Genentech Inc | Pyrrolobenzodiazepines and antibody disulfide conjugates thereof |
AU2015352545B2 (en) | 2014-11-25 | 2020-10-15 | Adc Therapeutics Sa | Pyrrolobenzodiazepine-antibody conjugates |
WO2016090050A1 (en) | 2014-12-03 | 2016-06-09 | Genentech, Inc. | Quaternary amine compounds and antibody-drug conjugates thereof |
GB201506402D0 (en) | 2015-04-15 | 2015-05-27 | Berkel Patricius H C Van And Howard Philip W | Site-specific antibody-drug conjugates |
GB201506411D0 (en) | 2015-04-15 | 2015-05-27 | Bergenbio As | Humanized anti-axl antibodies |
MA43345A (en) | 2015-10-02 | 2018-08-08 | Hoffmann La Roche | PYRROLOBENZODIAZEPINE ANTIBODY-DRUG CONJUGATES AND METHODS OF USE |
MA43354A (en) | 2015-10-16 | 2018-08-22 | Genentech Inc | CONJUGATE DRUG CONJUGATES WITH CLOUDY DISULPHIDE |
MA45326A (en) | 2015-10-20 | 2018-08-29 | Genentech Inc | CALICHEAMICIN-ANTIBODY-DRUG CONJUGATES AND METHODS OF USE |
GB201601431D0 (en) | 2016-01-26 | 2016-03-09 | Medimmune Ltd | Pyrrolobenzodiazepines |
GB201602356D0 (en) | 2016-02-10 | 2016-03-23 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates |
GB201602359D0 (en) | 2016-02-10 | 2016-03-23 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates |
JP6943872B2 (en) | 2016-03-25 | 2021-10-06 | ジェネンテック, インコーポレイテッド | Multiple whole antibody and antibody complex drug quantification assay |
GB201607478D0 (en) | 2016-04-29 | 2016-06-15 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates |
JP2019522633A (en) | 2016-05-20 | 2019-08-15 | ジェネンテック, インコーポレイテッド | PROTAC antibody conjugates and methods of use |
US20170370906A1 (en) | 2016-05-27 | 2017-12-28 | Genentech, Inc. | Bioanalytical analysis of site-specific antibody drug conjugates |
EP3464280B1 (en) | 2016-06-06 | 2021-10-06 | F. Hoffmann-La Roche AG | Silvestrol antibody-drug conjugates and methods of use |
EP3496763A1 (en) | 2016-08-11 | 2019-06-19 | Genentech, Inc. | Pyrrolobenzodiazepine prodrugs and antibody conjugates thereof |
EP3522933B1 (en) | 2016-10-05 | 2021-12-15 | F. Hoffmann-La Roche AG | Methods for preparing antibody drug conjugates |
GB201617466D0 (en) | 2016-10-14 | 2016-11-30 | Medimmune Ltd | Pyrrolobenzodiazepine conjugates |
RS61795B1 (en) | 2017-02-08 | 2021-06-30 | Adc Therapeutics Sa | Pyrrolobenzodiazepine-antibody conjugates |
GB201702031D0 (en) | 2017-02-08 | 2017-03-22 | Medlmmune Ltd | Pyrrolobenzodiazepine-antibody conjugates |
WO2018192944A1 (en) | 2017-04-18 | 2018-10-25 | Medimmune Limited | Pyrrolobenzodiazepine conjugates |
EP3612234B1 (en) | 2017-04-20 | 2024-03-13 | ADC Therapeutics SA | Combination therapy with an anti-axl antibody-drug conjugate |
MX2019015042A (en) | 2017-06-14 | 2020-08-06 | Adc Therapeutics Sa | Dosage regimes for the administration of an anti-cd19 adc. |
AU2018316532B2 (en) | 2017-08-18 | 2022-11-24 | Medimmune Limited | Pyrrolobenzodiazepine conjugates |
IL273387B2 (en) | 2017-09-20 | 2023-10-01 | Ph Pharma Co Ltd | Thailanstatin analogs |
GB201803342D0 (en) | 2018-03-01 | 2018-04-18 | Medimmune Ltd | Methods |
GB201806022D0 (en) | 2018-04-12 | 2018-05-30 | Medimmune Ltd | Pyrrolobenzodiazepines and conjugates thereof |
GB201814281D0 (en) | 2018-09-03 | 2018-10-17 | Femtogenix Ltd | Cytotoxic agents |
JP2022505450A (en) | 2018-10-24 | 2022-01-14 | エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト | Conjugated chemical decomposition inducers and usage |
WO2020123275A1 (en) | 2018-12-10 | 2020-06-18 | Genentech, Inc. | Photocrosslinking peptides for site specific conjugation to fc-containing proteins |
GB201901197D0 (en) | 2019-01-29 | 2019-03-20 | Femtogenix Ltd | G-A Crosslinking cytotoxic agents |
AU2020267598A1 (en) * | 2019-05-08 | 2021-12-16 | Auxolytic Ltd | Auxotrophic selection methods |
EP3972614A4 (en) | 2019-05-21 | 2023-08-23 | President and Fellows of Harvard College | Endocrine differentiation-inducing molecule |
GB2597532A (en) | 2020-07-28 | 2022-02-02 | Femtogenix Ltd | Cytotoxic compounds |
AU2022258097A1 (en) | 2021-04-11 | 2023-11-02 | President And Fellows Of Harvard College | Cardiomyocytes and compositions and methods for producing the same |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5256643A (en) * | 1990-05-29 | 1993-10-26 | The Government Of The United States | Human cripto protein |
US5264557A (en) * | 1991-08-23 | 1993-11-23 | The United States Of America As Represented By The Department Of Health And Human Services | Polypeptide of a human cripto-related gene, CR-3 |
US5843780A (en) * | 1995-01-20 | 1998-12-01 | Wisconsin Alumni Research Foundation | Primate embryonic stem cells |
US5856136A (en) * | 1996-07-03 | 1999-01-05 | Incyte Pharmaceuticals, Inc. | Human stem cell antigens |
US6090622A (en) * | 1997-03-31 | 2000-07-18 | The Johns Hopkins School Of Medicine | Human embryonic pluripotent germ cells |
US6667176B1 (en) * | 2000-01-11 | 2003-12-23 | Geron Corporation | cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells |
AU8617301A (en) * | 2000-08-01 | 2002-02-13 | Yissum Res Dev Co | Directed differentiation of embryonic cells |
GB2392674B (en) * | 2001-07-06 | 2005-08-10 | Geron Corp | Mesenchymal cells and osteoblasts from human embryonic stem cell |
US20050095708A1 (en) * | 2001-11-09 | 2005-05-05 | Pera Martin F. | Characterization and isolation of subsets of human embryonic stem cells (HES) and cells associated or derived therefrom |
US20030224411A1 (en) * | 2003-03-13 | 2003-12-04 | Stanton Lawrence W. | Genes that are up- or down-regulated during differentiation of human embryonic stem cells |
US7153650B2 (en) * | 2003-03-13 | 2006-12-26 | Geron Corporation | Marker system for preparing and characterizing high-quality human embryonic stem cells |
-
2003
- 2003-03-13 US US10/388,578 patent/US20030224411A1/en not_active Abandoned
-
2004
- 2004-03-13 WO PCT/US2004/008883 patent/WO2004083406A2/en active Application Filing
- 2004-03-13 SG SG200708419-7A patent/SG151119A1/en unknown
- 2004-03-13 EP EP04757690A patent/EP1608738A4/en not_active Withdrawn
- 2004-03-13 GB GB0520847A patent/GB2415781B/en not_active Expired - Fee Related
-
2009
- 2009-06-19 US US12/487,869 patent/US20090263835A1/en not_active Abandoned
Non-Patent Citations (1)
Title |
---|
See references of EP1608738A4 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007102787A1 (en) * | 2006-03-06 | 2007-09-13 | Agency For Science, Technology & Research | Human embryonic stem cell methods and podxl expression |
JP2009528838A (en) * | 2006-03-06 | 2009-08-13 | エージェンシー フォー サイエンス,テクノロジー アンド リサーチ | Method of human embryonic stem cells and expression of PODXL |
US8173374B2 (en) | 2006-03-06 | 2012-05-08 | Agency For Science, Technology And Research | Human embryonic stem cell methods and PODXL expression |
CN101454441B (en) * | 2006-03-06 | 2013-06-26 | 新加坡科技研究局 | Human embryonic stem cell methods and podxl expression |
US8710190B2 (en) | 2006-03-06 | 2014-04-29 | Agency For Science, Technology And Research | Human embryonic stem cell methods and PODXL expression |
Also Published As
Publication number | Publication date |
---|---|
WO2004083406A3 (en) | 2005-03-31 |
SG151119A1 (en) | 2009-04-30 |
EP1608738A2 (en) | 2005-12-28 |
US20030224411A1 (en) | 2003-12-04 |
GB2415781A (en) | 2006-01-04 |
GB0520847D0 (en) | 2005-11-23 |
EP1608738A4 (en) | 2007-02-07 |
GB2415781B (en) | 2007-07-18 |
US20090263835A1 (en) | 2009-10-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20090263835A1 (en) | Genes that are Up- or Down-Regulated During Differentiation of Human Embryonic Stem Cells | |
US7153650B2 (en) | Marker system for preparing and characterizing high-quality human embryonic stem cells | |
Zeng et al. | Properties of pluripotent human embryonic stem cells BG01 and BG02 | |
Palmqvist et al. | Correlation of murine embryonic stem cell gene expression profiles with functional measures of pluripotency | |
US10191050B2 (en) | Rationale, methods, and assays for identifying human and non-human primate taste specific genes and use thereof in taste modulator and therapeutic screening assays | |
Holm et al. | Loss-and gain-of-function analyses reveal targets of Pax6 in the developing mouse telencephalon | |
CN101273144B (en) | Method of diagnosing esophageal cancer | |
US20030027208A1 (en) | Progesterone receptor-regulated gene expression and methods related thereto | |
US20130296183A1 (en) | Functional genomics assay for characterizing pluripotent stem cell utility and safety | |
WO2003060470A2 (en) | Breast cancer expression profiling | |
US20060240441A1 (en) | Gene expression profiles and methods of use | |
KR101618950B1 (en) | Composition for screening skin irritant and method for screening skin irritant using the same | |
WO2006036943A2 (en) | Determination of molecular age by detection of ink4a/arf expression | |
US10106855B2 (en) | Genetic assay to determine prognosis in Polycythemia Vera patients | |
CA2692803A1 (en) | Compositions, methods and kits for the diagnosis of carriers of mutations in the brca1 and brca2 genes and early diagnosis of cancerous disorders associated with mutations in brca1 and brca2 genes | |
Andersen et al. | Ribosomal protein mRNAs are primary targets of regulation in RNase-L-induced senescence | |
AU2005316291A1 (en) | Methods for assessing patients with acute myeloid leukemia | |
Gupta et al. | Global gene profiling reveals novel glucocorticoid induced changes in gene expression of human lens epithelial cells | |
US20060134636A1 (en) | Standardization of growth conditions for human embryonic stem cells intended for use in regenerative medicine | |
Mandal et al. | S100A7 (psoriasin) influences immune response genes in human breast cancer | |
JP2010011843A (en) | Method for predicting developmental toxicity possessed by chemical substance | |
Weimer et al. | Genome‐wide expression analysis and EMX2 gene expression in embryonic myoblasts committed to diverse skeletal muscle fiber type fates | |
Gunji et al. | Global analysis of the expression patterns of transcriptional regulatory factors in formation of embryoid bodies using sensitive oligonucleotide microarray systems | |
GB2434867A (en) | Genes that are up- or down-regulated during differentiation of human embryonic stem cells | |
US20200347452A1 (en) | Method for evaluating state of undifferentiated cell and utilization thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 10804822 Country of ref document: US |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DPEN | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2004757690 Country of ref document: EP Ref document number: 0520847.5 Country of ref document: GB Ref document number: 0520847 Country of ref document: GB |
|
WWP | Wipo information: published in national office |
Ref document number: 2004757690 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 10804822 Country of ref document: US |